Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027475	li-eryt	e6/l (e6/l)	7322	10742	0.17%
3027475	li-eryt	— (—)	1968	2741	100.00%	Distribution not available
3027475	li-eryt-3	e6/l (e6/l)	225	241	0.00%
3027475	li-eryt-1	— (—)	208	221	100.00%	Distribution not available
3027475	li-erytrosyytit,likvor	e6/l (e6/l)	54	58	0.00%
3027475	li-eryt-1	e6/l (e6/l)	27	27	0.00%	Distribution not available
3027475	li-erytrosyytit	e6/l (e6/l)	18	18	0.00%
3027475	li-eryt-3	— (—)	10	11	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Unspecific neurodegenerative disorder

996

1661

4.26

323.01

1.3

1.4

419.70

2746.28

e6/l

1.11

796

1376

Disorders of optic nerve and visual pathways

490

746

7.33

312.58

1.5

1.7

459.00

1455.02

e6/l

1.33

394

599

Focal epilepsy

748

1663

4.77

312.32

1.7

1650.53

3153.49

e6/l

0.29

628

1328

Implicit Sepsis

2077

4651

3.49

307.65

1.5

1.4

2911.94

2073.22

e6/l

0.18

1685

3777

Inflammatory diseases of the central nervous system

638

615

12.44

307.65

1.9

1.4

753.86

1384.02

e6/l

0.57

509

499

Any mental disorder

2423

4698

2.64

307.65

1.5

2460.84

2219.52

e6/l

0.06

1967

3829

MS-disease / Multiple Sclerosis

570

536

12.77

307.65

1.2

1.5

520.65

1639.92

e6/l

1.02

457

433

Neurological diseases

2478

1737

7.43

307.65

1.6

1158.12

3537.59

e6/l

0.56

2025

1374

Migraine

1362

3223

3.54

307.65

1.4

1.5

1278.89

2157.02

e6/l

0.31

1124

2578

Other degenerative diseases of the nervous system

1544

490

26.04

307.65

1.2

426.61

563.05

e6/l

0.20

1217

392

Episodal and paroxysmal disorders

2552

4800

2.77

307.65

1.5

1449.08

2281.63

e6/l

0.41

2109

3841

Cerebrovascular diseases

1862

4063

3.33

307.65

1.8

1.4

7538.33

740.45

e6/l

2.29

1507

3328

Other demyelinating diseases of the central nervous system

354

272

16.66

307.65

1.2

1.6

617.93

1885.48

e6/l

0.58

278

224

Neurological diseases, wide definition

986

393

13.13

307.65

1.8

1.5

4850.70

787.20

e6/l

0.56

804

296

Degenerative diseases of the nervous system

928

1454

4.90

307.65

1.3

1.5

351.56

1094.46

e6/l

3.41

721

1211

Fever of other and unknown origin

1347

3100

3.99

307.65

1.9

1.4

614.53

2660.89

e6/l

1.03

1146

2495

STROKE

1516

3141

3.40

307.65

1.8

1.4

7350.73

714.88

e6/l

1.97

1229

2512

Hydrocephalus

906

394

31.95

307.65

2.4

1.5

2045.19

934.00

e6/l

0.80

781

311

Concussion

1052

1226

7.20

307.65

1.5

516.75

580.05

e6/l

0.13

862

983

Normal-pressure hydrocephalus

618

236

39.04

307.65

1.9

1.3

1487.15

950.05

e6/l

0.21

546

186

Implicit viral Sepsis

834

1951

4.47

307.65

1.6

1.4

1256.58

2321.90

e6/l

0.41

682

1607

Viral infections of the central nervous system

465

556

9.68

307.65

1.5

486.11

1533.88

e6/l

1.06

388

449

Alzheimer’s disease (Early onset), excluding more controls

224

65.84

307.65

1.2

124.42

47.68

e6/l

1.25

179

Convulsions, not elsewhere classified

803

1302

6.42

307.65

1.8

1.4

716.23

4105.55

e6/l

0.63

647

1039

Dizziness and giddiness

1678

4333

3.15

307.65

1.4

1.5

989.20

2041.62

e6/l

1.06

1396

3582

Other symptoms and signs involving cognitive functions and awareness

2039

2440

8.21

307.65

1.3

1.5

2982.83

2294.68

e6/l

0.13

1587

2029

Dementia, including avohilmo

1209

1875

4.63

307.65

1.3

1.5

453.80

2486.17

e6/l

1.08

968

1542

Organic, including symptomatic, mental disorders

1615

2220

5.46

307.65

1.3

1.4

678.58

2396.95

e6/l

1.04

1294

1814

Other headache syndromes

1139

3086

3.82

307.65

1.4

2150.90

2377.83

e6/l

0.06

926

2459

Disturbances of skin sensation

986

2408

4.33

307.65

1.3

1.4

1462.85

2712.53

e6/l

0.34

786

1967

Headache

2629

3455

6.42

307.65

1.5

1.4

1851.24

2574.00

e6/l

0.22

2196

2753

Malaise and fatigue

1363

2497

4.55

307.65

1.5

1.4

3045.12

2954.59

e6/l

0.01

1100

2023

General symptoms and signs

2941

3802

3.99

307.65

1.5

1.4

1454.35

2449.53

e6/l

0.46

2423

3037

Implicit Sepsis

2399

4858

3.74

307.65

1.4

1.5

2694.22

2002.70

e6/l

0.17

1907

3972

Viral infections of the central nervous system

481

595

9.29

307.65

1.5

481.07

1477.77

e6/l

1.08

400

480

Symptoms and signs involving the nervous and musculoskeletal systems

2243

4633

5.13

307.65

1.5

1660.72

2544.94

e6/l

0.32

1933

3703

Cerebrovascular diseases (FINNGEN)

1180

1715

5.14

307.65

1.9

1.3

8318.64

672.69

e6/l

1.66

947

1376

Alzheimer’s disease (Late onset), excluding more controls

401

123

22.51

307.65

1.3

1.2

355.66

576.52

e6/l

0.24

308

103

Any dementia, excluding more controls

975

1271

5.53

307.65

1.3

1.4

381.66

3310.83

e6/l

1.05

780

1047

Other neurological diseases

2604

4216

5.12

307.65

1.7

1.4

1835.80

2651.40

e6/l

0.34

2176

3400

Other mental disorders due to brain damage and dysfunction and to physical disease

449

587

8.32

307.65

1.3

1.5

837.95

1085.35

e6/l

0.24

365

485

Postprocedural disorders of nervous system

541

485

13.23

307.65

1.3

1.2

2027.63

9540.77

e6/l

0.48

455

389

Intracranial trauma

1271

1249

7.37

307.65

1.6

1.5

2293.29

573.98

e6/l

0.50

1028

999

Encephalitis

324

196

22.61

307.65

1.8

1.5

691.16

730.06

e6/l

0.02

251

156

Any dementia

994

1566

4.60

307.65

1.3

1.4

375.99

2423.48

e6/l

0.88

797

1296

Visual disturbances

1329

4220

3.27

307.65

1.5

1330.94

2592.35

e6/l

0.58

1081

3444

Other symptoms and signs involving the nervous and musculoskeletal systems

1608

3233

5.29

307.65

1.4

1.5

689.33

2660.97

e6/l

1.01

1427

2584

Abnormalities of gait and mobility

496

692

7.84

307.65

1.6

5409.07

1007.98

e6/l

0.51

403

544

Mood disorders, excluding more controls

2119

4577

2.83

307.65

1.4

1.5

2761.57

2231.22

e6/l

0.11

1715

3743

Epilepsy

1054

2114

5.24

307.65

1.8

1.7

1375.73

3757.99

e6/l

0.60

880

1674

Dementia

1127

1635

4.95

307.65

1.3

1.4

490.53

2695.38

e6/l

0.99

906

1345

Other encephalitis

311

183

23.51

307.65

1.8

1.5

723.91

769.30

e6/l

0.02

239

148

Symptoms and signs involving cognition, perception, emotional state and behaviour

3222

5240

4.37

307.65

1.4

1.5

2254.64

2003.04

e6/l

0.07

2587

4288

Demyelinating diseases of the central nervous system

687

662

12.48

307.65

1.2

1.4

487.59

6959.65

e6/l

0.60

554

529

Condition for Implicit Sepsis (Organ dysfunction codes)

2557

4847

3.86

307.65

1.4

1.5

2517.64

2004.33

e6/l

0.13

2021

3987

Visual disturbances and blindness

1389

4529

3.17

307.65

1.5

1279.89

2563.56

e6/l

0.65

1127

3701

Alzheimer disease, excluding more controls

665

160

29.48

307.65

1.3

1.2

290.21

476.63

e6/l

0.26

519

130

Condition for Implicit Sepsis (Organ dysfunction codes)

2670

5013

3.81

307.65

1.4

1.5

2443.75

1980.31

e6/l

0.12

2107

4104

Stroke, including SAH

1441

3444

3.13

307.56

1.9

1.4

7669.07

1363.58

e6/l

1.64

1177

2805

Focal epilepsy, strict definition

701

1530

4.87

299.72

1.7

1671.19

3416.04

e6/l

0.32

589

1218

Abnormal findings on diagnostic imaging of central nervous system

339

354

11.37

299.00

1.4

1.8

316.45

1479.10

e6/l

0.83

262

293

Anxiety disorders, excluding more controls

1797

4348

2.75

298.73

1.5

3483.51

2271.46

e6/l

0.24

1428

3542

Polyneuropathies and other disorders of the peripheral nervous system

704

1549

4.82

297.92

1.8

1.4

3661.04

1231.07

e6/l

0.37

576

1253

Psychiatric diseases

2068

4008

2.63

293.28

1.5

2527.12

2407.78

e6/l

0.02

1675

3271

Cerebral cysts

334

355

10.74

288.83

1.6

1.4

275.12

1869.49

e6/l

1.09

289

286

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

707

609

5.95

287.04

1.6

6029.43

1787.27

e6/l

0.38

568

473

Delirium, not induced by alcohol and other psychoactive substances

400

534

8.01

283.86

1.4

1028.91

902.34

e6/l

0.08

316

440

Focal epilepsy, mode (most common among epilepsy diagnosis)

661

1455

4.83

279.69

1.7

1827.31

3463.32

e6/l

0.28

555

1165

Alzheimer disease, including avohilmo

831

1424

4.26

273.45

1.3

1.4

328.12

2521.68

e6/l

0.86

657

1192

Implicit bacterial Sepsis

1021

2618

3.47

270.95

1.6

1.4

1235.86

2249.08

e6/l

0.53

839

2176

N06DA Anticholinesterases

788

1508

4.28

270.84

1.3

1.4

454.64

2447.40

e6/l

0.81

620

1261

Use of anticholinesterases

788

1508

4.28

270.84

1.3

1.4

454.64

2447.40

e6/l

0.81

620

1261

Mood [affective] disorders

2283

6501

2.32

268.43

1.4

1.5

2610.85

1880.83

e6/l

0.18

1842

5299

Mood disorders

2285

6508

2.32

267.42

1.4

1.5

2607.90

1878.66

e6/l

0.18

1844

5306

Other and unspecified hydrocephalus

205

114

25.04

266.33

3.0

1.4

1251.42

1203.84

e6/l

0.01

178

Meningitis

319

360

10.35

264.80

2.0

1.5

786.78

756.42

e6/l

0.02

259

294

Depression

2152

6322

2.35

263.99

1.4

1.5

2721.94

1906.54

e6/l

0.19

1734

5145

Alzheimer’s disease, strict definition

605

1018

5.10

260.12

1.2

1.4

284.53

1312.06

e6/l

3.66

465

850

Traumatic subdural haemorrhage

269

221

12.15

259.58

1.7

1.2

9199.69

168.72

e6/l

0.56

212

182

Viral Sepsis

604

1323

4.80

256.35

1.7

1.4

1275.65

1225.48

e6/l

0.02

510

1083

Other antidepressants

2161

4723

2.39

253.45

1.4

2930.51

1618.85

e6/l

0.33

1748

3835

Implicit viral Sepsis

600

1322

4.77

252.80

1.7

1.4

1279.01

1226.60

e6/l

0.02

506

1082

Pain, not elsewhere classified

663

1574

4.36

252.59

1.5

1.4

758.44

3693.55

e6/l

0.68

568

1276

Benign intracranial hypertension

161

45.86

251.23

1.4

1.3

175.94

29.31

e6/l

1.41

141

Infections, IBD-co-morbidities

317

203

11.51

250.67

1.9

1.4

526.58

271.01

e6/l

0.56

265

153

Alzheimer disease

718

1242

4.39

248.48

1.3

1.4

279.34

1182.55

e6/l

4.03

562

1041

Implicit bacterial Sepsis

914

2422

3.45

241.73

1.7

1.4

740.73

2307.37

e6/l

1.03

760

2006

Viral encephalitis, not elsewhere classified/unspecified

195

123

20.92

237.05

1.8

1.5

560.91

1008.66

e6/l

0.21

171

100

Aneurysms, operations, SAH

513

1051

5.17

236.50

2.5

1.3

12549.36

696.24

e6/l

5.04

434

864

Depression or dysthymia

1321

2529

2.94

236.07

1.4

1.5

1037.82

2060.60

e6/l

0.59

1081

2042

Bacterial Sepsis

1008

2779

3.19

233.25

1.7

1.4

798.76

2150.49

e6/l

1.00

840

2294

Communicating hydrocephalus

197

131

19.59

232.73

3.8

1.7

2275.85

1022.92

e6/l

0.50

155

Other and unspecified polyneuropathies, also in other diseases

575

1315

4.62

231.76

1.4

4367.66

1219.58

e6/l

0.40

474

1066

Nontraumatic intracranial haemmorrhage

531

1151

4.82

227.83

2.8

1.4

19546.02

921.06

e6/l

2.02

442

948

Syncope and collapse

882

2296

3.37

224.35

1.6

1.4

853.16

2943.74

e6/l

0.68

732

1874

Alzheimer’s disease (Early onset)

224

196

12.72

220.54

1.2

1.3

124.42

1070.46

e6/l

0.87

179

164

Stroke, excluding SAH

1233

3301

2.80

218.04

1.8

1.4

5137.91

1770.15

e6/l

0.56

1001

2694

Care involving use of rehabilitation procedures

1447

5519

2.47

210.57

1.6

1.5

1391.70

2444.39

e6/l

0.59

1231

4437

Anxiety disorders

1943

6266

2.20

205.77

1.5

3260.85

1750.25

e6/l

0.35

1548

5093

Neurotic, stress-related and somatoform disorders

1925

6239

2.20

203.57

1.5

3160.65

1781.57

e6/l

0.31

1535

5069

Parkinson's disease, excluding more controls

212

173

11.90

200.77

1.4

1.3

258.55

575.20

e6/l

0.54

186

142

Migraine without aura

565

1432

4.11

197.85

1.4

1.6

827.76

3616.96

e6/l

0.53

462

1134

Migraine with aura

631

1750

3.74

193.85

1.3

1.4

1481.18

3043.93

e6/l

0.30

523

1402

Other soft tissue disorders, not elsewhere classified

1964

5411

2.16

191.54

1.5

1368.90

2348.79

e6/l

0.55

1619

4370

Symptoms and signs involving the skin and subcutaneous tissue

1515

6591

2.30

190.34

1.5

1140.52

2346.79

e6/l

0.86

1222

5369

Optic neuritis

246

309

9.13

187.12

1.3

1.5

334.46

1907.15

e6/l

0.93

194

258

Diplopia

429

923

4.94

187.03

1.5

2235.37

5078.03

e6/l

0.30

353

755

Anxiety (asthma-related co-morbidities)

1347

4348

2.45

186.14

1.4

1.5

3974.20

1693.07

e6/l

0.37

1057

3561

Subarachnoid haemorrhage

345

616

5.98

185.93

3.0

1.4

18158.49

534.84

e6/l

5.19

295

505

Autoimmune diseases excluding thyroid diseases

2146

5724

2.08

185.64

1.4

1.6

1594.10

2342.54

e6/l

0.37

1745

4616

Other meningitis

159

113

18.61

181.50

2.1

1.2

1327.04

1088.65

e6/l

0.08

130

Dorsalgia

1988

5087

2.13

181.47

1.4

1.5

2967.11

1888.50

e6/l

0.25

1679

4051

Obstructive hydrocephalus

143

22.26

179.78

2.5

2.0

1041.39

238.37

e6/l

1.82

119

Recurrent or chronic depression

828

1893

3.15

178.75

1.4

1.5

1058.75

1389.88

e6/l

0.42

665

1527

General examination and investigation of persons without complaint and reported diagnosis

1307

2716

2.56

178.07

1.5

1.4

4201.49

965.54

e6/l

0.65

1142

2123

Autoimmune diseases excluding thyroid diseases, strict definition

2067

5549

2.07

177.64

1.4

1.6

1623.12

2357.93

e6/l

0.34

1682

4479

Bacterial infection, other or unspecified

1106

3791

2.59

176.46

2.0

1.4

999.61

2947.49

e6/l

1.04

924

3087

Parkinson's disease, strict definition, excluding more controls

188

160

11.52

175.50

1.5

1.3

282.01

605.76

e6/l

0.50

166

131

Persons encountering health services for specific procedures and health care

2178

6641

2.00

173.42

1.6

1.5

1679.41

2216.89

e6/l

0.32

1799

5344

Pain in limb

1683

5250

2.18

173.28

1.6

1.5

1279.75

2365.39

e6/l

0.65

1384

4240

Disorders of thyroid, IBD co-morbidities

277

246

8.09

172.57

1.5

1.4

1133.82

222.40

e6/l

0.86

225

192

Autoimmune diseases related-to ILD

1743

7239

2.10

170.52

1.3

1.5

992.46

2306.61

e6/l

1.14

1428

5885

Bacterial infection, other or unspecified

1172

4107

2.47

167.85

2.0

1.4

985.00

2834.16

e6/l

1.08

982

3340

Viral meningitis

215

265

9.33

166.24

1.4

1.5

242.18

1017.83

e6/l

0.63

187

213

ILD medications: immunosuppressive drugs

1368

5706

2.27

166.21

2.0

1.4

1110.87

2635.99

e6/l

0.99

1120

4599

Low back pain

1499

4907

2.23

165.76

1.4

1.5

3705.65

1926.72

e6/l

0.33

1252

3908

Sequelae of cerebrovascular disease

702

1944

3.20

164.39

2.0

1.4

5414.84

933.47

e6/l

2.82

586

1607

Motor neuron disease (with DMD)

51.29

163.35

1.2

1.8

586.97

1018.33

e6/l

0.15

Ischaemic Stroke, excluding all haemorrhages

1059

3109

2.59

163.29

1.6

1.4

1846.49

1971.23

e6/l

0.05

867

2543

Other dorsopathies, not elsewhere classified

1968

5101

2.05

162.51

1.4

1.5

3206.57

1885.46

e6/l

0.31

1656

4064

Cerebral palsy and other paralytic syndromes

384

849

4.81

162.06

1.6

527.37

1162.35

e6/l

0.84

290

690

Malignant neoplasm of brain, including Hilmo

245

360

7.58

161.74

2.0

1.4

2541.96

1494.59

e6/l

0.48

198

304

All anxiety disorders

1366

4844

2.27

160.80

1.4

1.5

3919.83

1597.89

e6/l

0.39

1074

3951

Anaemias

516

842

4.11

159.40

1.9

1.3

1519.05

764.99

e6/l

0.39

410

687

Status epilepticus

183

193

10.65

158.82

1.9

1045.38

577.30

e6/l

0.33

163

151

Other disorders of optic [2nd] nerve and visual pathways

281

487

6.35

157.61

1.6

1.8

516.39

1700.05

e6/l

1.03

228

395

Lower back pain or/and sciatica

2052

6962

1.95

156.90

1.4

2974.42

1740.56

e6/l

0.31

1726

5612

Medical observation and evaluation for suspected diseases and conditions

1273

2717

2.44

156.54

1.6

1.4

4031.48

968.67

e6/l

0.57

1083

2124

Papilloedema, unspecified

170

169

12.21

155.96

1.6

1.4

290.11

747.17

e6/l

0.32

142

138

Use of donepezil

425

986

4.28

155.96

1.3

1.4

504.33

1102.95

e6/l

0.96

343

824

ILD medications

2217

6334

1.92

155.34

1.8

1.4

1081.05

2465.27

e6/l

1.10

1822

5106

Nerve, nerve root and plexus disorders

2037

6487

1.95

153.11

1.4

1.5

2145.25

2085.90

e6/l

0.02

1707

5238

Depression medications

656

942

3.58

153.04

1.4

1.2

7190.98

596.65

e6/l

0.60

517

773

Certain infectious and parasitic diseases

1864

4621

2.05

152.23

1.6

1.4

2915.47

2236.98

e6/l

0.13

1518

3715

Alzheimer’s disease (Atypical or mixed), excluding more controls

143

17.31

149.19

1.4

1.2

363.28

162.29

e6/l

0.50

127

Subjective visual disturbances

616

2007

3.18

146.80

1.4

1.5

1560.13

3006.35

e6/l

0.31

494

1631

Other anxiety disorders

1042

3795

2.43

145.79

1.5

1.4

4616.21

1355.40

e6/l

0.43

827

3087

Malignant neoplasm of brain

191

240

9.08

145.18

2.0

1.3

2948.14

1668.25

e6/l

0.44

153

201

Dementia in Alzheimer disease

326

553

5.13

143.97

1.3

1.4

287.22

877.93

e6/l

1.47

290

469

Pain (limb, back, neck, head abdominally)

1314

2897

2.30

142.96

1.7

1.5

3852.02

1395.02

e6/l

0.42

1073

2304

Other bacterial diseases

1782

6191

1.96

139.34

1.9

1.4

1280.03

2436.10

e6/l

0.81

1479

4999

Selective serotonin reuptake inhibitors

1799

4763

2.00

139.18

1.4

1.5

1750.39

1607.89

e6/l

0.07

1477

3862

Used for control exclusion in common control thyroid runs

2003

5315

1.93

139.12

1.4

1.6

1399.59

2420.01

e6/l

0.58

1631

4281

Alzheimer’s disease (Late onset)

421

913

3.99

136.38

1.3

1.4

351.71

1266.57

e6/l

2.57

322

767

Intracranial injury

1172

5074

2.23

136.34

1.6

1.5

2443.97

1375.00

e6/l

0.25

936

4146

Abnormal involuntary movements

357

861

4.35

134.28

1.6

1.5

525.48

1374.76

e6/l

1.25

283

688

Malignant neoplasm of eye, brain and central nervous system

206

311

7.37

132.66

2.1

1.5

2787.61

1369.04

e6/l

0.59

163

260

Use of rivastigmine

324

729

4.61

132.27

1.2

1.4

347.98

869.21

e6/l

1.27

252

609

Primary_lymphoid and hematopoietic malignant neoplasms

550

1784

3.19

132.09

3.3

1.4

4333.87

1223.56

e6/l

0.38

457

1450

Opioids

1868

5084

1.93

131.68

1.4

972.96

2658.49

e6/l

1.19

1523

4120

Provisional assignment of new diseases of uncertain etiology

1081

4898

2.25

129.99

1.6

1.5

1256.62

2467.22

e6/l

0.59

854

4022

Codes for special purposes

1081

4904

2.25

129.60

1.6

1.5

1256.62

2467.83

e6/l

0.59

854

4028

Dorsopathies

1912

5153

1.91

129.34

1.4

1.5

3035.09

1866.51

e6/l

0.26

1597

4106

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

583

1968

3.03

128.94

1.3

1.4

7330.46

1694.60

e6/l

0.42

464

1620

Examination and observation for other reasons

1082

2701

2.35

128.67

1.5

1.4

1444.28

970.47

e6/l

0.33

881

2112

Sciatica+with lumbago

993

3995

2.33

128.34

1.4

1528.41

2082.07

e6/l

0.27

843

3150

Memory loss

252

474

5.64

128.31

1.4

614.90

1235.76

e6/l

0.88

160

387

Bleeding

1516

5455

2.01

127.72

2.0

1.4

9123.58

668.93

e6/l

2.36

1233

4435

Substance abuse, excluding more controls

963

3523

2.37

127.65

1.4

4833.83

2544.64

e6/l

0.26

782

2888

Pain in joint

1021

2782

2.38

127.37

1.3

1.5

1193.15

1405.58

e6/l

0.15

823

2214

Other special examinations and investigations of persons without complaint or reported diagnosis

1202

2717

2.27

127.15

1.5

1.4

4637.56

968.67

e6/l

0.65

1001

2124

Covid-19 confirmed case

766

3019

2.60

127.06

1.7

1.5

1603.94

2824.81

e6/l

0.34

595

2480

Cardiovascular diseases (excluding rheumatic etc)

1342

3679

2.13

126.03

1.7

1.5

4473.29

534.47

e6/l

0.81

1100

2926

Extrapyramidal and movement disorders

747

2935

2.61

124.69

1.4

1.5

538.71

3306.88

e6/l

1.25

592

2408

Guillain-Barre syndrome

122

105

14.34

123.44

1.4

1.3

476.38

1113.34

e6/l

0.27

Other bacterial diseases

1872

6476

1.86

122.95

1.9

1.4

1653.31

2312.65

e6/l

0.37

1541

5221

Nausea and vomiting

596

2055

2.92

122.84

1.9

1.6

1809.28

1261.46

e6/l

0.20

482

1653

Autoimmune diseases

2047

5760

1.83

121.56

1.4

1.6

1608.62

2332.41

e6/l

0.37

1665

4644

Use of memantine

466

1157

3.43

120.73

1.3

1.4

227.52

1104.08

e6/l

3.71

389

963

Use of other anti-dementia drugs

466

1157

3.43

120.73

1.3

1.4

227.52

1104.08

e6/l

3.71

389

963

Spirochaetal infections, other/unspecified

287

649

4.73

118.21

1.3

1.5

412.34

1269.85

e6/l

0.96

214

533

Bell's palsy

334

853

4.11

116.47

1.5

1.4

471.91

1316.70

e6/l

1.10

266

684

Explicit Sepsis

776

2975

2.48

115.94

2.3

1.5

1619.47

2079.48

e6/l

0.17

657

2445

Benzodiazepine use

1858

7140

1.81

115.14

1.4

1.5

2915.92

1806.97

e6/l

0.24

1522

5793

Tramadol

1445

4535

1.99

114.53

1.4

1.5

1201.14

2886.25

e6/l

0.98

1159

3684

Parasetamol

1391

3487

2.05

114.28

1.5

1.4

3898.89

1200.65

e6/l

0.51

1143

2764

First line medication for Crohn's disease

2045

6264

1.79

114.02

1.8

1.4

1268.47

2397.73

e6/l

0.79

1680

5046

Personality disorders, excluding more controls

534

1848

2.96

113.94

1.3

1.4

712.21

1766.96

e6/l

1.28

421

1521

Injuries to the head

2035

7183

1.76

111.88

1.5

4218.11

1379.63

e6/l

0.74

1650

5840

Other disorders of fluid, electrolyte and acid-base balance

602

2133

2.75

110.95

1.5

593.26

2439.87

e6/l

1.12

524

1774

GASTRO-related operations

1485

3813

1.98

110.85

1.8

1.3

862.05

2174.56

e6/l

0.71

1191

3104

Any gastric operation

1485

3813

1.98

110.85

1.8

1.3

862.05

2174.56

e6/l

0.71

1191

3104

Diseases of the eye and adnexa

1539

3998

1.95

110.79

1.6

1.5

3553.74

1823.74

e6/l

0.31

1248

3225

Cardiovascular diseases

1245

3241

2.10

110.27

1.7

1.5

4693.15

575.76

e6/l

0.77

1011

2581

Any reimbursement code in KELA

1162

2722

2.17

110.20

1.7

1.3

649.88

3480.35

e6/l

1.27

933

2164

Metabolic disorders

1703

5679

1.85

110.12

1.5

1602.76

2576.51

e6/l

0.54

1356

4658

Other intervertebral disc disorders

1453

4532

1.96

110.04

1.4

1.5

1609.91

2051.39

e6/l

0.23

1238

3608

Pain in throat and chest

1583

5074

1.90

109.75

1.4

1.5

1528.28

2792.92

e6/l

0.66

1291

4081

Other disorders of urethra and urinary system

1283

4668

2.01

109.64

1.5

1600.26

1966.38

e6/l

0.20

1031

3817

Viral hepatitis, IBD co-morbidity

107

12.61

108.31

1.8

1.3

34573.77

121.22

e6/l

0.51

ILD medications: prednisolone, methylprednisolone, prednisone

1951

6213

1.78

108.06

1.5

1.4

1163.78

2492.91

e6/l

0.99

1614

5010

Migraine without aura and triptan purchases

440

1415

3.23

107.56

1.5

767.91

1633.35

e6/l

0.73

363

1147

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1597

5234

1.87

106.20

1.6

1.4

1414.62

2494.29

e6/l

0.59

1309

4201

1597

5234

1.87

106.20

1.6

1.4

1414.62

2494.29

e6/l

0.59

1309

4201

Circumscribed brain atrophy

113

108

12.05

105.63

1.1

1.3

818.23

1198.36

e6/l

0.14

Codeine

1683

5002

1.85

105.52

1.3

1.4

1240.46

2699.35

e6/l

0.86

1368

4046

Hypothyroidism (congenital or acquired)

501

895

3.22

105.39

1.4

1.2

1811.03

602.99

e6/l

0.47

412

736

Other reaction to severe stress, and adjustment disorders

775

3367

2.35

103.79

1.6

1.4

603.72

1411.10

e6/l

1.91

632

2736

Spondylopathies

1334

4098

1.97

103.10

1.4

1.5

1673.12

2104.71

e6/l

0.23

1132

3248

Influenza and pneumonia

1915

7054

1.75

102.87

1.7

1.5

1270.56

2265.62

e6/l

0.76

1575

5685

Nonorganic sleeping disorders, excluding more controls

413

1311

3.24

102.73

1.4

1.5

314.82

1472.81

e6/l

1.42

327

1078

Hypothyroidism and >3 levothyroxin purchases

494

891

3.20

102.57

1.4

1.2

1833.17

605.45

e6/l

0.48

407

733

Hypothyroidism, levothyroxine purchases

494

891

3.20

102.57

1.4

1.2

1833.17

605.45

e6/l

0.48

407

733

Disorders of ocular muscles, binocular movement, accommodation and refraction

960

4534

2.14

102.13

1.6

1.5

5255.24

1279.54

e6/l

0.53

793

3665

Unspecified dementia

208

349

5.53

102.10

1.4

1.3

364.30

896.03

e6/l

0.74

186

296

Schizophrenia or delusion, excluding more controls

558

2078

2.72

101.37

1.3

1.4

7064.35

2011.49

e6/l

0.35

449

1707

Secondary parkinsonism, excluding more controls

26.75

100.71

1.4

88.30

39.86

e6/l

0.42

Non-invasive ventilation

480

1478

2.97

100.45

1.5

2890.45

826.98

e6/l

0.88

421

1200

Speech disturbances, not elsewhere classified

250

589

4.48

97.35

1.4

161.10

955.56

e6/l

2.11

198

481

Liquid cancers, helper endpoint

740

2806

2.35

96.35

2.8

1.4

3381.71

1519.25

e6/l

0.29

616

2330

Migraine with aura and triptan purchases

409

1347

3.15

96.04

1.3

1.5

460.62

1677.95

e6/l

1.41

340

1089

Abnormalities of breathing

1617

5271

1.80

94.99

1.4

1.5

740.96

2713.82

e6/l

1.62

1368

4239

Hard cardiovascular diseases

1468

4779

1.86

94.98

1.6

1.5

5044.77

1845.10

e6/l

0.67

1227

3817

Non-Hodgkin lymphoma, all, including Hilmo

326

943

3.61

94.73

1.9

1.4

6770.72

1161.01

e6/l

0.43

277

780

Hypo-osmolality and hyponatraemia

358

1098

3.35

93.41

1.5

721.80

1435.52

e6/l

1.10

310

906

Lumbar disc prolapse

1104

4313

1.99

92.87

1.4

1.5

1275.81

1994.71

e6/l

0.42

940

3430

Paralytic strabismus

218

487

4.76

91.14

1.6

781.94

859.43

e6/l

0.07

180

397

Oedema, not elsewhere classified

480

1743

2.77

90.79

1.4

1723.85

3670.23

e6/l

0.36

399

1409

Persons encountering health services in other circumstances, wide

2039

6321

1.68

90.74

1.5

1446.57

2320.70

e6/l

0.56

1667

5137

Benign neoplasm of meninges

273

724

3.96

90.50

1.6

1.4

1445.11

1334.63

e6/l

0.07

211

580

Benign neoplasm: Cerebral meninges

258

660

4.12

90.06

1.6

1.4

1475.66

1340.63

e6/l

0.08

199

531

Intracerebral haemorrhage

260

665

4.05

90.06

2.6

1.4

18952.93

945.83

e6/l

0.68

207

542

Cerebral aneurysm, nonruptured

237

575

4.34

88.83

1.8

1.3

5401.32

763.55

e6/l

1.32

202

470

Persons encountering health services for examination and investigation

1091

2717

2.04

88.58

1.5

1.4

4560.39

968.67

e6/l

0.55

895

2124

Neuromuscular dysfunction of bladder

246

615

4.20

88.49

1.5

1.4

1223.62

1604.12

e6/l

0.20

199

501

Non-follicular lymphoma

252

642

4.13

88.41

2.0

1.5

8258.03

822.73

e6/l

0.46

222

522

Soft tissue disorders

1811

5486

1.72

87.79

1.5

1952.23

2318.92

e6/l

0.15

1474

4427

Septicaemia

730

3086

2.25

87.72

2.4

1.5

1684.54

3275.00

e6/l

0.49

619

2520

Transient ischemic attack

819

3116

2.16

86.61

1.4

2102.18

1937.95

e6/l

0.05

683

2544

Symptoms and signs involving the circulatory and respiratory systems

1797

5298

1.72

86.50

1.5

1288.73

2701.78

e6/l

0.85

1480

4258

All pneumoniae

1779

7110

1.69

86.15

1.6

1.5

1307.81

2265.73

e6/l

0.71

1459

5739

Other diseases of urinary system

1731

5722

1.72

85.87

1.5

3571.46

1778.13

e6/l

0.38

1403

4681

Asthma

1334

3785

1.87

85.81

1.4

971.97

2496.94

e6/l

0.82

1090

3024

Spondylosis

893

3552

2.08

85.75

1.4

1.5

1119.15

2346.69

e6/l

0.97

766

2832

Diffuse large B-cell lymphoma

164

304

5.86

85.61

1.6

1.3

830.29

853.43

e6/l

0.01

145

261

Diffuse large B-cell lymphoma, including Hilmo

164

304

5.86

85.61

1.6

1.3

830.29

853.43

e6/l

0.01

145

261

Diffuse large B-cell lymphoma, helper endpoint

164

304

5.86

85.61

1.6

1.3

830.29

853.43

e6/l

0.01

145

261

Use of teriflunomide

13.75

85.23

1.1

1.4

61.99

192.78

e6/l

0.62

Pneumonias (Asthma/COPD co-morbidities)

1764

7090

1.69

85.16

1.6

1.5

1314.38

2272.98

e6/l

0.70

1446

5721

Asthma (mode)

1312

3806

1.87

84.61

1.4

985.04

2489.04

e6/l

0.81

1075

3041

Other septicaemia

655

2770

2.32

84.56

2.4

1.5

1835.17

3501.64

e6/l

0.45

558

2259

Hypertensive diseases (excluding secondary)

966

2756

2.07

84.46

1.5

1.4

2281.11

595.27

e6/l

1.27

763

2193

Systemic atrophies primarily affecting the central nervous system

154

273

6.13

84.32

1.7

1.6

495.16

936.05

e6/l

0.36

127

223

Oral corticosteroids

1851

6632

1.67

84.27

1.5

1.4

1166.74

2369.87

e6/l

0.91

1558

5336

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

173

338

5.37

84.14

1.4

1486.76

538.71

e6/l

0.82

129

278

Inflammatory bowel disease treatment related agents

2002

6880

1.64

84.13

1.7

1.4

1141.15

2311.24

e6/l

0.93

1668

5535

Traumatic subarachnoid haemorrhage

15.11

84.00

1.5

1.3

2209.76

182.41

e6/l

1.44

Symptoms and signs involving the digestive system and abdomen

1724

5066

1.72

83.99

1.6

1.5

4234.62

1456.74

e6/l

0.59

1421

4071

Pneumonia, organism unspecified

1572

6441

1.73

83.62

1.6

1.5

1402.55

2398.55

e6/l

0.64

1292

5198

Asthma, excluding more controls

1301

3674

1.87

83.47

1.4

984.51

2563.23

e6/l

0.83

1063

2929

Certain infectious and parasitic diseases

1254

3363

1.89

82.31

1.6

1.4

3687.18

1882.29

e6/l

0.26

1004

2737

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1714

7038

1.68

81.27

1.6

1.5

1377.28

2283.48

e6/l

0.64

1404

5685

Other/unspecified dorsalgia

657

2925

2.27

81.11

1.3

1.5

819.62

2339.97

e6/l

1.11

542

2340

Complications of surgical and medical care, not elsewhere classified

1695

6985

1.68

80.63

1.7

1.4

2798.89

1905.29

e6/l

0.27

1400

5666

Codeine or tramadol medication

1942

6552

1.64

80.09

1.3

1.4

1324.05

2298.80

e6/l

0.68

1584

5338

Strabismus

568

2414

2.41

79.92

1.7

1068.96

2641.68

e6/l

0.49

472

1946

Other and unspecified degenerative diseases of nervous system

105

131

8.87

79.90

1.3

250.10

963.84

e6/l

0.42

109

Enlarged lymph nodes

284

844

3.45

78.64

1.6

1.4

1106.64

5741.98

e6/l

0.53

229

679

Bacterial meningitis

140

246

6.24

77.58

2.1

1.5

767.94

907.16

e6/l

0.08

115

196

Small fibre neuropathy

126

200

7.01

77.57

1.4

136.73

658.88

e6/l

0.47

108

162

Hemiplegia

164

332

5.27

77.22

1.6

1.5

293.25

686.73

e6/l

0.46

129

271

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1672

6998

1.67

77.14

1.9

1.4

1022.56

2339.93

e6/l

1.20

1388

5645

Other extrapyramidal and movement disorders in other diseases

456

1792

2.61

76.50

1.3

1.5

648.70

3308.54

e6/l

0.71

351

1462

L04AA Selective immunosuppressants

487

1991

2.52

75.31

1.7

1.5

585.44

3209.01

e6/l

0.77

400

1594

Hypertension, essential

1341

4315

1.78

75.24

1.5

1.4

2229.57

2156.13

e6/l

0.02

1070

3514

Undefined dementia

208

468

4.21

74.84

1.4

364.30

762.97

e6/l

0.67

186

392

COPD/asthma related infections

1725

5238

1.67

74.39

1.5

1.4

1348.38

2491.92

e6/l

0.65

1420

4205

COPD/asthma/ILD related infections

1725

5238

1.67

74.39

1.5

1.4

1348.38

2491.92

e6/l

0.65

1420

4205

Cervicobrachial syndrome

425

1641

2.65

73.82

1.4

9655.17

1475.70

e6/l

0.51

369

1298

Second line medication for Crohn's disease

1035

5673

1.85

73.29

2.2

1.4

1242.13

2565.82

e6/l

0.72

859

4607

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1861

6315

1.62

72.93

1.5

1515.49

2321.43

e6/l

0.49

1507

5132

Dysphagia

451

1803

2.56

72.85

1.5

5691.98

1097.75

e6/l

0.46

360

1466

L04AX Other immunosuppressants

1006

5492

1.86

72.19

2.2

1.4

1258.64

2640.34

e6/l

0.73

832

4455

Symptoms and signs involving speech and voice

601

2738

2.24

72.08

1.3

1.4

356.32

2660.03

e6/l

1.05

475

2235

Asthma, unspecified (mode), excluding more controls

872

3354

1.97

71.22

1.5

1.4

1027.52

2769.11

e6/l

0.83

705

2680

Other disorders of central nervous system

12.24

71.06

1.7

1.4

5324.18

243.00

e6/l

0.88

Complications of medical and surgical care

1233

6577

1.74

70.88

1.7

1.4

3708.72

1881.44

e6/l

0.46

994

5371

Antihypertensive medication - note that there are other indications

1162

3403

1.83

70.53

1.5

1673.63

2112.70

e6/l

0.13

926

2751

Asthma, unspecified (mode)

882

3447

1.95

70.17

1.5

1.4

1013.37

2693.26

e6/l

0.82

715

2761

Cystitis

1411

4957

1.71

69.87

1.5

3859.64

1885.04

e6/l

0.34

1141

4059

Fall on same level

1958

6829

1.58

69.84

1.4

1.5

963.20

2401.57

e6/l

1.37

1570

5561

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1060

5284

1.82

69.84

1.4

1.5

3084.79

2319.65

e6/l

0.13

845

4326

Abdominal and pelvic pain

1652

5065

1.65

69.56

1.5

4933.47

1435.68

e6/l

0.76

1373

4070

Dental caries

491

2021

2.39

67.74

2.3

1.5

923.60

3960.05

e6/l

0.82

399

1641

Invasive ventilation

207

556

3.93

67.66

2.1

1.8

3470.55

1647.75

e6/l

1.02

170

447

Other and unspecified visual disturbances

248

750

3.45

67.43

1.3

1.5

706.14

1470.50

e6/l

0.61

192

611

Other disorders of eye and adnexa

330

1177

2.90

67.36

1.5

1.6

722.46

4334.07

e6/l

0.60

253

946

Asthma (only as main-diagnosis), excluding more controls

1145

3674

1.80

67.20

1.4

861.07

2563.23

e6/l

0.92

956

2929

Asthma (only as main-diagnosis)

1158

3785

1.79

66.75

1.4

875.35

2496.94

e6/l

0.90

965

3024

Symptoms and signs involving the urinary system

1243

5550

1.73

66.75

1.5

1187.05

2624.36

e6/l

0.97

1020

4518

ILD differential diagnosis

1310

3806

1.74

66.54

1.5

1.4

1434.79

2489.04

e6/l

0.44

1062

3041

COPD differential diagnosis

1310

3807

1.74

66.49

1.5

1.4

1434.79

2488.22

e6/l

0.44

1062

3042

Meningitis, viral

22.11

66.19

1.5

1.4

26.28

259.17

e6/l

0.77

Bipolar affective disorders

390

1525

2.62

66.18

1.3

1.4

653.60

1293.08

e6/l

0.61

318

1248

Somatoform disorder

347

1281

2.79

66.17

1.3

1.5

1088.62

1729.39

e6/l

0.38

282

1044

Cervicalgia

376

1446

2.66

65.88

1.3

1.4

339.98

1007.33

e6/l

2.54

310

1151

Tick-borne viral encephalitis

20.39

65.14

1.1

1.2

58.19

290.32

e6/l

0.77

Other pulmonary diagnosis

1309

3829

1.73

64.95

1.5

1.4

1523.97

2467.01

e6/l

0.38

1064

3062

Endovascular or surgical operations to intracerebral aneurysms

165

388

4.48

64.60

2.1

1.3

12062.67

711.57

e6/l

2.24

146

321

Tick-borne viral encephalitis

22.88

64.52

1.1

1.2

58.93

332.15

e6/l

0.80

Excluding asthma or asthma-COPD overlap

1305

3829

1.72

64.06

1.5

1.4

1455.47

2467.01

e6/l

0.42

1059

3062

Diseases of the musculoskeletal system and connective tissue

967

2593

1.89

63.98

1.7

1.6

4911.59

2361.91

e6/l

0.29

777

2048

1850

6137

1.57

63.80

1.5

1.4

1534.63

2218.39

e6/l

0.38

1549

4947

Unspecified mental disorder

745

3860

1.96

63.03

1.2

1.4

675.24

2543.40

e6/l

1.19

596

3145

Bronchitis

1769

7182

1.57

62.57

1.6

1.4

1171.63

2192.21

e6/l

0.85

1480

5799

Symptoms and signs concerning food and fluid intake

189

500

3.89

62.35

1.7

1.5

1209.86

8962.29

e6/l

0.52

167

395

Other general symptoms and signs

126

241

5.42

62.12

1.8

1065.95

17603.79

e6/l

0.55

193

Disorders of lipoprotein metabolism and other lipidaemias

1256

4615

1.70

61.89

1.4

1.5

2133.75

2211.92

e6/l

0.03

959

3787

Migraine, single triptan purchase ok & required. ICD-code if available is included

1336

5495

1.67

61.52

1.4

1.5

3532.78

1671.22

e6/l

0.30

1093

4439

Triptan medication for migraine, single purchase ok

1336

5495

1.67

61.52

1.4

1.5

3532.78

1671.22

e6/l

0.30

1093

4439

Hypertensive diseases

1329

4509

1.68

61.23

1.5

2175.55

2082.94

e6/l

0.03

1073

3665

Somnolence, stupor and coma

120

226

5.61

61.22

1.8

1.6

592.75

742.89

e6/l

0.09

104

179

Hypertension

1327

4501

1.68

61.15

1.5

2177.57

2085.78

e6/l

0.03

1072

3660

Other disorders of lacrimal gland

611

2992

2.08

60.84

1.5

1.4

1445.79

2794.36

e6/l

0.40

508

2422

Implicit fungal Sepsis

161

389

4.33

60.73

1.5

1.4

297.62

1187.17

e6/l

1.38

133

323

Viral infections characterized by skin and mucous membrane lesions

745

3911

1.93

60.51

1.8

1.5

539.79

2224.65

e6/l

1.09

615

3174

Acute upper respiratory infections of multiple and unspecified sites

1267

5675

1.67

60.40

1.7

1.4

1248.72

2255.69

e6/l

0.60

1059

4559

304

1100

2.85

60.35

1.7

1.5

912.84

4894.36

e6/l

0.62

235

895

Caries of dentine

431

1787

2.40

60.33

2.0

1.4

783.33

4379.22

e6/l

0.88

356

1454

Use of hypnotics and sedatives

1750

6525

1.55

58.85

1.4

1.5

1733.68

2243.97

e6/l

0.26

1443

5286

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

583

2848

2.09

58.54

1.3

1.4

7330.46

1254.78

e6/l

0.47

464

2320

Diarrhoea and gastroenteritis of presumed infectious origin

1188

6469

1.67

58.48

1.5

653.64

2206.95

e6/l

1.57

974

5237

Myalgia

434

1894

2.34

57.84

1.3

1.4

2258.32

2931.60

e6/l

0.11

352

1536

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

112

128

6.30

57.41

1.2

1.5

592.07

470.77

e6/l

0.09

104

Other lack of coordination

9.25

57.25

1.4

1.5

1119.56

1393.73

e6/l

0.07

Acute upper respiratory infections

1669

6671

1.55

57.17

1.5

1.4

1587.74

2138.88

e6/l

0.30

1397

5378

Non-selective monoamine reuptake inhibitors

553

2582

2.09

56.12

1.4

1517.72

2186.26

e6/l

0.31

450

2106

All kidney diseases

1616

7185

1.55

55.85

1.5

4985.32

1387.93

e6/l

0.77

1333

5811

Radiculopathy

282

1021

2.83

55.74

1.4

1240.67

1164.35

e6/l

0.05

246

814

Intestinal infectious diseases

1548

7606

1.56

55.65

1.5

918.30

2264.98

e6/l

1.36

1281

6145

Other diseases of spinal cord

161

6.40

55.57

2.5

1.2

1046.17

1412.60

e6/l

0.15

129

Behavioural syndromes associated with physiological disturbances and physical factors

1524

6959

1.57

55.55

1.4

1.5

1060.06

2325.19

e6/l

0.98

1230

5651

Viral infections characterized by skin and mucous membrane lesions

1418

7742

1.58

55.28

1.6

1.5

2433.70

1954.43

e6/l

0.12

1166

6270

Dementia in other diseases classified elsewhere

109

209

5.49

54.48

1.3

146.84

656.41

e6/l

0.48

170

Acute lymphocytic leukaemia, helper endpoint

12.81

54.34

13.2

1.3

27.89

370.00

e6/l

0.63

Acute lymphocytic leukaemia, including Hilmo

12.81

54.34

13.2

1.3

27.89

370.00

e6/l

0.63

Acute lymphocytic leukaemia

12.81

54.34

13.2

1.3

27.89

370.00

e6/l

0.63

Substance abuse

963

5291

1.73

54.25

1.4

4833.83

1733.59

e6/l

0.38

782

4310

Retention of urine

532

2093

2.12

53.99

1.5

1.4

522.70

4260.21

e6/l

1.20

440

1728

Disorders of adult personality and behaviour

565

2812

2.05

53.97

1.4

511.49

2580.11

e6/l

0.92

444

2292

Sleep disorders (combined)

1810

6308

1.52

53.96

1.4

1.5

940.53

2414.79

e6/l

1.34

1475

5121

Endocrine, nutritional and metabolic diseases

1371

4321

1.62

53.78

1.5

1433.21

2415.17

e6/l

0.46

1106

3505

Diagnoses used for exclusion with ILD

434

1956

2.26

53.60

1.6

1.4

492.44

1186.35

e6/l

2.07

352

1607

Pure hypercholesterolaemia

1084

4215

1.70

53.31

1.4

1.5

1873.62

2191.79

e6/l

0.14

826

3468

Mental and behavioural disorders due to psychoactive substance use

985

5395

1.71

53.20

1.4

4739.76

1809.18

e6/l

0.36

798

4392

Poisoning by medicine

445

2042

2.23

52.75

1.3

1.5

368.21

1250.64

e6/l

1.71

341

1663

Exclusions for E4_PCOS_BROAD

367

1554

2.43

52.66

1.6

1.8

869.67

3784.77

e6/l

0.64

302

1249

Poisoning by drugs, medicaments and biological substances

478

2259

2.16

52.54

1.4

1.5

8401.89

1182.76

e6/l

0.43

370

1837

Kela-code for severe mental illness

648

3414

1.93

52.33

1.2

1.4

660.66

2552.56

e6/l

1.02

520

2771

Post-traumatic stress disorder

204

640

3.30

52.28

1.3

1.5

413.05

1541.17

e6/l

1.19

157

525

Diarrhoea and gastroenteritis of presumed infectious origin

1642

7160

1.52

52.24

1.5

817.88

2329.40

e6/l

1.66

1329

5795

Asthma-related infections

957

5536

1.71

52.22

1.5

845.22

2529.45

e6/l

1.38

800

4509

Asthma, hospital admission 2, infections

957

5536

1.71

52.22

1.5

845.22

2529.45

e6/l

1.38

800

4509

Other specific joint derangements/joint disorders

1254

5040

1.62

52.13

1.3

1.5

1126.44

2474.34

e6/l

0.79

1019

4037

Factors influencing health status and contact with health services

466

1021

2.32

52.12

1.5

1.3

757.28

1148.86

e6/l

0.25

377

787

Shoulder lesions

1173

4331

1.66

52.11

1.5

1438.07

2729.37

e6/l

0.64

988

3510

Other functional intestinal disorders

754

3859

1.84

51.89

1.5

1.6

1987.35

2516.99

e6/l

0.13

621

3136

Visual field defects

186

554

3.49

51.88

1.7

1.5

1320.26

1434.89

e6/l

0.05

160

462

Systemic connective tissue disorders

571

2892

2.01

51.80

1.4

1224.57

2556.53

e6/l

0.48

470

2368

Personality disorders

534

2644

2.06

51.79

1.3

1.4

712.21

2638.28

e6/l

0.74

421

2152

Brain meningioma, including Hilmo

145

367

4.18

51.69

1.9

1.4

2005.01

1546.95

e6/l

0.19

121

304

Fibromyalgia

198

616

3.32

51.40

1.3

1.4

651.29

6832.61

e6/l

0.52

164

497

severe traumatic brain injury, does not include concussion

367

1572

2.38

51.13

1.7

1.4

7318.97

1205.31

e6/l

0.49

281

1290

Spinal stenosis

708

2893

1.88

50.78

1.5

1367.61

2592.26

e6/l

0.72

599

2311

Brain meningioma

141

355

4.21

50.65

1.9

1.4

2073.18

860.41

e6/l

0.96

117

294

Sleep disorders

1448

6809

1.55

50.59

1.3

1.5

1094.84

2362.84

e6/l

0.94

1160

5535

Nonorganic sleeping disorders

413

1876

2.25

50.26

1.4

1.5

314.82

3237.60

e6/l

0.85

327

1521

Diseases of the myoneural junction and muscle

247

885

2.88

50.09

1.7

1.6

1479.36

1171.82

e6/l

0.16

207

725

Herpesviral [herpes simplex] infections

251

908

2.85

50.02

1.7

1.5

424.24

1487.90

e6/l

1.85

217

733

Progressive vascular leukoencephalopathy

154

6.10

49.72

1.2

1.4

58.97

720.43

e6/l

0.79

127

Disorders of eyelid, lacrimal system and orbit

1334

6516

1.57

49.53

1.5

1518.80

2377.63

e6/l

0.46

1083

5314

Neoplasms

1354

4556

1.59

49.52

2.1

1.4

1619.53

2231.32

e6/l

0.26

1067

3740

Renal tubulo-interstitial diseases

1369

6593

1.56

49.45

1.5

3891.10

1746.63

e6/l

0.37

1125

5352

Dissociative [conversion] disorders

117

260

4.76

49.38

1.2

1.7

547.55

835.25

e6/l

0.22

101

210

Other sleep disorders

202

652

3.18

49.19

1.3

1.4

3151.35

6497.49

e6/l

0.22

179

518

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

955

5661

1.68

49.10

1.7

1.4

4552.01

1978.61

e6/l

0.53

778

4637

Disorders of lacrimal system

689

3775

1.85

48.76

1.5

2060.42

2700.33

e6/l

0.17

574

3072

All influenza

438

2059

2.17

48.69

1.6

576.15

3049.80

e6/l

0.77

374

1665

Complications of procedures, not elsewhere classified

1267

6716

1.58

48.62

1.6

1.4

2870.56

1870.05

e6/l

0.24

1038

5448

Specific personality disorders

463

2229

2.12

48.52

1.4

488.31

2824.48

e6/l

0.79

373

1818

Exposure to unspecified factor

1603

7738

1.50

48.51

1.4

1.5

2438.88

1897.43

e6/l

0.15

1259

6330

Complications of other internal prosthetic devices, implants and grafts

117

264

4.70

48.49

2.9

1.5

852.64

922.62

e6/l

0.04

102

220

Acute tubulo-interstitial nephritis

989

5163

1.67

48.38

1.6

1.5

5057.99

1797.61

e6/l

0.42

817

4205

Cluster headache, strict

183

5.53

48.38

1.4

1.3

252.90

1645.72

e6/l

0.78

143

Certain disorders involving the immune mechanism

362

1586

2.34

48.10

2.5

1.5

211.14

1215.39

e6/l

4.03

290

1284

Other diseases of intestines

1730

6657

1.49

48.02

1.4

1.5

835.66

1992.47

e6/l

1.27

1403

5414

Constipation

1372

6171

1.55

47.90

1.5

2401.82

2111.92

e6/l

0.06

1107

5035

Benign neoplasm of brain and other parts of central nervous system

165

481

3.60

47.83

2.0

1.6

1156.69

1371.94

e6/l

0.09

131

383

Non-Hodgkin lymphoma, all

116

263

4.66

47.74

1.8

1.4

143.13

663.49

e6/l

0.71

224

Focal brain injury

113

6.78

47.57

1.8

1.2

3548.47

120.60

e6/l

2.91

Oxycodone

579

2727

1.95

47.54

1.7

1.5

714.54

2493.88

e6/l

1.36

486

2230

Ocular pain

203

674

3.13

47.46

1.6

945.15

6790.03

e6/l

0.55

160

551

Falls/tendency to fall

1747

5918

1.49

47.22

1.5

1041.25

2492.32

e6/l

1.13

1419

4811

Other acute disseminated demyelination

9.15

46.93

1.4

1.3

166.39

183.06

e6/l

0.04

Psychotic depression

117

269

4.49

46.93

1.4

1.6

308.93

471.16

e6/l

0.23

231

Persons encountering health services in other circumstances

658

3592

1.85

46.68

1.5

1733.25

2860.60

e6/l

0.34

547

2919

Mental and behavioural disorders due to alcohol, excluding acute intoxication

717

4021

1.80

46.58

1.3

1.4

5878.40

1990.61

e6/l

0.35

586

3256

Other medical care

680

3377

1.83

46.42

1.7

1.5

1094.33

3069.35

e6/l

0.87

542

2741

Mental and behavioural disorders due to alcohol

822

4626

1.73

46.37

1.3

1.4

5189.35

1788.74

e6/l

0.35

671

3768

Acute sinusitis

854

4674

1.71

46.19

1.5

1.4

3181.83

2002.91

e6/l

0.39

713

3756

Intestinal infectious diseases

1815

7140

1.46

46.11

1.5

1024.90

2328.96

e6/l

1.22

1481

5794

Cluster headache, wide

199

5.17

45.96

1.4

1.3

249.82

1821.60

e6/l

0.99

156

Alcohol abuse, main dg, excluding more controls

247

927

2.72

45.63

1.3

1.5

873.87

1430.75

e6/l

0.64

199

770

Speech and linguistic disorders, excluding more controls

180

530

3.30

45.60

2.2

1132.54

859.27

e6/l

0.12

145

423

Pain in thoracic spine

273

1079

2.59

45.47

1.3

1.5

1519.25

1070.80

e6/l

0.26

238

857

Alcohol use disorder, Swedish definition

865

4725

1.70

45.39

1.4

5075.77

1816.41

e6/l

0.35

701

3851

Third [oculomotor] nerve palsy

115

7.00

45.29

1.4

1308.13

1051.45

e6/l

0.08

Paraplegia, diplegia of upper limbs

139

6.26

44.90

1.8

1.6

432.67

1371.45

e6/l

0.49

113

Frontotemporal dementia, wide, incl. Pick's disease

15.25

44.64

1.1

1.2

146.10

104.96

e6/l

0.16

738

4216

1.76

44.45

1.5

1.6

734.36

2180.31

e6/l

0.94

624

3421

Alzheimer’s disease (Atypical or mixed)

145

401

3.68

44.45

1.4

360.45

1013.19

e6/l

1.05

128

336

Any death

909

3910

1.68

44.40

1.7

1.4

5464.62

1775.12

e6/l

0.46

761

3172

Schizophrenia, schizotypal and delusional disorders

561

2985

1.91

44.10

1.3

1.4

7033.13

1284.79

e6/l

0.42

451

2410

Unspecified fall

786

4547

1.72

44.09

1.5

1.6

1660.51

2618.10

e6/l

0.34

615

3715

Gastrointestinal diseases

1026

3127

1.66

44.09

1.7

1.4

727.34

2603.57

e6/l

0.92

825

2541

Rare circulating lymphoid malignancy, including Hilmo

212

5.02

43.95

10.2

1.3

46.33

862.54

e6/l

1.03

186

Schizophrenia or delusion

558

2973

1.91

43.69

1.3

1.4

7064.35

1296.65

e6/l

0.42

449

2400

Dyspnoea

1381

6795

1.51

43.61

1.4

1.5

628.53

2345.49

e6/l

1.94

1174

5469

Zoster [herpes zoster]

309

1319

2.39

43.57

1.8

1.5

353.30

1265.43

e6/l

2.24

247

1082

909

5015

1.66

43.34

1.3

1.4

4753.79

1823.65

e6/l

0.33

734

4092

Asthma (diagnoses ohter than nonallergic)

1368

7587

1.51

43.16

1.4

1.5

1192.83

2125.78

e6/l

0.81

1120

6164

952

5182

1.63

43.03

1.4

4663.00

1767.96

e6/l

0.34

770

4226

Sixth [abducent] nerve palsy

103

232

4.74

42.95

1.5

1.7

467.93

673.77

e6/l

0.15

187

Follow-up examination after treatment for conditions other than malignant neoplasms

626

2245

1.86

42.78

1.4

1209.15

1056.84

e6/l

0.14

495

1767

Other diseases of blood and blood-forming organs, wide

382

1795

2.17

42.73

2.3

1.5

504.97

1221.75

e6/l

1.77

335

1448

Cervicocranial syndrome

203

716

2.91

42.39

1.3

1.5

3134.14

1055.08

e6/l

1.02

173

576

Other and unspecified nonorganic psychotic disorders

381

1795

2.17

42.37

1.3

1.4

9896.14

1331.84

e6/l

0.43

309

1458

Cervical disc disorders

528

2789

1.92

42.34

1.5

1321.88

2650.07

e6/l

0.73

457

2213

Brain glioblastoma and astrocytoma

114

6.76

42.05

1.8

1.3

3792.53

1604.08

e6/l

0.38

Other viral diseases

667

3773

1.78

41.78

1.8

1.6

566.53

2101.92

e6/l

0.88

536

3056

Alcohol use disorder, ICD-based

655

3717

1.79

41.68

1.3

1.4

6410.50

1937.98

e6/l

0.37

532

3009

Other spirochaetal diseases

499

2609

1.95

41.44

1.3

1.5

505.62

2768.73

e6/l

0.93

379

2127

Frontotemporal dementia

16.00

41.15

1.1

1.3

153.93

117.04

e6/l

0.13

Other complications of surgical and medical care, not elsewhere classified

208

758

2.83

41.00

1.6

1.4

4799.84

1552.67

e6/l

0.55

178

614

Triptan medication for migraine, min. 3 purchases

964

4593

1.62

40.96

1.4

4390.41

1528.18

e6/l

0.35

788

3702

Other spirochaetal diseases

493

2582

1.94

40.75

1.3

1.5

309.97

2799.17

e6/l

1.07

374

2102

Spirochaetal infections, other/unspecified

491

2572

1.94

40.57

1.3

1.5

309.94

2808.98

e6/l

1.07

373

2095

Insomnia

1372

6749

1.49

40.47

1.3

1.5

1141.01

2293.24

e6/l

0.79

1092

5500

Lyme disease

488

2556

1.94

40.34

1.3

1.5

311.36

2825.14

e6/l

1.07

370

2082

Unknown and unspecified causes of morbidity

124

333

3.83

40.33

1.4

1.5

5846.27

1517.89

e6/l

0.45

111

271

Suicide or other Intentional self-harm

449

2295

1.99

39.95

1.3

1.4

9765.52

1268.84

e6/l

0.49

347

1869

Other heart diseases

746

2844

1.73

39.73

1.4

1.5

1357.63

585.74

e6/l

1.58

623

2276

Disorders of other endocrine glands

702

4048

1.73

39.71

1.6

814.57

1997.56

e6/l

0.67

581

3281

Disorders of vestibular function (Vertigo)

689

3953

1.74

39.67

1.4

1185.93

3016.34

e6/l

0.93

579

3209

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

515

2728

1.90

39.59

2.5

1.5

7919.53

1275.56

e6/l

0.44

407

2229

Injuries to the abdomen, lower back, lumbar spine and pelvis

606

3389

1.79

39.01

1.5

543.57

2321.86

e6/l

0.98

487

2784

Benign neoplasm: Pituitary gland, craniopharyngeal duct

134

391

3.59

38.90

1.5

1375.48

1155.51

e6/l

0.11

109

320

Other CVD (FINNGEN)

199

546

2.89

38.80

1.6

1.3

817.34

823.73

e6/l

0.01

164

431

Other external causes of accidental injury

1278

4230

1.52

38.80

1.5

4068.99

1688.16

e6/l

0.38

1011

3457

Other acute lower respiratory infections

808

4705

1.65

38.76

1.6

1.5

1489.98

2491.34

e6/l

0.39

667

3833

Use of peginterferon beta-1a

15.15

38.51

1.0

1.2

86.97

35.79

e6/l

0.32

Other disorders of binocular movement

168

5.27

38.46

1.5

1966.03

777.98

e6/l

0.26

130

Other symptoms and signs involving general sensations and perceptions

214

4.60

38.45

1.2

1.5

1157.68

1475.59

e6/l

0.12

170

Other intracranial haemorrhages

152

5.41

38.43

2.2

1.4

27249.51

309.46

e6/l

0.53

123

Other viral diseases

528

2873

1.86

38.40

1.8

1.6

661.57

2284.25

e6/l

0.66

429

2325

Generalized anxiety disorder

303

1356

2.28

38.34

1.2

1.5

674.66

1396.11

e6/l

0.58

244

1109

Hypothyroidism, drug reimbursement

209

532

2.82

38.23

1.4

1.2

686.95

835.20

e6/l

0.13

169

441

Herpesviral [herpes simplex] infections

440

2268

1.98

38.22

1.5

819.12

2817.83

e6/l

0.64

373

1853

Postviral fatigue syndrome

10.14

38.12

1.3

1.6

14.70

81.84

e6/l

0.83

External causes of morbidity and mortality

1047

3341

1.58

37.48

1.6

1.5

4640.21

1456.63

e6/l

0.43

834

2713

Diseases of the respiratory system

988

3112

1.60

37.35

1.5

1.4

1240.44

2464.13

e6/l

0.48

794

2477

Use of levodopa decarboxylase inhibitor

216

840

2.63

37.35

1.4

632.45

1086.81

e6/l

0.45

188

691

Hyperkinetic disorders, excluding more controls

218

811

2.63

37.33

1.3

1.8

298.61

1632.31

e6/l

0.94

174

675

Rotator cuff syndrome

875

3911

1.62

37.06

1.3

1.5

1540.31

2965.06

e6/l

0.63

731

3188

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

855

5372

1.61

36.74

1.7

1.4

4946.43

2042.16

e6/l

0.54

696

4395

Brachial plexus disorders

193

717

2.77

36.70

1.3

1.5

454.99

6202.20

e6/l

0.58

169

578

Diseases of the ear and mastoid process

1819

6540

1.41

36.46

1.5

1.4

1130.60

2408.00

e6/l

1.10

1507

5265

Genitourinary diseases

954

3002

1.61

36.38

1.6

4847.81

1260.61

e6/l

0.46

779

2423

Panic disorder

276

1216

2.32

36.28

1.3

1.5

731.72

1484.83

e6/l

0.59

221

1000

Other systemic involvement of connective tissue (FG)

397

1984

2.01

36.16

1.4

1455.85

3004.18

e6/l

0.36

321

1627

Accidents

1262

4230

1.51

36.16

1.5

4126.63

1688.16

e6/l

0.39

1007

3457

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

542

3039

1.81

36.10

1.5

1.6

1133.25

2369.33

e6/l

0.48

432

2471

Asthma-related pneumonia or sepsis

531

2960

1.81

35.71

1.6

1062.00

2443.44

e6/l

0.55

440

2429

Asthma, hospital admissions 3, pneumonia

531

2960

1.81

35.71

1.6

1062.00

2443.44

e6/l

0.55

440

2429

Superficial injury of head

376

1879

2.03

35.63

1.6

1027.19

877.40

e6/l

0.15

296

1535

Asthma-related pneumonia

529

2951

1.81

35.50

1.6

1064.42

2449.63

e6/l

0.55

439

2421

Vascular dementia

117

316

3.64

35.37

1.5

1.4

979.89

930.99

e6/l

0.03

263

Hypopituitarism

171

612

2.90

35.08

1.6

2.3

686.01

627.85

e6/l

0.06

151

484

Asthma, including avohilmo

1813

7386

1.39

34.51

1.4

1.5

919.90

2225.05

e6/l

1.36

1481

5991

Other joint disorders

1410

5151

1.45

34.41

1.4

1.5

940.46

2433.04

e6/l

0.97

1175

4123

Phobic anxiety disorders

250

1081

2.36

34.25

1.5

1007.52

1075.66

e6/l

0.03

198

888

Sarcoidosis

246

1060

2.38

34.21

1.7

1.5

250.05

1370.49

e6/l

2.72

197

859

Diseases of inner ear

771

4657

1.62

34.04

1.4

1117.96

2990.51

e6/l

1.18

643

3782

Diseases of oesophagus, stomach and duodenum

1610

6881

1.41

33.90

1.4

1.5

2096.61

2114.15

e6/l

0.00

1322

5578

Lymphoid leukaemia

124

376

3.44

33.88

8.5

1.4

833.80

694.76

e6/l

0.06

104

307

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

184

696

2.72

33.84

1.4

1.5

451.76

1298.01

e6/l

1.12

148

573

Other strabismus

389

2002

1.97

33.66

1.7

1199.98

1191.77

e6/l

0.00

325

1606

Hypotension

241

1034

2.37

33.65

1.6

1.4

685.70

913.68

e6/l

0.30

202

846

Other necrotizing vasculopathies (FG)

123

376

3.39

33.11

1.3

1.5

1243.66

831.61

e6/l

0.17

103

302

Use of galantamine

126

391

3.31

32.97

1.3

1.4

421.44

865.02

e6/l

0.60

334

Emotionally unstable personality disorder

251

1110

2.32

32.87

1.3

1.4

571.52

4895.71

e6/l

0.70

199

900

Finngen Rheumatological endpoints

1507

6080

1.42

32.85

1.4

1.5

1821.22

2338.18

e6/l

0.23

1240

4918

Parkinson's disease, including avohilmo

237

1026

2.36

32.51

1.4

266.86

1082.89

e6/l

3.10

207

830

Panhypopituitarism

108

6.00

32.49

2.0

1.5

910.72

1160.10

e6/l

0.09

ILD medications: azathioprine

264

1198

2.25

32.41

1.6

1.4

336.63

3885.14

e6/l

0.60

221

962

Persistent mood disorders

304

1458

2.12

32.33

1.4

1428.58

1592.46

e6/l

0.07

235

1199

Other and unspecified nerve root and plexus disorders, also in other diseases

322

1579

2.08

32.31

1.3

1.4

2341.92

1151.22

e6/l

0.29

282

1256

Other disorders of nervous system

123

382

3.33

32.23

1.9

1.3

358.10

1580.79

e6/l

0.92

103

306

Hypothyroidism, strict autoimmune

1011

4416

1.52

31.85

1.3

1.5

1387.14

2757.58

e6/l

0.62

839

3568

Abnormalities of heart beat

524

2960

1.76

31.63

1.4

1.5

478.29

3785.28

e6/l

1.55

434

2396

Persons encountering health services for specific procedures, not carried out

168

628

2.75

31.63

1.3

1.6

2872.47

7208.03

e6/l

0.32

118

504

Sequelae of external causes of morbidity and mortality

392

2080

1.91

31.29

1.7

1.4

1287.00

2875.02

e6/l

0.40

313

1689

Osteopathies and chondropathies

810

4860

1.57

31.21

1.6

1.4

1362.77

2904.39

e6/l

0.70

666

3959

Optic atrophy

117

5.62

30.86

1.9

1328.33

1065.42

e6/l

0.08

Secondary parkinsonism+Parkinsonism in other disease

155

4.84

30.75

1.4

1.3

86.85

986.00

e6/l

0.70

128

Optic atrophy

118

5.60

30.61

1.9

1328.33

1076.52

e6/l

0.08

Agranulocytosis

207

870

2.44

30.55

2.6

1.5

194.55

1441.94

e6/l

2.55

185

695

Secondary parkinsonism

152

4.87

30.53

1.4

1.3

88.30

1003.62

e6/l

0.71

126

Use of glatiramer acetate

119

5.55

30.34

1.2

1.8

587.81

171.13

e6/l

0.48

Other systemic involvement of connective tissue

402

2173

1.88

30.28

1.4

1433.72

3168.45

e6/l

0.46

326

1775

Abnormal findings on examination of blood, without diagnosis

649

3669

1.64

30.23

1.5

3869.67

2287.64

e6/l

0.19

524

3000

Other and unspecified myopathies

156

575

2.79

30.20

1.9

1.6

1818.63

838.07

e6/l

0.45

134

474

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

311

1547

2.05

30.13

1.3

1.4

12766.65

1355.61

e6/l

0.45

239

1264

Other degenerative diseases of the basal ganglia

109

5.78

30.07

1.4

1.3

313.95

1315.72

e6/l

0.48

Acute bronchitis

582

3434

1.68

29.94

1.5

1.6

850.65

2894.08

e6/l

0.97

478

2793

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

384

1817

1.91

29.93

1.8

1.7

9883.28

951.86

e6/l

0.46

310

1462

Dental pulpitis, including avohilmo

1421

6618

1.40

29.81

1.4

1431.44

2320.37

e6/l

0.53

1119

5392

Injury, poisoning and certain other consequences of external causes

823

2626

1.58

29.68

1.6

1.5

5829.67

1660.30

e6/l

0.45

658

2087

Obesity related asthma

521

3064

1.72

29.45

1.4

1.5

977.56

2702.40

e6/l

0.72

444

2498

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

645

2480

1.66

29.35

1.6

1.3

1529.13

607.92

e6/l

0.95

540

1983

Other CVD

266

1259

2.15

29.30

1.6

1.5

851.74

1222.80

e6/l

0.41

222

1037

Polyuria

326

1664

1.99

29.25

1.4

381.41

4852.95

e6/l

1.10

268

1358

Sleep apnoea

1358

6284

1.41

29.12

1.5

1629.30

2389.89

e6/l

0.41

1131

5073

Brain glioblastoma

6.34

28.96

1.8

1.3

4884.61

2056.29

e6/l

0.35

Other and unspecified drugs and medicaments

168

658

2.63

28.90

1.4

1.5

487.70

1141.17

e6/l

0.73

137

533

Injuries to the thorax

631

3916

1.63

28.80

1.4

949.79

2884.60

e6/l

1.04

511

3202

Open wound of head

743

4612

1.57

28.80

1.5

1083.34

1221.73

e6/l

0.14

611

3781

Injuries to the neck

383

2077

1.87

28.65

1.3

1.5

1166.77

2979.63

e6/l

0.49

312

1694

Benign neoplasm of other and unspecified endocrine glands

228

1027

2.27

28.64

1.4

1.5

1929.88

1193.04

e6/l

0.47

180

827

Diffuse brain injury

6.93

28.52

2.0

1.3

828.73

122.47

e6/l

1.15

Other and unspecified mood [affective] disorders

142

514

2.84

28.47

1.5

1.6

353.76

1239.29

e6/l

0.80

107

421

Sleep apnoea, including avohilmo

1451

6519

1.39

28.29

1.4

1.5

1557.15

2316.16

e6/l

0.43

1203

5272

Bacterial pneumoniae

560

2975

1.68

28.24

1.7

1.5

667.05

3354.11

e6/l

1.18

455

2416

Asthma, hospital admissions , main diagnosis only

1218

7644

1.42

28.19

1.5

920.14

2264.67

e6/l

1.43

1017

6173

Azathioprine

264

1270

2.12

28.03

1.6

1.5

336.63

3771.17

e6/l

0.62

221

1021

Other problems related to primary support group, including family circumstances

229

1013

2.25

28.01

4.1

1.5

16338.34

1177.80

e6/l

0.46

183

812

Cramp and spasm

113

365

3.23

27.98

1.5

1.6

346.80

1824.65

e6/l

0.98

293

Chronic lower respiratory diseases

1828

7301

1.34

27.96

1.4

1.5

1044.95

2239.35

e6/l

1.16

1500

5914

Other and unspecified anaemias

552

3178

1.67

27.92

1.9

1.5

1878.54

3197.72

e6/l

0.39

447

2600

Arthropathies

1419

5175

1.40

27.87

1.4

1.5

1522.50

2427.97

e6/l

0.42

1164

4138

Other necrotizing vasculopathies

137

493

2.87

27.86

1.3

1.4

1134.21

944.31

e6/l

0.08

114

400

Bacterial pneumonia, not elsewhere classified

531

2789

1.69

27.85

1.7

1.5

690.74

3537.15

e6/l

1.17

431

2271

Other disorders of bladder

182

756

2.46

27.52

1.4

613.48

1313.53

e6/l

0.85

160

617

Other anaemias

554

3198

1.66

27.46

1.9

1.5

1870.19

3177.02

e6/l

0.39

449

2617

Leukaemia of unspecified cell type

7.82

27.32

7.5

1.3

7.80

593.67

e6/l

0.96

Other viral diseases, not elsewhere classified

444

2549

1.76

26.91

1.9

1.7

546.44

2466.94

e6/l

0.71

358

2063

Other symptoms and signs involving the urinary system

178

742

2.46

26.78

1.8

1.6

1141.18

1129.75

e6/l

0.00

147

614

Rheumatism, unspecified

214

966

2.26

26.70

1.3

1.4

1444.15

1121.42

e6/l

0.15

179

784

Persons with potential health hazards related to communicable diseases

623

3896

1.60

26.69

1.7

1.5

1308.57

2078.62

e6/l

0.24

522

3133

Aplastic and other anaemias

591

3422

1.62

26.68

1.9

1.5

1769.99

3010.64

e6/l

0.40

479

2804

Disorders of sclera, cornea, iris and ciliary body

798

5319

1.51

26.64

1.4

1.5

6816.28

1916.64

e6/l

0.54

663

4325

Viral pneumonia

216

981

2.25

26.58

1.6

601.18

1075.49

e6/l

0.66

185

794

Zoster [herpes zoster]

672

4248

1.57

26.56

1.6

1.4

4134.56

2417.02

e6/l

0.22

541

3465

Bacterial pneumonia (organism specified)

604

3423

1.61

26.49

1.7

1.5

635.61

3079.20

e6/l

1.26

497

2789

Cough

581

3410

1.63

26.45

1.8

1.6

793.44

3568.65

e6/l

1.44

467

2741

Other metabolic disorders

224

1035

2.21

26.42

1.6

1.5

246.84

1185.85

e6/l

2.08

179

857

Disorders of refraction and accommodation

432

2481

1.76

26.32

1.7

10438.47

1136.99

e6/l

0.56

354

1984

Lesion of lateral popliteal nerve

104

332

3.25

26.21

1.3

1.5

801.13

1994.48

e6/l

0.56

264

Irregular menses

745

3852

1.54

26.17

1.5

1.4

6474.84

1453.45

e6/l

0.51

609

3111

Benign neoplasm: Brain, supratentorial

113

5.25

25.82

2.3

1.7

2593.87

142.95

e6/l

0.80

Fungal Sepsis

251

3.61

25.79

1.8

1.3

40.22

1035.89

e6/l

1.30

211

Other and unspecified dermatitis

749

4969

1.52

25.60

1.6

1.5

1413.57

2593.52

e6/l

0.56

618

4041

Dermatitis

879

5998

1.47

25.60

1.6

1.5

1310.14

2375.07

e6/l

0.62

730

4868

Trigeminal neuralgia

117

405

2.98

25.60

1.5

364.73

1398.53

e6/l

0.80

321

Hypokalaemia

185

800

2.36

25.59

1.7

1.5

412.63

1229.91

e6/l

1.28

161

660

Cluster headache, strict, including avohilmo

112

379

3.07

25.58

1.4

1.5

218.45

1713.09

e6/l

1.07

303

Volume depletion

145

560

2.64

25.58

1.5

1.7

426.50

709.22

e6/l

0.39

124

466

Other and unspecified types of non-Hodgkin lymphoma, hilmo

277

3.46

25.56

1.7

1.3

529.77

596.90

e6/l

0.04

227

Implicit fungal Sepsis

229

3.74

25.54

1.7

1.3

42.39

743.88

e6/l

0.88

192

Other infectious diseases

159

644

2.53

25.50

1.7

1.5

218.89

1405.45

e6/l

1.63

129

528

Parkinson's disease

212

974

2.22

25.34

1.4

258.55

1127.22

e6/l

3.21

186

794

Pneumonitis due to solids and liquids

136

512

2.72

25.31

1.6

630.89

1105.37

e6/l

0.48

111

423

Cardiac arrhythmias

854

3740

1.49

25.20

1.3

1.4

1144.15

600.42

e6/l

1.18

713

2974

Neuralgia and neuritis, unspecified

104

340

3.16

25.17

1.8

1.4

685.06

414.61

e6/l

0.21

279

Dermatitis and eczema

1630

7603

1.34

25.15

1.5

1476.82

2128.90

e6/l

0.40

1335

6165

Drug-induced neutropenia

140

539

2.68

25.06

2.1

1.4

254.59

1277.67

e6/l

1.15

128

432

Benign paroxysmal vertigo

399

2282

1.77

25.03

1.4

1220.91

1437.30

e6/l

0.15

338

1858

Transport accidents

674

3760

1.55

25.02

1.3

1.5

767.14

1688.86

e6/l

1.53

547

3080

Type 2 diabetes, wide definition

1101

4996

1.42

24.82

1.5

1.4

1361.66

2590.76

e6/l

0.76

910

4049

Irritable bowel syndrome

421

2456

1.74

24.62

1.3

1.5

354.20

2892.14

e6/l

1.03

346

2010

Disorders of psychological development

237

1063

2.11

24.58

2.0

931.80

4496.14

e6/l

0.50

192

847

Vocal cord dysfunction

195

779

2.28

24.58

1.5

876.19

1284.61

e6/l

0.37

157

645

Chronic sinusitis

629

4057

1.56

24.43

1.4

4820.51

2187.78

e6/l

0.32

507

3281

Cluster headache, wide,, including avohilmo

114

401

2.94

24.30

1.4

1.5

216.20

1743.40

e6/l

1.19

321

Other viral diseases, not elsewhere classified

317

1705

1.89

24.25

2.1

1.7

690.41

3429.13

e6/l

0.67

259

1386

Hypothyreosis and Thyroxine purchase for inclusion criteria

1325

6386

1.37

24.24

1.4

1.5

1314.89

2349.95

e6/l

0.65

1091

5183

Substance use, excluding alcohol

322

1746

1.87

24.20

1.6

1.4

13293.84

989.51

e6/l

0.52

250

1419

Functional dyspepsia

395

2281

1.75

23.98

1.4

1.5

1005.88

2998.36

e6/l

0.63

329

1862

Other and unspecified paralytic syndromes

5.75

23.96

1.3

301.79

214.66

e6/l

0.18

Other and unspecified effects of external causes

444

2653

1.70

23.82

1.3

1.6

2327.08

2302.07

e6/l

0.00

356

2142

Diabetes insipidus

7.00

23.62

1.7

1.3

1222.04

170.27

e6/l

0.84

Infections of the skin and subcutaneous tissue

856

5870

1.46

23.57

1.9

1.5

1319.15

2372.73

e6/l

0.59

716

4743

Undetermined asthma, excluding more controls

196

899

2.22

23.51

1.5

1.4

320.36

5009.96

e6/l

0.61

165

733

Other bacterial intestinal infections

327

1798

1.84

23.47

1.7

1.5

693.01

3448.06

e6/l

0.73

259

1454

Coxibs

388

1137

1.81

23.44

1.3

1.6

1266.85

1215.97

e6/l

0.02

308

937

Thrombocytopenia, unspecified

131

507

2.66

23.19

2.7

1.6

359.83

688.74

e6/l

0.52

115

409

Hypothyroidism, other/unspecified

1275

6171

1.37

23.12

1.4

1.5

1363.70

2407.18

e6/l

0.62

1047

4998

Undetermined asthma

196

906

2.20

23.07

1.5

1.4

320.36

4972.01

e6/l

0.61

165

740

Other bacterial intestinal infections

258

1323

1.98

22.98

1.9

1.5

805.03

1125.54

e6/l

0.34

213

1066

Statin medication

1011

4016

1.42

22.75

1.5

1.4

1916.47

1916.19

e6/l

0.00

803

3261

Sequelae with surgical and medical care as external cause

295

1589

1.89

22.68

1.8

1.4

1541.57

1278.70

e6/l

0.11

239

1293

Other infectious diseases

135

537

2.58

22.57

1.7

1.5

111.45

793.75

e6/l

1.87

110

439

Speech and linguistic disorders

184

804

2.25

22.52

2.2

2.1

1117.13

5353.98

e6/l

0.43

147

631

Disorders of the thyroid gland

1352

6566

1.35

22.45

1.4

1.5

1395.32

2289.18

e6/l

0.55

1117

5322

Emotional disorders starting during childhood or adolecense, excluding more controls

291

3.17

22.42

3.2

2.2

344.64

645.17

e6/l

0.22

233

Hypersomnia

5.27

22.23

1.3

34.69

1289.58

e6/l

0.62

Other shoulder lesions

159

688

2.36

22.07

1.4

1619.81

766.19

e6/l

0.42

130

553

Secondary and unspecified malignant neoplasm of lymph nodes

142

585

2.49

22.05

1.9

1.4

607.27

1154.03

e6/l

0.35

113

491

Temporomandibular joint disorders, including avohilmo

671

4432

1.51

21.95

1.4

2458.15

2076.76

e6/l

0.09

555

3605

Postprocedural endocrine and metabolic disorders, not elsewhere classified

197

934

2.15

21.86

1.5

1.4

278.21

1239.54

e6/l

1.83

155

775

Vascular dementia (subcortical)

112

4.70

21.86

1.5

1.4

226.03

260.69

e6/l

0.06

Dislocation, sprain and strain of joints and ligaments at neck level

262

1378

1.94

21.77

1.3

1.5

1105.29

3559.12

e6/l

0.44

214

1124

Fracture of lumbar spine and pelvis

286

1542

1.88

21.77

1.5

1.4

775.24

1197.02

e6/l

0.64

229

1269

Coagulation defects, purpura and other haemorrhagic conditions

295

1611

1.86

21.75

2.1

1.6

890.38

3745.88

e6/l

0.65

257

1299

Fracture of skull and facial bones

322

1806

1.81

21.71

1.5

3431.70

951.07

e6/l

0.63

246

1469

Benign neoplasms

1455

6052

1.33

21.67

1.5

1730.84

1888.11

e6/l

0.07

1182

4928

Inflammatory diseases of female pelvic organs

873

4498

1.44

21.63

1.3

1.4

1046.96

2326.68

e6/l

0.78

708

3653

Sequelae of injuries, of poisoning and of other consequences of external causes

357

2067

1.75

21.58

1.6

1.4

657.64

2844.21

e6/l

0.65

286

1670

Congenital malformations of the nervous system

199

3.73

21.47

2.0

3.5

169.11

254.99

e6/l

0.41

149

Polyarthropathies

955

4432

1.42

21.46

1.4

1.5

928.91

2715.27

e6/l

1.06

803

3553

Type of accident

429

2613

1.66

21.42

1.7

1.5

2323.71

2467.98

e6/l

0.03

375

2118

Injuries to the ankle and foot

1052

6815

1.38

21.31

1.5

908.85

2392.48

e6/l

1.24

863

5516

Supplementary factors related to causes of morbidity and mortality classified elsewhere

462

2870

1.63

21.30

1.7

1.5

2229.77

2318.28

e6/l

0.02

395

2324

Parkinson's disease, strict definition

188

885

2.16

21.23

1.5

1.3

282.01

1050.49

e6/l

2.41

166

725

172

3.90

21.19

1.4

1.6

2665.91

822.48

e6/l

0.46

140

Enthesopathies of lower limb, excluding foot

299

1655

1.83

21.04

1.3

1.5

601.84

1463.64

e6/l

1.24

237

1316

Other/unspecified cytomegaloviral diseases

134

4.37

20.93

2.0

1.3

202.58

938.61

e6/l

0.44

109

Fracture of rib(s), sternum and thoracic spine

398

2392

1.68

20.92

1.5

1.4

1036.64

1315.33

e6/l

0.24

337

1962

KRA_PSY_EATING, excluding more controls

135

553

2.48

20.91

1.2

1.6

304.57

2627.80

e6/l

0.98

112

457

Fasciculation

5.77

20.83

1.3

1.4

580.53

113.63

e6/l

0.37

Manic episode

183

3.75

20.82

1.2

1.4

261.33

521.79

e6/l

0.25

151

Other and unspecified tonsillitis

528

2848

1.57

20.66

1.5

1.4

466.09

2093.87

e6/l

0.67

428

2303

Mixed and other personality disorders

150

653

2.35

20.63

1.3

1.5

469.58

7253.57

e6/l

0.62

113

519

Hyperlipidaemia, other/unspecified

469

2703

1.61

20.63

1.4

1.5

2167.30

2309.25

e6/l

0.04

381

2251

Alcohol dependence

372

2205

1.71

20.63

1.3

1.4

1086.06

1193.58

e6/l

0.10

309

1801

Heterophoria

152

668

2.33

20.46

1.7

1.9

1320.95

1065.55

e6/l

0.09

132

536

Other disorders of ear

1282

6319

1.34

20.09

1.5

1174.04

2366.39

e6/l

0.95

1075

5109

Cytomegalovirus infection, IBD co-morbidity

147

4.09

20.05

2.0

1.3

198.63

874.48

e6/l

0.43

118

Specific development disorders of speech and language

131

523

2.49

20.05

2.0

2.5

1442.32

7806.08

e6/l

0.41

105

402

Diseases of the skin and subcutaneous tissue

1474

5645

1.32

19.89

1.6

1.5

1355.91

2341.22

e6/l

0.55

1225

4556

Visual impairment including blindness (binocular or monocular)

110

422

2.67

19.84

1.5

1.7

194.99

718.78

e6/l

0.96

345

Exclusions for E4_PCOS_CONSORTIUM

1063

4880

1.37

19.75

1.4

1.5

4523.49

1436.67

e6/l

0.44

876

3956

Viral infections of central nervous system, not elsewhere classified/unspecified

4.91

19.73

1.4

1.3

333.51

149.83

e6/l

0.49

Other arthritis (FG)

436

2727

1.62

19.58

1.4

1.5

537.60

3385.01

e6/l

1.16

360

2229

Acute alcohol intoxication

355

2111

1.70

19.48

1.3

1.4

1036.39

1219.33

e6/l

0.17

286

1727

Lung diseases due to external agents

182

876

2.11

19.41

1.6

1.5

561.82

878.39

e6/l

0.47

149

728

Other specified/unspecified arthritis

384

2333

1.66

19.41

1.4

1.5

569.92

3825.80

e6/l

1.11

320

1888

Paracetamol or NSAID medication

244

623

1.99

19.34

1.9

2.0

846.92

746.73

e6/l

0.07

202

510

Covid-19 suspected case

344

2034

1.71

19.33

1.5

384.36

2722.25

e6/l

0.71

287

1653

Allergic asthma (mode), excluding more controls

332

1899

1.73

19.31

1.4

428.71

3106.84

e6/l

0.76

276

1515

Other enthesopathies

400

2459

1.64

19.28

1.3

1.5

1615.60

3253.94

e6/l

0.48

330

1997

Malignant neoplasm, wide definition for exclusion

1272

5631

1.33

19.22

2.2

1.4

993.14

2203.25

e6/l

1.04

984

4624

Social phobias

145

641

2.31

19.20

1.6

1.5

1498.59

1242.88

e6/l

0.07

110

523

Early lumbar disc prolapse, operated

160

737

2.21

19.17

1.3

1.5

375.17

1073.28

e6/l

1.24

140

597

Exposure to other specified factors

1087

7440

1.35

19.16

1.5

1579.49

2144.08

e6/l

0.28

865

6058

Cytomegaloviral disease

152

3.94

19.14

2.0

1.3

198.63

596.13

e6/l

0.38

123

Allergic asthma (mode)

332

1905

1.72

19.11

1.4

428.71

3099.80

e6/l

0.76

276

1522

Immunodeficiency with predominantly antibody defects

190

3.59

19.07

2.6

1.7

57.18

193.30

e6/l

1.51

149

Inflammatory disease of uterus

235

1250

1.91

18.95

1.2

1.4

299.57

4361.55

e6/l

0.77

195

1016

Ptosis of eyelid

166

781

2.17

18.89

1.6

1.5

636.69

1205.61

e6/l

0.76

137

630

Injuries to the wrist and hand

1439

7704

1.30

18.86

1.4

1.5

1440.10

2104.97

e6/l

0.41

1150

6286

Monoplegia

106

4.63

18.84

1.4

1.3

273.89

118.33

e6/l

0.29

Nystagmus and other irregular eye movements

102

4.72

18.82

1.8

2.3

183.39

152.30

e6/l

0.06

Injuries to the shoulder and upper arm

1156

7009

1.34

18.80

1.5

673.44

2448.30

e6/l

2.13

965

5683

Restless leg syndrome

203

1032

2.00

18.73

1.4

754.53

1259.49

e6/l

0.66

152

839

Voice disturbances

362

2188

1.67

18.71

1.3

1.4

482.71

3137.16

e6/l

0.93

286

1786

Intracranial and intraspinal abscess and granuloma

5.88

18.69

3.1

1.3

289.86

1793.85

e6/l

0.43

Iridocyclitis

324

1904

1.72

18.64

1.4

1.5

3816.21

1418.00

e6/l

0.52

267

1534

Disorders of synovium and tendon

705

4302

1.45

18.60

1.5

3005.63

2713.08

e6/l

0.07

592

3479

Disorders of speech understanding and production

100

374

2.72

18.37

1.9

3.0

1835.37

11076.24

e6/l

0.42

283

Speech therapy

353

2131

1.68

18.35

1.7

1.5

894.99

1224.62

e6/l

0.35

289

1737

Gastro-oesophageal reflux disease

928

5862

1.37

18.30

1.3

1.5

2858.51

2198.98

e6/l

0.11

766

4777

Chronic apical periodontitis

1597

7123

1.28

18.26

1.4

1.5

2533.58

1925.61

e6/l

0.29

1293

5810

Alcohol abuse, main dg

247

1352

1.86

18.20

1.3

1.5

873.87

3860.30

e6/l

0.57

199

1099

Superficial injury of abdomen, lower back and pelvis

235

1270

1.88

18.03

1.4

1.6

505.72

3922.65

e6/l

0.62

192

1027

Viral infections of central nervous system, not elsewhere classified/unspecified

5.25

17.92

1.5

1.3

378.45

124.68

e6/l

0.59

Sequelae of injuries of head

102

398

2.64

17.91

1.6

1.5

788.93

1638.33

e6/l

0.46

323

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

302

2.90

17.88

1.5

1.4

340.38

615.83

e6/l

0.32

251

Unspecified acute lower respiratory infection

227

1217

1.89

17.86

1.5

1.6

3327.88

1328.60

e6/l

0.34

190

1002

Explicit bacterial Sepsis

141

635

2.26

17.85

2.3

1.5

949.04

1529.92

e6/l

0.38

118

520

Disturbance of activity and attention

211

1083

1.94

17.81

1.3

1.9

303.84

811.02

e6/l

0.92

171

878

Osteoporosis

314

1728

1.72

17.73

1.8

1.5

2406.57

1324.40

e6/l

0.23

260

1420

Acute alcohol intoxication, ICD10

303

1774

1.73

17.72

1.3

1.5

616.79

3205.97

e6/l

0.67

241

1440

Congenital malformations, deformations and chromosomal abnormalities

857

5945

1.38

17.71

1.6

1.5

1629.44

1861.30

e6/l

0.10

693

4828

Any event in cancer register

1323

5986

1.31

17.68

2.2

1.4

1152.63

2172.60

e6/l

0.86

1043

4902

Need for other prophylactic measures

112

460

2.51

17.68

2.5

1.8

61.97

1191.83

e6/l

1.77

369

Dystonia

102

401

2.62

17.64

1.4

1.5

427.34

1490.20

e6/l

0.74

327

Problems related to lifestyle

170

829

2.09

17.63

1.6

1.5

768.40

5508.17

e6/l

0.56

144

682

Other nutritional deficiencies

937

6522

1.36

17.61

1.4

1.5

1072.93

2338.88

e6/l

1.00

752

5286

Monoamine oxidase A inhibitors

156

736

2.15

17.61

1.2

1.4

992.34

672.16

e6/l

0.19

124

603

Erysipelas

899

5017

1.38

17.59

1.4

2214.47

2789.83

e6/l

0.19

744

4065

Arnold-Chiari syndrome

5.46

17.56

2.1

137.82

143.03

e6/l

0.02

Fall on and from stairs and steps

362

2227

1.64

17.50

1.3

1.5

895.16

3082.58

e6/l

0.69

289

1812

Venous thromboembolism

666

4499

1.44

17.49

1.6

1.4

1420.88

2721.05

e6/l

0.65

555

3683

Dentofacial anomalies [including malocclusion]

1011

6060

1.35

17.46

1.5

1877.32

1985.85

e6/l

0.03

830

4904

Pain and other conditions associated with female genital organs and menstrual cycle

320

1748

1.70

17.46

1.4

1062.42

1526.63

e6/l

0.31

260

1434

Bacterial intestinal infections, IBD co-morbidities

248

1379

1.82

17.34

1.9

1.5

621.15

1182.68

e6/l

0.85

203

1119

Vascular syndromes of brain in cerebrovascular disorders

212

3.25

17.21

1.5

1.4

2413.93

1037.03

e6/l

0.50

177

Other disorders of optic disc

4.63

17.19

1.4

1.2

29.43

132.44

e6/l

0.93

Non-allergic asthma (mode)

248

1369

1.81

17.13

1.3

1.5

3161.13

3582.71

e6/l

0.05

203

1109

Deforming dorsopathies

352

2161

1.64

17.12

1.4

1.6

922.73

1180.15

e6/l

0.24

294

1727

Unspecified/other endometriosis

164

801

2.09

16.98

1.4

367.74

892.36

e6/l

0.73

132

661

Atypical facial pain

351

2.70

16.91

1.4

1.5

180.21

1365.70

e6/l

0.85

283

Disorders of muscles

150

709

2.15

16.90

1.3

1.4

295.76

512.70

e6/l

0.52

120

580

Urticaria and erythema

527

3555

1.50

16.88

1.6

1009.32

2251.20

e6/l

0.58

444

2881

Purpura and other haemorrhagic conditions

200

1050

1.94

16.84

2.4

1.5

559.60

4825.71

e6/l

0.65

175

855

Secondary uncertain malignant neoplasm

181

919

2.00

16.78

1.8

1.4

482.28

1292.56

e6/l

0.87

151

760

Erysipelas

668

4159

1.43

16.76

1.5

1.4

1683.27

2806.18

e6/l

0.37

561

3377

Nonpyogenic thrombosis of intracranial venous system

5.77

16.69

1.8

1.3

8496.43

139.13

e6/l

0.48

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

130

585

2.27

16.64

2.0

1.6

30307.19

1222.80

e6/l

0.49

101

481

Hypermobility syndrome

106

437

2.50

16.62

1.3

1.6

1774.72

9901.88

e6/l

0.46

351

Dementia due to Parkinsons disease, excluding more controls

13.73

16.55

1.5

1.1

257.64

25.13

e6/l

0.56

Non-allergic asthma (mode), excluding more controls

248

1385

1.79

16.50

1.3

1.5

3161.13

3649.27

e6/l

0.06

203

1122

Malignant neoplasm

1200

5442

1.31

16.40

2.3

1.4

1071.10

2269.77

e6/l

0.96

926

4461

Congenital malformations, deformations and chromosomal abnormalities

927

6373

1.35

16.39

1.6

1.5

1572.65

2341.98

e6/l

0.40

752

5178

Diaphragmatic hernia

451

2965

1.53

16.36

1.4

714.10

1484.83

e6/l

1.85

355

2435

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

714

4980

1.40

16.23

1.4

1.5

959.69

2240.36

e6/l

0.94

605

4015

Other disorders of glucose regulation and pancreatic internal secretion

141

664

2.17

16.11

1.8

1.9

307.72

1262.71

e6/l

1.10

119

534

Soft tissue disorders related to use, overuse and pressure

341

2112

1.63

16.06

1.3

1.4

899.53

2408.34

e6/l

0.77

275

1725

Other congenital malformations of nervous system

4.99

15.99

2.1

2.3

137.82

222.59

e6/l

0.30

Hyperkinetic disorders

220

1189

1.84

15.82

1.3

2.0

296.91

3863.25

e6/l

0.61

175

964

Superficial injury of lower leg

354

2223

1.61

15.79

1.3

1.5

577.27

2800.04

e6/l

0.73

281

1806

Adrenocortical insufficiency

262

2.93

15.77

1.6

109.02

275.26

e6/l

0.83

206

Propionic acid derivatives

391

1225

1.62

15.75

1.6

1.8

668.40

1169.04

e6/l

0.66

314

1005

Schizoaffective disorder

136

639

2.18

15.68

1.2

1.5

379.51

1433.05

e6/l

1.17

111

513

Mycoses

1183

7987

1.29

15.60

1.4

1.5

1253.86

2121.48

e6/l

0.66

940

6520

Other heart diseases, wide

1350

6478

1.28

15.52

1.4

1.5

995.08

2421.94

e6/l

1.30

1124

5197

Haemorrhage from respiratory passages

421

2479

1.54

15.52

1.6

1.5

2212.18

4014.51

e6/l

0.37

340

2029

Appendectomy

910

6535

1.34

15.49

1.4

3889.91

1966.35

e6/l

0.35

756

5280

Paralytic ileus and intestinal obstruction

319

1962

1.64

15.43

1.5

562.14

1295.16

e6/l

1.85

273

1601

Diseases of pulp and periapical tissues, including avohilmo

1477

6051

1.27

15.43

1.4

1.5

1468.32

2099.32

e6/l

0.33

1198

4954

Malignant immunoproliferative diseases

5.66

15.42

1.6

1.4

132.86

2166.34

e6/l

0.50

Pulmonary heart disease

354

2237

1.60

15.34

1.6

1.4

1178.99

1287.69

e6/l

0.08

290

1816

Use of pramipexole

278

1658

1.70

15.25

1.3

1.5

381.11

1399.44

e6/l

3.32

225

1353

Other facial nerve disorders

187

3.28

15.25

1.2

1.3

147.30

2199.78

e6/l

0.75

146

Disorders of brain, other and unspecified

5.74

15.20

2.2

1.3

975.04

322.98

e6/l

0.40

Pulmonary embolism

354

2243

1.59

15.17

1.6

1.4

1178.99

1339.98

e6/l

0.13

290

1822

Other disorders of eyelid

522

3416

1.47

15.11

1.4

1.5

779.30

2009.14

e6/l

1.17

423

2811

Myasthenia gravis

107

4.14

15.10

1.6

1.4

119.24

1157.68

e6/l

0.50

Hypoglycaemia, other or unspecified

118

532

2.27

15.08

1.8

2.0

106.29

1384.74

e6/l

1.43

100

429

Other disorders of skin and subcutaneous tissue

886

5907

1.34

15.05

1.6

1.5

1465.06

2539.79

e6/l

0.57

721

4826

Mental disorders, not otherwise specified

146

716

2.08

15.05

1.2

1.5

533.11

6204.32

e6/l

0.58

112

585

Chorioretinal inflammation

210

3.12

14.99

1.4

132.04

1066.03

e6/l

0.86

170

Excessive vomiting in pregnancy

142

691

2.10

14.95

1.3

1.4

283.50

6589.20

e6/l

0.62

112

554

Other and unspecified iron deficiency

419

2766

1.53

14.91

1.5

1968.66

2609.11

e6/l

0.15

343

2242

Anterior Iridocyclitis

285

1722

1.68

14.91

1.4

1.5

4023.18

3321.75

e6/l

0.08

240

1394

Disorders of conjunctiva

1160

7246

1.29

14.90

1.5

558.81

2365.76

e6/l

2.36

923

5894

Autonomic disorders

126

3.80

14.88

1.4

1.2

1165.74

1617.57

e6/l

0.14

Behavioural disorders, excluding more controls

121

3.85

14.86

1.3

2.0

80420.49

711.66

e6/l

0.49

DVT of lower extremities and pulmonary embolism

492

3345

1.48

14.86

1.6

1.4

1434.22

2169.35

e6/l

0.38

410

2743

Lesion of ulnar nerve

191

1031

1.88

14.81

1.4

548.74

1301.65

e6/l

0.92

165

828

Tetraplegia

6.30

14.76

2.7

2.5

2472.43

2569.64

e6/l

0.01

Diseases of the digestive system

565

3946

1.43

14.73

1.5

1423.81

2842.35

e6/l

0.64

476

3206

Sleep disorders, other/unspecified

250

2.89

14.68

1.2

1.6

388.22

1105.31

e6/l

0.48

213

6-mercaptopurine

250

2.89

14.68

10.0

1.6

343.69

1120.51

e6/l

0.54

207

Disorders of skin appendages

665

4804

1.39

14.61

1.5

1.4

1278.83

2001.40

e6/l

0.32

561

3898

Intestinal stricture

375

2433

1.56

14.53

1.5

592.40

1254.44

e6/l

1.75

323

1968

Other specified disorders of muscle

152

3.46

14.50

1.3

1.4

39.12

283.77

e6/l

2.29

124

Alcohol withdrawal state with delirium

112

503

2.28

14.48

1.3

1.4

582.84

1039.44

e6/l

0.44

406

Mental and behavioural disorders due to opioids

303

2.69

14.47

2.1

1.6

50357.35

1246.95

e6/l

0.49

250

Cauda equina syndrome

4.42

14.40

1.4

1.3

800.26

1255.01

e6/l

0.13

Attention to artificial openings

253

2.85

14.35

2.8

1.8

1944.84

950.82

e6/l

0.53

200

Dental caries, including avohilmo

984

3815

1.33

14.26

1.7

1.5

5354.08

1830.36

e6/l

0.44

784

3135

Other diseases of upper respiratory tract

1511

6313

1.25

14.13

1.4

1.5

2723.80

1955.96

e6/l

0.20

1233

5092

Other noninfective gastroenteritis and colitis

338

2156

1.58

14.11

1.5

1.7

531.36

2893.69

e6/l

0.76

277

1751

Conjunctivitis

1059

6857

1.30

14.11

1.6

1.5

549.21

2069.24

e6/l

2.01

840

5585

Diseases of oral cavity, salivary glands and jaws

777

2930

1.37

14.06

1.6

1.5

1489.28

2954.93

e6/l

0.48

629

2396

Transplanted organ and tissue status

160

831

1.96

14.04

3.7

1.7

130.23

1359.18

e6/l

2.34

126

661

Injuries to the knee and lower leg

1660

7479

1.24

14.01

1.4

1.5

1184.07

2122.04

e6/l

0.83

1356

6082

Mental and behavioural disorders due to sedatives or hypnotics

120

562

2.18

14.01

1.3

1.5

899.54

1465.58

e6/l

0.33

467

Asthma and allergy

190

1029

1.84

13.94

1.4

1.5

576.74

4434.41

e6/l

0.54

166

822

Acetic acid derivatives and related substances

344

1115

1.61

13.93

1.4

1.5

1117.01

1243.41

e6/l

0.08

272

915

Caries of dentine, including avohilmo

1064

4180

1.31

13.91

1.6

5104.26

1746.30

e6/l

0.47

859

3418

SLE (Finngen)

208

3.02

13.91

1.4

1.8

1261.94

1906.91

e6/l

0.17

171

Asthma and allergy, excluding more controls

190

1030

1.84

13.90

1.4

576.74

4455.29

e6/l

0.55

166

819

Other disorders of bone

283

1740

1.65

13.86

1.5

1.4

775.64

3549.79

e6/l

0.71

231

1418

Fourth [trochlear] nerve palsy

148

3.46

13.75

1.9

1.3

150.98

881.69

e6/l

0.47

116

Disturbances of smell and taste

220

2.94

13.74

1.4

1.6

1056.30

1486.35

e6/l

0.16

181

Acute and subacute iridocyclitis

266

1614

1.67

13.74

1.4

1.5

4176.54

1171.69

e6/l

0.56

225

1304

Thiamine deficiency

6.69

13.72

1.1

1.5

175.93

224.45

e6/l

0.08

Other congenital malformations of circulatory system

190

3.12

13.61

2.5

1.4

456.36

724.95

e6/l

0.17

150

Protozoal diseases

206

3.02

13.59

1.7

1.3

168.27

717.45

e6/l

0.51

168

Pulmonary heart disease, diseases of pulmonary circulation

371

2438

1.53

13.57

1.6

1.4

1130.57

2150.38

e6/l

0.52

304

1986

Agoraphobia

211

2.98

13.57

1.2

1.5

197.87

2009.57

e6/l

0.73

174

Other symptoms and signs involving the circulatory and respiratory systems

106

478

2.26

13.56

1.5

1.6

471.79

1261.29

e6/l

0.72

381

Diseases of male genital organs

673

2446

1.40

13.55

1.4

1.7

2478.20

1941.90

e6/l

0.16

545

1975

Nonhereditary hypogammaglobulinemia

4.86

13.54

1.4

1.2

52.54

115.19

e6/l

0.31

Diseases of liver

435

2957

1.48

13.54

1.5

1.4

1529.43

2690.30

e6/l

0.33

345

2425

Acute appendicitis, no complications

778

5814

1.34

13.47

1.4

4726.35

2059.55

e6/l

0.43

643

4708

Other and unspecified disorders of binocular movement

6.03

13.42

2.2

320.16

35.78

e6/l

0.46

All influenza (not pneumonia)

214

1233

1.76

13.40

1.5

1.6

563.46

4234.70

e6/l

0.65

177

991

Disorders of lens

841

3951

1.34

13.35

1.5

1.4

896.62

2213.13

e6/l

1.35

685

3193

Contact with and exposure to communicable diseases

466

3208

1.46

13.29

1.4

1.6

1560.04

2341.81

e6/l

0.19

410

2581

Unspecified haematuria

488

2806

1.45

13.29

1.5

1575.47

2229.38

e6/l

0.23

409

2293

Keratitis

470

3258

1.45

13.23

1.5

1.4

8775.46

1273.28

e6/l

0.50

393

2641

Degeneration of the brain due to alcohol

127

3.61

13.22

1.1

1.4

145.11

1003.33

e6/l

0.51

106

Algoneurodystrophy

248

2.79

13.21

1.4

1.5

562.62

2412.91

e6/l

0.85

198

Disorders of mineral metabolism

122

588

2.11

13.21

1.5

1.6

1204.01

1434.23

e6/l

0.09

101

488

Beningn neoplasm: Meninges, unspecified

104

3.95

13.20

1.9

1.3

1052.88

197.43

e6/l

0.77

Temporal arteritis

237

2.83

13.17

1.2

1.3

2058.73

725.67

e6/l

0.32

196

Trochanteric bursitis

179

985

1.84

13.10

1.3

1.4

832.87

1104.03

e6/l

0.23

142

797

Diseases of arteries, arterioles and capillaries (FINNGEN)

285

1213

1.64

13.10

1.6

1.3

1401.79

871.39

e6/l

0.38

239

964

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

540

3827

1.42

13.09

1.4

1.5

1137.85

2198.17

e6/l

0.39

434

3089

Disorders of optic nerve, not elsewhere classified

133

3.53

13.07

1.4

1.3

22.18

947.21

e6/l

0.60

109

Giant cell arteritis with polymyalgia rheumatica

238

2.82

13.07

1.2

1.3

2058.73

725.93

e6/l

0.32

196

Noninfective enteritis and colitis

623

4540

1.38

13.03

1.5

1.6

549.45

2073.22

e6/l

1.15

505

3699

Varicella [chickenpox]

436

2.30

13.00

2.1

2.3

1087.71

1023.24

e6/l

0.03

348

L04AD Calcineurin inhibitors

176

969

1.85

12.95

2.7

1.9

229.13

1101.36

e6/l

1.73

135

766

Anti-inflammatory and antirheumatic products, non-steroids

376

1226

1.55

12.91

1.5

1.8

1088.03

1169.04

e6/l

0.05

304

1005

Streptococcal septicaemia

119

573

2.11

12.91

2.4

1.4

985.73

1064.03

e6/l

0.04

100

471

Giant cell arteritis

268

2.69

12.90

1.2

1.3

1915.84

896.03

e6/l

0.25

220

Use of dimethyl fumarate

4.83

12.88

1.0

1.2

17.52

226.85

e6/l

1.08

Carpal tunnel syndrome

743

4905

1.34

12.87

1.3

1.4

1534.49

2331.44

e6/l

0.43

627

3949

Other/unspecified disorders of vestibular function

280

2.65

12.86

1.3

1.5

2985.32

960.56

e6/l

0.34

235

Other diseases of the respiratory system

237

1422

1.68

12.78

1.7

1.6

1035.40

870.01

e6/l

0.10

194

1142

Other respiratory disorders and diseases

237

1422

1.68

12.78

1.7

1.6

1035.40

870.01

e6/l

0.10

194

1142

Spondyloarthritis

233

1392

1.69

12.78

1.4

3080.10

4164.92

e6/l

0.11

198

1123

Nutritional anaemias

593

4149

1.39

12.74

1.5

1553.08

2853.85

e6/l

0.51

495

3396

Use of fingolimod

4.73

12.64

1.3

1.7

0.88

132.16

e6/l

0.96

Special screening examination for infectious and parasitic diseases

305

1423

1.59

12.56

1.4

303.40

649.87

e6/l

1.26

212

1098

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

115

554

2.12

12.53

1.4

1.6

840.62

1470.52

e6/l

0.43

452

Candidiasis

388

2622

1.49

12.51

1.5

1.4

1113.76

2646.21

e6/l

0.52

315

2139

Adverse effects, not elsewhere classified

287

1819

1.60

12.47

1.3

1.7

3014.89

3113.72

e6/l

0.01

236

1467

Special screening examination for other diseases and disorders

135

688

1.98

12.47

1.6

1.4

843.88

652.12

e6/l

0.21

118

538

Infections with a predominantly sexual mode of transmission

568

3832

1.39

12.37

1.5

1.4

2101.27

1890.97

e6/l

0.06

450

3123

Diseases of pulp and periapical tissues and dental caries

877

3423

1.32

12.35

1.7

1.5

1620.27

1798.25

e6/l

0.08

699

2823

Polycystic ovarian syndrome, consortium definition

964

4425

1.30

12.34

1.5

1.4

5318.05

1397.44

e6/l

0.52

794

3587

Weight loss

144

755

1.94

12.34

1.7

333.09

1248.81

e6/l

1.33

127

610

Chronic rhinitis, nasopharyngitis and pharyngitis

430

2977

1.46

12.23

1.4

1.6

594.63

2439.50

e6/l

0.85

342

2416

Abnormal weight loss

133

682

1.99

12.18

1.3

1.7

353.55

1187.42

e6/l

1.04

116

551

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1341

7061

1.24

12.15

1.9

1.4

986.06

2343.24

e6/l

1.30

1104

5696

Iron deficiency anaemia

507

3564

1.41

12.15

1.5

1646.58

2852.24

e6/l

0.38

415

2916

Abnormal blood-pressure reading, without diagnosis

330

2.45

12.14

1.3

1.7

904.75

1482.67

e6/l

0.25

267

Leisure time condition

250

1543

1.64

12.14

1.7

1.6

1537.25

3431.11

e6/l

0.34

220

1254

Excessive, frequent and irregular menstruation

546

2129

1.41

12.10

1.4

8175.63

1395.59

e6/l

0.50

448

1754

Cutaneous abscess, furuncle and carbuncle

351

2341

1.51

12.09

1.6

1.4

439.53

2944.17

e6/l

0.92

293

1893

Missing teeth due to accident, extraction or parodontitis

719

5106

1.33

12.08

1.5

1.4

1485.77

2764.40

e6/l

0.75

576

4182

Other obstetric conditions, not elsewhere classified

485

2163

1.44

12.05

1.3

728.34

2889.56

e6/l

0.64

400

1761

Other and unspecified injuries of head

103

483

2.17

12.02

1.4

1.8

1513.18

1454.80

e6/l

0.02

397

Urticaria

423

2931

1.46

12.01

1.6

807.28

2406.46

e6/l

0.64

351

2378

Disorders of choroid and retina

990

5510

1.28

12.00

1.5

1325.79

2696.59

e6/l

0.85

790

4512

Hypothyroidism, strict autoimmune, 3 medication purchases required

1106

5927

1.27

11.94

1.4

1438.21

2443.47

e6/l

0.54

922

4812

Enterocolitis due to Clostridium difficile

139

728

1.94

11.93

2.1

1.6

296.72

918.73

e6/l

1.36

115

596

Other disorders of adrenal gland

352

2.39

11.90

1.6

1.8

800.12

288.17

e6/l

0.33

274

Amenorrhoea

118

586

2.05

11.85

1.4

32790.18

998.47

e6/l

0.49

486

Hernia of abdominal wall, postoperative

209

1240

1.70

11.80

1.5

1.3

10713.04

1911.76

e6/l

0.43

179

1029

Acute pharyngitis

224

1344

1.67

11.77

1.6

1.5

1089.31

3794.32

e6/l

0.47

185

1064

Obsessive-compulsive disorder

106

507

2.13

11.76

1.3

1.6

588.51

1332.58

e6/l

0.45

421

Diabetic neuropathy

136

707

1.94

11.76

1.6

1.5

16794.17

989.57

e6/l

0.51

113

570

Insulin, intermediate and long-acting

678

4949

1.34

11.72

1.6

1.5

1667.89

2411.42

e6/l

0.31

578

4042

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

109

528

2.10

11.70

1.3

1.5

19739.48

899.11

e6/l

0.50

440

Panniculitis affecting regions of neck and back

229

2.73

11.69

1.4

1.5

10154.44

511.08

e6/l

0.48

180

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

5.36

11.68

2.4

1.2

1819.65

332.00

e6/l

0.42

Other postsurgical states

106

511

2.12

11.56

2.1

1.7

486.57

1465.84

e6/l

0.88

409

Other or unspecified ileus, impaction or obstruction

221

1338

1.67

11.55

1.5

744.13

1220.99

e6/l

0.67

189

1098

Other viral hepatitis

107

518

2.11

11.55

1.8

1.5

33816.56

1327.90

e6/l

0.49

417

Conjunctivitis (acute, non atopic)

389

2665

1.47

11.52

1.6

572.07

2628.90

e6/l

0.84

317

2160

Superficial injury of hip and thigh

180

1032

1.76

11.52

1.2

1.5

985.59

1004.09

e6/l

0.01

148

838

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

196

1153

1.72

11.49

1.7

1.4

518.89

1028.06

e6/l

0.56

161

952

Maternal care for other conditions predominantly related to pregnancy

302

1936

1.55

11.44

1.3

1.4

344.71

3467.48

e6/l

0.95

233

1559

Immunodeficiencies

384

2.30

11.41

2.3

1.9

73.18

1642.41

e6/l

1.35

305

Other disorders starting during childhood or adolecense, excluding more controls

330

2.37

11.37

3.4

2.6

198.12

658.25

e6/l

0.45

257

Oter anti-inflammatory and antirheumatic agents, non-steroids

257

872

1.64

11.36

1.3

1.5

1305.17

1395.12

e6/l

0.05

207

729

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

472

2115

1.43

11.36

1.4

1.3

745.10

2935.95

e6/l

0.63

391

1723

Mycoses

339

2276

1.50

11.34

1.6

1.4

548.35

2946.58

e6/l

0.82

285

1838

Chronic gastritis

309

2036

1.53

11.28

1.3

1.5

674.42

1294.67

e6/l

1.28

247

1678

Hypermetropia

119

604

2.01

11.26

1.8

2.2

1490.72

1166.81

e6/l

0.12

475

Lagophthalmos

4.35

11.24

1.7

1.3

740.67

164.98

e6/l

0.54

Drug-induced polyneuropathy

4.67

11.21

13.5

1.8

5.05

206.43

e6/l

1.29

Injuries to the hip and thigh

555

3684

1.37

11.21

1.5

822.61

2787.14

e6/l

1.02

456

3012

Myeloid leukaemia

168

3.01

11.17

3.1

1.3

42.54

855.09

e6/l

0.69

139

Internal derangement of knee

485

3471

1.40

11.17

1.3

1.5

779.40

3279.44

e6/l

1.25

403

2790

Asthma/COPD (KELA code 203)

1304

7284

1.23

11.16

1.4

1.5

969.68

2244.16

e6/l

1.26

1068

5901

Maltreatment syndromes

427

2.20

11.09

1.2

1.6

181.63

9826.29

e6/l

0.60

355

Spondylolisthesis/Spondylolysis

209

1262

1.67

11.08

1.2

1.5

1503.63

973.42

e6/l

0.34

175

1009

Metatarsalgia

129

678

1.93

11.01

1.2

1.5

1484.62

839.73

e6/l

0.31

100

543

Mouth breathing

516

3756

1.38

11.00

1.5

1.6

618.32

3013.29

e6/l

1.38

428

3027

Arthrosis

924

3962

1.29

10.98

1.3

1.5

2526.98

3024.74

e6/l

0.13

765

3176

Other specified and unspecified personality disorders

139

750

1.88

10.97

1.4

1.5

145.24

6212.75

e6/l

0.67

112

612

Lack of expected normal physiological development

3.61

10.97

2.7

1.8

248.61

46631.92

e6/l

0.52

Decubitus ulcer and pressure area

352

2.31

10.94

2.3

1.4

770.35

852.70

e6/l

0.06

287

Unspecified privation

152

844

1.83

10.93

1.2

1.5

645.21

1165.14

e6/l

0.43

110

693

Symptoms and signs involving emotional state

181

2.89

10.90

1.2

2.0

336.95

145.79

e6/l

0.41

145

Viral and other specified intestinal infections

300

1932

1.53

10.90

1.5

1.7

1819.03

2741.15

e6/l

0.16

264

1556

Degeneration of nervous system due to alcohol

144

3.17

10.90

1.1

1.4

145.11

927.82

e6/l

0.53

119

Obesity and other hyperalimentation

846

6377

1.28

10.86

1.4

1.5

1031.40

2386.07

e6/l

1.06

688

5167

Heart failure, not strict

915

4880

1.28

10.85

1.5

4795.35

1651.70

e6/l

0.69

776

3941

Other enthesopathy of foot (+metatarsalgia)

136

732

1.88

10.80

1.2

1.5

1429.82

920.81

e6/l

0.24

104

588

Other gastritis (incl. Duodenitis)

263

1692

1.57

10.75

1.5

1.4

629.86

1436.63

e6/l

1.62

223

1392

Abnormal findings on diagnostic imaging of other body structures

182

1070

1.72

10.73

1.5

1.4

1112.43

1422.31

e6/l

0.24

142

866

Obesity

842

6363

1.28

10.73

1.4

1.5

1034.89

2390.04

e6/l

1.05

685

5158

Assault

201

1214

1.68

10.72

1.3

1.5

321.81

4116.68

e6/l

0.68

150

985

Ovarian cyst

492

2032

1.41

10.71

1.3

1.4

2712.35

1453.11

e6/l

0.36

402

1677

Fall on same level involving ice and snow

727

5596

1.31

10.67

1.4

1.5

1030.73

2508.70

e6/l

1.04

585

4566

Pain associated with micturition

159

904

1.78

10.57

1.6

1144.37

1291.70

e6/l

0.07

128

733

Malnutrition

131

3.25

10.56

2.0

2.3

5129.41

1016.24

e6/l

0.44

104

Oxicams

272

983

1.58

10.56

1.4

1.6

1627.25

1309.70

e6/l

0.13

232

820

Other disorders of peripheral nervous system

5.53

10.53

1.2

5.13

159.72

e6/l

0.54

Viral hepatitis

118

613

1.96

10.50

1.8

1.5

31056.67

1370.29

e6/l

0.48

498

Other eating disorders

417

2.18

10.48

1.3

1.8

418.53

9408.30

e6/l

0.52

342

Varicella [chickenpox]

366

2.27

10.47

1.9

1366.38

1156.70

e6/l

0.07

298

Acute renal failure

247

1577

1.58

10.46

1.5

1.4

703.82

1054.65

e6/l

0.63

195

1277

Diseases of appendix

997

7200

1.25

10.40

1.4

3836.16

1924.38

e6/l

0.38

816

5848

Acute appendicitis

934

6947

1.26

10.39

1.4

4014.91

1966.78

e6/l

0.39

765

5626

Failure and rejection of transplanted organs and tissues

3.65

10.36

3.6

1.3

6.76

1289.27

e6/l

0.63

Viral and other specified intestinal infections

389

2633

1.44

10.33

1.6

1566.90

2534.01

e6/l

0.23

333

2135

Adhesive capsulitis of shoulder

195

1181

1.67

10.27

1.5

1.4

511.37

1154.53

e6/l

1.18

166

957

Vascular dementia (undefined)

101

3.47

10.27

1.4

1.3

69.97

299.36

e6/l

0.81

Anankastic personality disorder

294

2.41

10.24

1.5

878.81

732.92

e6/l

0.09

238

Faecal incontinence

113

583

1.97

10.22

2.1

1.4

495.94

1104.85

e6/l

0.85

472

Early lumbar disc prolapse operation

165

959

1.75

10.19

1.3

1.4

362.31

5654.46

e6/l

0.77

145

782

Convergence insufficiency and excess

104

3.53

10.17

1.3

1.2

15.14

98.08

e6/l

1.51

Endometriosis

468

1970

1.40

10.11

1.4

813.34

1479.05

e6/l

0.64

382

1631

Emotional disorders and disorders of social functioning with onset specific to childhood

482

2.06

10.09

3.0

2.2

327.10

183.04

e6/l

0.27

378

Other diseases of hard tissues of teeth

737

2922

1.31

10.09

1.7

1.5

1720.37

2958.98

e6/l

0.38

584

2390

Diverticular disease of intestine

847

4242

1.28

10.08

1.4

3213.93

1671.82

e6/l

0.26

683

3472

Emotional disorders starting during childhood or adolescence

447

2.11

10.06

3.2

2.2

341.62

8619.37

e6/l

0.48

348

Appendicitis, broad definition

986

7170

1.25

10.01

1.4

3877.39

1933.26

e6/l

0.39

807

5819

Chronic diseases of tonsils and adenoids

1084

5536

1.24

9.99

1.4

1.5

1543.13

2104.13

e6/l

0.21

891

4429

Nephropathy related operations

164

959

1.73

9.92

1.8

1.7

359.97

1137.54

e6/l

1.23

129

775

Fracture of foot, except ankle

329

2259

1.47

9.91

1.5

1752.40

2907.38

e6/l

0.23

266

1828

Dental operations

783

3115

1.30

9.91

1.5

1560.04

1650.83

e6/l

0.04

642

2497

Diseases of middle ear and mastoid

782

5009

1.28

9.82

1.6

1.4

923.60

2028.68

e6/l

0.79

657

4059

Fenamates

183

736

1.70

9.80

1.5

1.6

725.87

1463.19

e6/l

0.95

153

604

Convergent concomitant strabismus

483

2.05

9.78

1.5

2.0

2360.99

1323.14

e6/l

0.24

387

Insulin, combination of fast acting with intermediate-acting or long-acting

747

5329

1.29

9.75

1.6

1.5

1532.09

2404.96

e6/l

0.42

636

4351

Paroxysmal tachycardia

267

1468

1.53

9.71

1.4

1.5

1101.00

770.74

e6/l

0.29

231

1171

Systemic lupus erythematosus

252

2.49

9.71

1.4

1.5

1261.94

452.33

e6/l

0.36

207

Vitamin deficiency, wide

352

2.24

9.70

1.2

1.7

815.43

622.49

e6/l

0.09

290

Vitamin deficiency

352

2.24

9.70

1.2

1.7

815.43

622.49

e6/l

0.09

290

Conductive and sensorineural hearing loss

958

5176

1.25

9.69

1.5

1336.32

2771.73

e6/l

0.93

810

4185

Mixed connective tissue disease

479

2.04

9.63

1.4

1.5

171.70

1220.06

e6/l

1.07

388

Other and unspecified immunodeficiencies with predominantly antibody defects

3.75

9.54

4.0

1.5

62.04

284.85

e6/l

1.33

Senile cataract

725

3442

1.30

9.48

1.5

1.4

967.76

2384.62

e6/l

1.23

602

2789

Viral pneumonia (unknown virus, not influenza)

105

544

1.96

9.46

1.6

858.59

1193.59

e6/l

0.21

438

GI-bleeding

352

2471

1.43

9.40

1.5

1362.17

3739.10

e6/l

0.74

294

2010

Acute and transient psychotic disorders

166

989

1.70

9.40

1.4

1.5

388.66

1271.49

e6/l

1.20

128

813

SLE, strict definition

244

2.48

9.39

1.5

1308.31

211.25

e6/l

0.54

197

SLE, ICD10

244

2.48

9.39

1.5

1308.31

211.25

e6/l

0.54

197

Obesity due to excess calories

619

4753

1.31

9.35

1.4

1.5

1335.95

2700.03

e6/l

0.71

514

3872

Other diseases of the digestive system

354

2491

1.43

9.34

1.5

1363.29

3696.62

e6/l

0.73

293

2029

Tubulo-interstitial nephritis, not specified as acute or chronic

457

2.04

9.32

1.5

38424.72

1236.62

e6/l

0.49

378

Other condition

197

1230

1.62

9.28

1.9

1.5

3137.30

4047.73

e6/l

0.10

172

996

Insulin medication

746

4925

1.28

9.26

1.6

1.5

1534.50

2164.52

e6/l

0.29

635

4028

Generalized epilepsy

327

2.25

9.24

1.5

2.0

881.79

1379.64

e6/l

0.20

264

Schizophrenia

219

1404

1.58

9.21

1.3

1.5

555.61

1198.48

e6/l

1.20

175

1144

Disorders of gallbladder, biliary tract and pancreas

1269

6629

1.21

9.18

1.5

2625.64

2052.76

e6/l

0.12

1030

5394

Osteoporosis with pathological fracture (FG)

399

2.11

9.18

1.7

1.5

193.20

1233.51

e6/l

2.03

319

Acute myeloid leukaemia and myelodysplastic syndromes

116

3.20

9.17

2.4

1.3

30.57

1185.55

e6/l

0.75

104

Secondary hypertension

494

1.99

9.17

1.5

6620.85

1470.78

e6/l

0.54

384

Misadventures to patients during surgical and medical care

180

1103

1.65

9.14

1.7

1.4

805.87

1411.07

e6/l

0.77

141

901

Other/unspecified enthesopathies of lower limb, excluding foot

474

2.01

9.14

1.3

1.6

371.74

1088.64

e6/l

0.81

385

Disorders of acoustic nerve

194

2.66

9.11

1.8

1.3

2214.85

729.75

e6/l

0.34

159

Scleritis and episcleritis

476

2.01

9.07

1.1

1.5

1472.35

1530.59

e6/l

0.01

383

Dialysis, with operation codes

167

1007

1.68

9.05

1.7

1.6

354.09

1239.08

e6/l

1.49

131

807

Hyperhidrosis

127

3.05

9.05

1.2

1.7

102.63

1462.22

e6/l

0.59

105

Other specified/unspecified systemic involvement of connective tissue

417

2.08

8.96

1.4

1.5

266.53

1389.05

e6/l

0.95

335

Elevated blood glucose level

114

621

1.86

8.83

1.8

1.7

606.63

1410.77

e6/l

0.76

503

Other specified and unspecified disorders of eye and adnexa

251

2.41

8.83

1.4

1.5

328.81

810.97

e6/l

0.44

206

Disorders of calcium metabolism

419

2.06

8.83

1.6

1.7

402.92

909.49

e6/l

0.56

343

Other arthrosis

635

3392

1.30

8.83

1.4

1.5

2029.71

2379.19

e6/l

0.15

526

2736

Childhood asthma (age<16), excluding more controls

176

844

1.66

8.82

1.5

716.91

5071.08

e6/l

0.47

143

650

All chronic kidney diseases

622

3925

1.30

8.81

1.5

4783.51

1182.04

e6/l

0.54

525

3205

Heartburn

140

811

1.75

8.80

1.4

1.5

322.47

1168.08

e6/l

1.95

112

646

Transient global amnesia

102

537

1.93

8.76

1.3

1.4

1629.59

1293.88

e6/l

0.11

432

Fracture of shoulder and upper arm

424

3109

1.37

8.74

1.7

1.5

892.77

2291.24

e6/l

0.60

348

2533

Intermittent heterotropia

101

531

1.94

8.74

1.7

2.5

979.71

1194.06

e6/l

0.09

416

Childhood asthma (age<16)

176

847

1.65

8.72

1.5

716.91

5047.57

e6/l

0.47

143

653

Mental retardation, excluding more controls

227

2.45

8.69

2.3

2.9

398.17

517.56

e6/l

0.12

171

Personal history of risk-factors, not elsewhere classified

3.40

8.61

2.2

1.7

179.96

189.47

e6/l

0.02

Mental and behavioural disorders due to use of other stimulants, including caffeine

236

2.44

8.60

1.6

1.7

77668.79

1097.78

e6/l

0.50

193

Noninfectious colitis NAS

181

1129

1.62

8.59

1.4

1.7

128.42

1126.34

e6/l

2.84

146

910

Eating disorders

160

968

1.67

8.55

1.3

1.6

266.07

4701.93

e6/l

0.62

132

784

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.46

8.50

1.2

676.32

150.54

e6/l

0.54

Use of riluzole

8.43

8.47

1.0

1.3

144.46

294.50

e6/l

0.20

Chronic viral hepatitis

440

2.02

8.47

2.0

1.5

42845.72

936.06

e6/l

0.50

359

Tinnitus

283

1952

1.46

8.42

1.3

1.4

624.64

3292.89

e6/l

0.78

225

1588

Rash and other nonspecific skin eruption

124

704

1.78

8.40

2.0

1.6

442.76

1259.22

e6/l

0.88

103

566

Causalgia

107

3.20

8.37

1.3

1.6

732.44

1113.98

e6/l

0.13

Haemorrhage, not elsewhere classified

150

2.78

8.32

2.7

1.4

1883.43

296.85

e6/l

0.51

117

Other female pelvic inflammatory diseases

205

1328

1.56

8.29

1.4

901.65

4310.03

e6/l

0.64

171

1077

Lateral epicondylitis

162

992

1.65

8.29

1.3

1.4

2453.19

843.89

e6/l

0.53

138

804

Assault by bodily force

120

678

1.80

8.29

1.2

1.6

184.87

6604.95

e6/l

0.63

551

Superficial injury of wrist and hand

276

1902

1.46

8.27

1.4

1.6

1119.69

2848.54

e6/l

0.39

229

1547

Hyperplasia of prostate

390

1596

1.39

8.26

1.4

1027.76

2407.99

e6/l

0.49

312

1308

Other and unspecified mononeuropathies, also in other diseases

192

2.56

8.23

1.3

1.5

2290.10

1149.50

e6/l

0.21

151

Unspecified visual impairment (binocular)

103

3.23

8.22

1.3

2.0

289.22

1234.22

e6/l

0.43

False labour

425

1947

1.37

8.20

1.3

1.4

505.53

3008.90

e6/l

0.72

359

1570

Other abnormal immunological findings in serum

141

2.86

8.18

1.1

1.6

461.43

204.90

e6/l

0.34

117

Cholecystectomy

854

5965

1.24

8.18

1.4

3592.83

2154.12

e6/l

0.24

707

4849

Benign neoplasm: Cranial nerves

205

2.51

8.17

1.9

1.3

2161.86

677.63

e6/l

0.35

165

Disorders of vitreous body and globe

575

4277

1.30

8.16

1.5

2786.35

2285.72

e6/l

0.15

473

3481

Corneal ulcer

240

1614

1.50

8.15

1.4

15291.78

1064.89

e6/l

0.50

210

1306

Benign neoplasm: Brain, infratentorial

4.59

8.13

2.4

2.3

95.69

268.20

e6/l

0.55

Orchitis and epididymitis

108

594

1.84

8.12

1.6

6599.30

959.65

e6/l

0.51

492

Reimbursement for rheumatic diseases

706

5591

1.26

8.11

1.3

1.5

1673.95

2613.36

e6/l

0.35

579

4546

Other fall from one level to another

292

2040

1.44

8.11

2.0

1.6

814.67

2791.95

e6/l

0.54

246

1629

Episcleritis

406

2.03

8.10

1.1

1.5

1675.39

1590.67

e6/l

0.02

323

Sensorineural hearing loss

878

4829

1.24

8.10

1.5

1426.52

2908.01

e6/l

0.88

739

3911

Behavioural disorders

177

2.62

8.03

1.3

1.8

80420.49

566.65

e6/l

0.49

144

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

354

2563

1.39

8.02

1.5

1.4

571.42

2776.74

e6/l

0.87

297

2076

Other and unspecified urticaria

261

1792

1.47

7.99

1.6

1114.33

3420.29

e6/l

0.54

226

1438

Gingivitis and periodontal diseases

1356

5896

1.19

7.96

1.5

1458.16

2323.49

e6/l

0.53

1080

4847

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

130

761

1.73

7.94

1.7

1.5

935.78

1330.05

e6/l

0.26

110

624

Other maternal disorders predominantly related to pregnancy

740

3693

1.26

7.94

1.4

799.92

2767.60

e6/l

1.10

624

2952

Persistent delusional disorders

102

557

1.86

7.89

1.2

1.5

360.06

1444.86

e6/l

1.08

457

Other specified/unspecified hearing loss

106

586

1.83

7.87

1.3

1.5

455.79

1447.92

e6/l

1.14

478

Retinal detachments and breaks

383

2820

1.37

7.82

1.5

1.4

1082.03

2165.95

e6/l

0.67

296

2322

Eating disorder

135

801

1.71

7.81

1.2

1.6

304.57

5288.77

e6/l

0.56

112

652

Otalgia

116

662

1.78

7.78

1.9

887.77

1305.99

e6/l

0.34

537

Fracture at wrist and hand level

436

3271

1.34

7.76

1.4

1.5

1087.27

2314.13

e6/l

0.53

353

2672

Sequelae of injuries of neck and trunk

204

2.46

7.75

1.8

1.6

970.80

1041.75

e6/l

0.03

161

Injuries to the elbow and forearm

893

6428

1.23

7.74

1.4

1.5

1118.28

2320.19

e6/l

0.81

722

5213

Fentanyl

108

602

1.81

7.74

1.4

1.5

512.43

985.93

e6/l

0.46

494

Disorders of vitreous body

557

4181

1.29

7.73

1.5

2841.48

2334.45

e6/l

0.15

458

3401

Other/unspecified synovitis and tenosynovitis

138

828

1.68

7.69

1.3

1.4

994.40

859.12

e6/l

0.07

109

669

Other/unspecified soft tissue disorders related to use, overuse and pressure

169

2.60

7.66

1.4

1.3

1556.14

401.34

e6/l

0.37

140

Diseases of salivary glands

387

2865

1.36

7.66

1.3

1.4

734.01

2526.80

e6/l

0.76

311

2343

Spondylopathies (FG)

182

1172

1.57

7.60

1.4

3886.03

4263.61

e6/l

0.03

155

956

Diabetic retinopathy, excluding more controls

277

1070

1.46

7.57

1.5

1.4

2296.94

884.50

e6/l

0.44

227

871

Spasmodic torticollis

225

2.37

7.56

1.2

1.5

105.85

1057.15

e6/l

0.96

178

Insulin, fast-acting

438

3307

1.33

7.55

1.5

1504.19

3025.27

e6/l

0.47

375

2691

Early onset COPD, excluding more controls

206

1363

1.52

7.54

1.6

1.4

1615.93

1728.00

e6/l

0.05

168

1109

Infections with a predominantly sexual mode of transmission

414

3100

1.34

7.53

1.6

1.4

2595.16

2167.09

e6/l

0.09

327

2525

Hyperfunction of pituitary gland

376

2.03

7.52

1.4

1.7

1057.43

1359.76

e6/l

0.09

301

Crohn disease

179

1152

1.57

7.52

1.5

1.6

977.94

4330.40

e6/l

0.53

144

934

Intentional self-harm by unspecified means

3.31

7.50

1.3

605.30

119.21

e6/l

0.63

Suppurative and unspecified otitis media

492

3344

1.31

7.50

1.9

1.5

619.43

2262.32

e6/l

0.83

410

2694

Obesity, other/unspecified

436

3300

1.33

7.44

1.4

1128.23

2474.09

e6/l

0.52

345

2699

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.16

7.44

1.3

1.5

209.09

135.08

e6/l

0.20

Other specified/unspecified dorsopathies

214

2.38

7.43

1.2

1.7

313.45

526.03

e6/l

0.20

171

Sacroiliitis, not elsewhere classified

324

2.10

7.40

1.3

1.5

351.47

858.05

e6/l

0.40

257

Vertical strabismus

247

2.28

7.35

2.0

1.7

1046.60

937.58

e6/l

0.05

195

Anomalies of pupillary function

150

2.68

7.30

1.0

1.5

500.63

121.00

e6/l

0.60

120

Other disorders of the musculoskeletal system and connective tissue

177

1144

1.56

7.30

1.4

621.07

1248.10

e6/l

1.01

143

931

Other specified/unspecified inflammatory spondylopathies

320

2.10

7.25

1.3

1.5

360.71

938.66

e6/l

0.50

259

Cellulitis

269

1896

1.43

7.20

1.8

1.5

3062.00

3161.73

e6/l

0.01

222

1531

Ulcer of vagina/vulva

193

2.45

7.20

1.2

1.5

1031.26

165.39

e6/l

0.46

155

Astigmatism

510

1.85

7.13

2.5

2.3

6788.97

591.25

e6/l

0.47

414

Other arrhythmias

825

5094

1.23

7.10

1.3

1.5

1403.00

2682.10

e6/l

0.77

683

4106

Other hearing loss

276

1915

1.42

7.09

1.4

1265.00

2237.91

e6/l

0.34

234

1566

Glaucoma

602

4105

1.27

7.06

1.5

1.4

1255.76

1862.85

e6/l

0.40

504

3342

Hernia

1186

6723

1.19

7.04

1.4

1.5

1206.26

2120.40

e6/l

0.78

969

5483

Gonarthrosis [arthrosis of knee](FG)

905

4333

1.22

7.03

1.4

1825.25

2138.81

e6/l

0.13

741

3524

Reactive arthropathies, FINNGEN

520

1.83

7.03

1.2

1.6

223.11

1541.07

e6/l

1.49

422

Myositis

159

2.58

7.00

1.3

1.4

165.16

313.89

e6/l

0.64

132

Use of amantadine

108

2.97

7.00

1.2

76.45

157.34

e6/l

0.53

Meniscus derangement

668

3600

1.25

6.99

1.4

1.5

713.06

3242.79

e6/l

1.37

543

2899

Other diseases of intestine

163

1045

1.57

6.98

1.4

1.5

709.67

1241.54

e6/l

0.52

132

857

Malignant neoplasm of digestive organs

213

2450

0.68

6.97

1.5

1.4

269.75

1651.95

e6/l

4.88

174

2033

Menorrhagia

438

1837

1.33

6.94

1.4

3113.63

1530.24

e6/l

0.44

352

1522

Cholecystitis

154

976

1.59

6.92

1.3

1.4

934.37

1188.55

e6/l

0.13

128

805

Vasomotor and allergic rhinitis

487

3714

1.29

6.86

1.4

1.6

599.72

2356.04

e6/l

1.05

409

2985

Cholelithiasis, broad definition with cholecystitis

1067

6034

1.19

6.85

1.4

3014.28

2136.00

e6/l

0.17

877

4929

Insulin, fast-acting or short human

439

3365

1.31

6.84

1.5

1504.19

3014.67

e6/l

0.47

375

2740

Systemic lupus erythematosus, unspecified

217

2.31

6.80

1.3

1.5

1546.09

220.83

e6/l

0.55

171

Conduct disorder

186

2.43

6.80

1.3

1.9

82625.50

533.20

e6/l

0.49

148

Tonsillectomy and adenotomy

793

4518

1.23

6.77

1.5

804.68

2119.26

e6/l

0.86

640

3643

Reactive arthropathies

113

667

1.71

6.76

1.3

1.5

251.08

949.71

e6/l

1.66

103

546

Impingement syndrome of shoulder

263

1868

1.42

6.76

1.6

1.4

3052.91

1778.06

e6/l

0.51

230

1521

Superficial injury of thorax

179

1181

1.53

6.75

1.3

1.5

1518.15

1049.22

e6/l

0.21

135

968

Postzoster neuralgia

3.08

6.74

1.3

30.91

1425.85

e6/l

0.59

Poisoning by narcotics and psychodysleptics [hallucinogens]

116

2.85

6.73

3.1

1.4

129504.22

1466.33

e6/l

0.48

Other cataract

488

2865

1.29

6.73

1.5

1.4

514.09

2061.32

e6/l

1.32

402

2321

Hypogonadotropic hypogonadism

193

2.39

6.71

1.4

1.3

878.59

1976.83

e6/l

0.43

149

Gout

274

1722

1.41

6.70

1.6

1.4

1060.51

2748.19

e6/l

0.64

226

1407

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

367

2755

1.34

6.69

1.3

1.5

3109.83

2536.55

e6/l

0.10

287

2242

Other diseases of pleura

476

3237

1.29

6.69

1.6

1.5

5302.27

1413.70

e6/l

0.41

387

2651

Amblyopia ex anopsia

318

2.05

6.64

1.8

2.6

2147.22

789.10

e6/l

0.55

250

Injury of eye and orbit

179

1186

1.52

6.63

1.4

1.5

22874.99

838.73

e6/l

0.54

143

969

Motor disorders, excluding more controls

121

2.75

6.61

2.5

4.6

34.63

263.15

e6/l

0.69

Atrial fibrillation and flutter

326

1546

1.37

6.59

1.4

1.3

1062.82

718.62

e6/l

0.42

262

1235

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

129

2.73

6.58

4.7

2.7

41.48

972.91

e6/l

0.61

110

Disorders of pituitary gland, other and/or unspecified

4.18

6.58

1.5

9.42

21.97

e6/l

0.61

Presbyopia

488

1.83

6.57

1.3

1.4

1655.21

1818.05

e6/l

0.04

386

Other embolism and thrombosis

152

974

1.58

6.56

1.4

856.43

1094.27

e6/l

0.14

127

799

Anogenital herpesviral [herpes simplex] infection

150

959

1.58

6.55

1.4

2371.76

4994.15

e6/l

0.27

123

773

Unspecified misadventure during surgical and medical care

403

1.92

6.54

1.9

1.5

244.08

1623.47

e6/l

1.23

330

Urolithiasis

356

2670

1.34

6.54

1.5

1.4

2372.44

3392.91

e6/l

0.24

299

2176

Tobacco use

418

1.90

6.51

1.4

1.5

298.50

1169.71

e6/l

0.89

338

Toxic effects of substances chiefly nonmedicinal as to source

155

1003

1.56

6.43

1.3

1.7

23013.37

1103.70

e6/l

0.48

131

813

Necrosis of pulp, including avohilmo

741

6073

1.22

6.41

1.4

1.5

2044.43

2435.66

e6/l

0.13

598

4932

Abnormal serum enzyme levels

321

2316

1.36

6.41

1.4

1.5

430.31

1515.11

e6/l

2.87

249

1911

Otitis media, unspecified

165

995

1.54

6.41

1.9

1.7

271.17

4804.59

e6/l

0.64

134

790

Impotence

329

2.01

6.40

1.5

1185.53

687.84

e6/l

0.30

276

Procreative management

443

2859

1.30

6.35

1.6

457.81

2650.05

e6/l

0.99

335

2275

Other coagulation defects

100

582

1.74

6.34

1.7

1.6

1553.60

1277.43

e6/l

0.09

476

Other neurotic disorders

296

2.06

6.34

1.3

1.5

61.85

1044.93

e6/l

1.43

242

Gonarthrosis

757

3527

1.23

6.33

1.3

1.5

2126.00

2298.86

e6/l

0.06

622

2837

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

704

5602

1.23

6.31

1.5

615.48

2193.88

e6/l

1.56

551

4543

Event of undetermined intent

525

1.78

6.26

1.5

1.6

991.74

1425.43

e6/l

0.23

426

Lesion of radial nerve

251

2.15

6.26

1.3

1.5

3135.96

1914.55

e6/l

0.21

202

Inflammatory diseases of prostate (prostatitis)

135

852

1.60

6.24

1.4

852.15

3573.44

e6/l

0.55

113

708

Budesonide

171

1138

1.52

6.23

1.7

1.4

1171.82

4266.16

e6/l

0.46

137

916

Viral pneumonia (known virus, not influenza)

181

2.38

6.23

1.9

2.1

84.19

123.82

e6/l

0.26

146

Vestibular neuronitis

110

661

1.68

6.21

1.3

1.4

301.53

1589.06

e6/l

1.78

542

Other inflammation of eyelid

160

1051

1.54

6.21

1.7

1.5

234.58

1327.20

e6/l

2.52

124

848

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

286

2.07

6.18

1.3

1.7

312.62

1307.29

e6/l

0.75

232

Renal failure

469

3247

1.28

6.17

1.5

1712.60

1992.66

e6/l

0.09

381

2667

Anosmia

3.09

6.15

1.7

1.2

308.60

1148.64

e6/l

0.44

Medical abortion

785

3505

1.22

6.14

1.4

1239.12

2085.20

e6/l

0.35

632

2838

Toxic effect of other and unspecified substances

2.98

6.14

1.7

1.4

18.45

143.30

e6/l

1.13

Endometriosis of pelvic peritoneum

209

1382

1.45

6.14

1.3

1.4

552.26

1724.26

e6/l

0.96

166

1141

Ischemic heart diseases

1013

5136

1.19

6.13

1.3

1.6

2266.71

2052.74

e6/l

0.09

878

4093

Mixed disorders of conduct and emotions, excluding more controls

158

2.46

6.09

1.3

2.2

103622.14

82.95

e6/l

0.50

129

Sequelae of other external causes

413

1.87

6.09

1.7

1.5

498.80

1314.68

e6/l

0.81

346

Glaucoma suspect

379

2903

1.31

6.04

1.4

1240.46

1198.07

e6/l

0.02

328

2373

Drug-induced adrenocortical insufficiency

130

2.62

5.96

1.7

1.3

7.37

172.69

e6/l

1.81

101

Rheumatoid arthritis

354

2409

1.32

5.95

1.3

1.4

926.95

4403.22

e6/l

1.14

291

1943

Vitamin D deficiency

136

2.57

5.95

1.2

1.5

65.79

194.74

e6/l

0.85

112

Other and unspecified erythematous conditions

217

2.21

5.94

1.4

1.9

1252.17

746.66

e6/l

0.15

172

Candidiasis

165

1102

1.51

5.94

1.7

1.4

119.37

4668.47

e6/l

0.74

139

874

Other retinal disorders

698

4465

1.22

5.94

1.5

1394.98

2717.54

e6/l

0.60

561

3668

Cholelithiasis

1015

5938

1.18

5.91

1.4

3147.13

2159.65

e6/l

0.19

838

4848

Osteonecrosis

439

1.83

5.90

2.0

1.4

720.31

990.01

e6/l

0.21

358

Thyroiditis, ILD-related definition

138

888

1.57

5.90

1.4

1.5

1272.61

5613.18

e6/l

0.50

119

708

Sicca syndrome [Sjögren]

105

634

1.68

5.85

1.5

1.4

37.07

1549.58

e6/l

2.67

509

Viral haemorrhagic fevers, not elsewhere classified/unspecified

195

1350

1.46

5.85

1.9

1.7

1596.36

1179.18

e6/l

0.27

149

1092

Acute suppurative otitis media

361

2574

1.32

5.83

2.2

1.5

607.00

2637.52

e6/l

0.77

298

2073

Allergic conjunctivitis

734

5930

1.21

5.83

1.5

597.16

2092.88

e6/l

1.57

574

4815

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

213

1501

1.43

5.82

1.3

1.4

1687.50

3698.40

e6/l

0.33

167

1212

Glomerular diseases

207

1451

1.44

5.82

1.6

13030.10

3792.18

e6/l

0.40

167

1166

Disease of hard tissues of teeth, NOS

671

2859

1.23

5.81

1.5

1133.18

2920.07

e6/l

0.63

532

2344

Alcohol induced polyneuropathy

3.59

5.81

1.3

47.93

2066.44

e6/l

0.52

Calculus of kidney and ureter

329

2486

1.33

5.80

1.5

1.4

2430.76

3503.83

e6/l

0.24

279

2030

Pedestrian injured in transport accident

515

1.75

5.80

1.2

1.5

513.82

1054.27

e6/l

0.58

418

Type 1 diabetes

316

2372

1.34

5.78

1.6

2074.44

2821.93

e6/l

0.15

271

1933

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

200

2.25

5.78

1.4

1.7

53.16

1054.41

e6/l

0.89

160

Other symptoms and signs involving the digestive system and abdomen

180

1231

1.47

5.76

1.6

1.5

3405.85

1655.40

e6/l

0.22

154

983

Divergent concomitant strabismus

101

607

1.69

5.74

1.7

1.6

1952.29

1238.70

e6/l

0.30

487

Diabetes mellitus

1337

6780

1.16

5.74

1.5

1202.54

2078.06

e6/l

0.69

1091

5501

Other erythematous conditions

247

2.11

5.72

1.4

1.8

1141.59

658.84

e6/l

0.16

199

Cerebral palsy

133

2.56

5.70

2.7

2.1

949.17

153.53

e6/l

0.47

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1193

6582

1.16

5.70

1.5

1.4

2299.71

2146.26

e6/l

0.06

981

5345

Disorders of synovium and tendon in diseases classified elsewhere

115

2.67

5.70

1.4

1.3

188.12

208.76

e6/l

0.06

Pregnancy examination and test

224

981

1.43

5.69

1.3

1597.96

5025.86

e6/l

0.41

188

786

Disorders of tooth development and eruption

208

1180

1.44

5.68

1.7

1.4

748.47

3760.08

e6/l

0.48

156

959

Other specified/unspecified soft tissue disorders

288

2.01

5.68

1.5

1.4

92.02

402.94

e6/l

1.08

235

Other peripheral vascular diseases

101

609

1.68

5.67

1.2

1.5

1226.07

1338.18

e6/l

0.03

497

Collagenous colitis

114

709

1.63

5.66

1.5

859.76

1411.63

e6/l

0.37

579

Patent foramen ovale

196

2.26

5.66

1.2

3.0

130.30

653.77

e6/l

0.70

150

Dermatographic urticaria

550

1.71

5.63

1.4

1.5

408.79

1621.24

e6/l

1.23

448

Other maltreatment syndromes

256

2.08

5.61

1.5

306.35

1458.04

e6/l

0.82

208

Pyogenic arthritis

439

1.80

5.59

1.2

1.5

55.38

762.40

e6/l

2.25

357

Malignant neoplasm of breast, including Hilmo

307

2634

0.75

5.59

1.4

732.89

2097.18

e6/l

1.88

233

2168

Malignant neoplasm of breast, HER2-negative, including Hilmo

307

2634

0.75

5.59

1.4

732.89

2097.18

e6/l

1.88

233

2168

Superficial injury of forearm

130

837

1.57

5.58

1.3

1.8

1165.55

5442.76

e6/l

0.48

109

677

Other congenital malformations

124

790

1.59

5.57

1.6

2.2

1642.65

5905.77

e6/l

0.42

629

Arthropod-borne viral fevers and viral haemorrhagic fevers

215

1530

1.42

5.56

1.9

1.6

1427.72

3656.11

e6/l

0.43

167

1234

Injury of muscle and tendon at shoulder and upper arm level

384

2982

1.29

5.56

1.3

1.4

492.15

2206.00

e6/l

1.58

325

2428

Myopia

165

1120

1.49

5.53

1.5

1.6

24977.61

945.69

e6/l

0.58

140

897

Nonsuppurative otitis media

303

1968

1.34

5.52

1.8

1.5

830.64

2981.54

e6/l

0.59

255

1583

Acute lymphadenitis

471

1.77

5.51

2.2

1.6

395.97

1355.15

e6/l

0.75

386

Calcific tendinitis of shoulder

398

1.83

5.49

1.6

1.4

896.44

580.84

e6/l

0.21

320

Malignant neoplasm of breast, HER2-negative

293

2550

0.75

5.49

1.4

946.04

2163.00

e6/l

1.44

222

2097

Meralgia paraesthetica

231

2.12

5.49

1.3

1.6

431.56

2041.73

e6/l

0.69

183

Fracture of lower leg, including ankle

658

5380

1.21

5.48

1.4

1.5

1348.22

2582.49

e6/l

0.72

536

4370

Chondrocostal junction syndrome [Tietze]

272

2.02

5.47

1.3

1.6

64.97

205.10

e6/l

1.90

221

Care involving dialysis

524

1.72

5.47

1.5

1.7

554.97

1150.01

e6/l

0.55

415

Respiratory insufficiency

426

1.80

5.46

1.7

1.5

917.15

1460.68

e6/l

0.30

342

Diabetes medication

1338

6912

1.15

5.45

1.4

1.5

1236.73

2045.48

e6/l

0.63

1093

5604

Use of disulfiram, acamprosate or naltrexone

118

748

1.60

5.44

1.4

1.5

554.00

1475.55

e6/l

1.03

606

Neovascular glaucoma

259

2.04

5.42

1.7

1.4

177.38

769.36

e6/l

0.77

213

L02BA Anti-estrogens

1328

0.58

5.41

1.4

1767.22

1842.47

e6/l

0.03

1084

Other congenital malformations of skin

322

1.93

5.41

1.9

2.0

3169.19

1568.86

e6/l

0.24

249

Continuous positive airway pressure

186

1087

1.45

5.41

1.7

3865.17

1208.88

e6/l

0.37

153

861

Other diseases of liver

210

1498

1.41

5.39

1.5

2709.56

1250.07

e6/l

0.31

167

1212

Arthropathies in other diseases classified elsewhere

253

2.05

5.39

1.9

1.5

984.98

737.73

e6/l

0.13

213

Other skin changes

192

1348

1.43

5.38

1.6

1.4

240.41

4107.47

e6/l

0.81

160

1101

Other disorders of patella

210

1499

1.41

5.37

1.2

1.4

1174.54

3789.69

e6/l

0.52

177

1210

Other diseases of oesophagus

104

641

1.64

5.36

1.4

1.5

20656.42

1361.32

e6/l

0.46

523

Other and unspecified syphilis

6.38

5.36

1.1

73.25

449.27

e6/l

—

Haemorrhage in early pregnancy

342

2559

1.31

5.36

1.3

1.4

426.27

2898.46

e6/l

1.02

299

2057

Type 2 diabetes

1247

6325

1.15

5.33

1.5

1.4

1218.32

2173.82

e6/l

0.71

1019

5136

Dislocation, sprain and strain of joints and ligaments of thorax

227

2.11

5.33

1.4

1.5

101.22

448.65

e6/l

0.56

189

Orthopaedic devices associated with adverse incidents

133

0.00

5.32

0.0

1.3

—

1049.02

—

109

Bulimia nervosa (incl. atypical)

268

2.01

5.32

1.2

1.6

702.88

13347.09

e6/l

0.47

224

Heart failure and antihypertensive medication

263

1263

1.37

5.31

1.5

945.67

1825.24

e6/l

0.83

225

1018

Iridocyclitis in diseases classified elsewhere

138

2.46

5.29

1.6

1.7

2005.79

972.95

e6/l

0.22

110

Polyarthrosis

209

1385

1.41

5.28

1.5

1363.39

1973.37

e6/l

0.26

178

1114

Phlebitis and thrombophlebitis (not including DVT)

249

1833

1.37

5.28

1.6

1.4

1000.90

1129.37

e6/l

0.10

202

1493

Intentional self-harm by sharp object

195

2.20

5.28

1.3

1.5

514.79

131.64

e6/l

0.64

157

Medicines for HER+ breast cancer

232

2992

0.73

5.28

1.4

1.5

777.78

3147.42

e6/l

1.14

175

2443

Diabetes, varying definitions

1323

6771

1.15

5.25

1.5

1216.44

2076.08

e6/l

0.67

1078

5493

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.47

5.24

1.2

1.6

8.77

214.51

e6/l

1.03

Use of biperiden

390

1.82

5.24

1.4

1.5

844.14

2020.66

e6/l

0.65

313

Malignant neoplasm of breast

301

2583

0.76

5.24

1.4

875.14

2137.44

e6/l

1.57

229

2125

Melanocytic naevi

351

2721

1.30

5.20

1.5

1.4

746.90

2532.80

e6/l

0.67

285

2219

Raynaud syndrome

111

702

1.60

5.19

1.4

1090.85

1301.41

e6/l

0.07

573

Diseases of peritoneum

116

741

1.58

5.18

1.5

158.33

1276.06

e6/l

2.01

608

Benign neoplasm of colon, rectum, anus and anal canal

681

4922

1.21

5.17

1.5

1.4

4773.02

1722.56

e6/l

0.46

549

4031

Abnormal findings on diagnostic imaging of lung

491

3795

1.24

5.17

1.4

6004.95

1450.82

e6/l

0.49

392

3124

Hypoplasia of dental enamel

104

2.73

5.15

10.9

4.1

525.35

549.68

e6/l

0.02

Fibroblastic disorders

224

1628

1.38

5.15

1.4

1400.16

2692.29

e6/l

0.40

184

1338

Ankylosing spondylitis

100

618

1.63

5.13

1.5

6583.00

953.26

e6/l

0.47

497

Fitting and adjustment of other devices

346

2416

1.30

5.12

1.8

1.4

2807.45

2210.47

e6/l

0.12

318

1958

Fissure and fistula of anal and rectal regions

272

2042

1.34

5.08

1.5

1.4

5042.53

3283.05

e6/l

0.19

218

1666

Glaucoma secondary to other eye disorders

266

1.99

5.06

1.7

1.4

177.38

762.91

e6/l

0.76

215

Glomerulonephritis

119

770

1.56

5.04

1.6

1.7

19490.24

1282.35

e6/l

0.48

629

Ganglion

235

1728

1.37

5.04

1.4

6289.58

3138.02

e6/l

0.38

199

1401

Acute laryngitis and tracheitis

155

1043

1.47

5.02

2.3

1.5

174.11

4518.22

e6/l

0.65

126

830

Effects of other external causes

233

2.06

5.01

1.2

1.6

593.14

1602.86

e6/l

0.50

190

Superficial injury of shoulder and upper arm

136

908

1.51

4.99

1.4

1.6

680.96

4942.43

e6/l

0.53

112

738

Chondropathies

189

1344

1.42

4.98

1.5

918.31

3853.96

e6/l

0.54

152

1091

Congenital iodine-deficiency syndrome/hypothyroidism

180

2.21

4.98

1.8

1.9

193.68

1782.98

e6/l

0.57

143

Other disorders of white blood cells

404

1.78

4.97

2.8

1.6

637.48

739.86

e6/l

0.09

329

Vertigo of central origin

2.73

4.97

1.2

300.00

1299.12

e6/l

0.40

Specific development disorders of scholastic skills

421

1.76

4.95

3.1

2.4

222.93

9843.20

e6/l

0.54

326

Other diseases of anus and rectum

317

2435

1.31

4.95

1.4

1.5

3419.52

3021.16

e6/l

0.04

258

1996

Thyrotoxicosis, other and/or unspecified

226

1657

1.37

4.95

1.6

1.4

1367.80

3271.81

e6/l

0.38

185

1337

Hypercalcemia

311

1.90

4.93

1.3

1.6

125.98

966.93

e6/l

1.29

257

Dermatitis due to substances taken internally

398

1.78

4.91

1.7

1.6

87.79

1142.58

e6/l

1.43

330

Amyloidosis

137

2.39

4.88

1.4

1.3

1909.54

1019.82

e6/l

0.23

112

Striking against or struck by other objects

408

3246

1.26

4.88

1.4

1.6

788.97

2324.20

e6/l

0.71

331

2624

Familial hypercholesterolemia

144

977

1.48

4.87

1.4

1189.86

989.76

e6/l

0.09

126

811

Dipeptidyl peptidase 4 (DPP-4) inhibitors

585

3865

1.22

4.86

1.5

1.4

1073.71

1512.51

e6/l

0.68

485

3154

Other and unspecified disorders of adult personality and behaviour

3.46

4.85

1.2

1.3

17.50

26.84

e6/l

—

Solid cancers, helper endpoint

1053

5375

1.16

4.84

1.5

1.4

1177.77

2272.01

e6/l

0.82

812

4411

Medial epicondylitis

236

2.02

4.83

1.4

528.61

449.17

e6/l

0.08

186

Gout, FINNGEN

274

2071

1.33

4.81

1.6

1.4

1060.51

2603.67

e6/l

0.69

226

1698

Testicular hypofunction

223

2.06

4.81

1.3

1.5

184.85

1257.35

e6/l

0.73

171

Myocarditis

299

1.89

4.80

1.9

1.4

142.43

1125.27

e6/l

0.99

240

Other and unspecified coagulation defects

394

1.78

4.80

1.5

309.90

1429.73

e6/l

0.89

324

Methotrexate

159

1105

1.45

4.77

1.3

1.4

471.29

4376.04

e6/l

0.62

127

890

Benign neoplasm of other and ill-defined parts of digestive system

189

1355

1.40

4.77

1.4

1442.49

1317.16

e6/l

0.05

162

1103

Other specified/unspecified disorders of bone/cartilage

177

2.19

4.77

1.2

1.3

248.55

1205.78

e6/l

0.66

139

Abnormal findings on antenatal screening of mother

116

757

1.55

4.76

1.4

679.21

7147.84

e6/l

0.71

108

613

Car occupant injured in other and unspecified transport accidents

232

1720

1.36

4.76

1.4

567.36

3047.99

e6/l

0.61

193

1403

Other and unspecified intracranial injuries

177

2.18

4.76

3.7

1.4

518.90

1148.61

e6/l

0.34

144

Other and unspecified mononeuropathies of upper limb

197

2.12

4.75

1.7

1.4

58.25

1081.40

e6/l

0.87

151

Fracture of femur

241

1626

1.35

4.74

1.6

1.5

894.64

1186.66

e6/l

0.39

203

1325

Overexertion and strenuous or repetitive movements

127

846

1.52

4.74

1.5

1393.35

1148.43

e6/l

0.14

690

Burns and corrosions

175

1240

1.42

4.74

1.7

1007.38

3894.17

e6/l

0.47

147

1008

Testicular dysfunction

259

1.96

4.73

1.3

1.5

169.26

1109.07

e6/l

0.76

201

Rosacea

139

944

1.49

4.72

1.4

273.41

1418.09

e6/l

2.31

114

758

Gastric ulcer

171

1207

1.43

4.71

1.5

1.4

1736.21

1406.03

e6/l

0.14

144

991

Colorectal adenocarcinoma

1362

0.62

4.70

1.3

1.4

279.25

1643.53

e6/l

2.36

1131

Intentional self-harm by other and unspecified firearm discharge

15.59

4.70

2.1

1.4

1065.29

3.00

e6/l

—

Disorder of lipoprotein metabolism, unspecified

127

847

1.51

4.69

1.3

1.4

724.16

830.67

e6/l

0.08

100

702

Amyloidosis, other/unspecified

109

2.54

4.68

1.3

609.90

1141.09

e6/l

0.20

Acute mastoiditis

3.32

4.68

1.2

1.7

7244.08

139.09

e6/l

0.47

Sulfasalazine

323

2517

1.29

4.64

1.4

3056.48

3021.20

e6/l

0.00

269

2025

Mental and behavioural disorders due to cannabinoids

261

1.95

4.64

1.7

1.6

610.61

761.64

e6/l

0.07

211

Fracture of neck

413

1.74

4.63

1.3

1.4

1638.81

1019.06

e6/l

0.17

335

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

297

1.88

4.60

1.7

1092.00

2635.68

e6/l

0.68

240

Redundant prepuce, phimosis and paraphimosis

226

1661

1.35

4.60

1.4

1.6

1764.46

2215.35

e6/l

0.12

187

1360

Paralytic ileus

248

1.97

4.57

1.4

1.6

109.09

1027.86

e6/l

1.06

201

Other disorders involving the immune mechanism, not elsewhere classified

221

2.03

4.55

8.4

1.6

210.19

1293.68

e6/l

0.70

183

Unspecified nephritic syndrome

148

2.28

4.55

1.4

1.2

173.12

856.67

e6/l

0.46

123

275

1.90

4.55

1.4

1.3

188.93

1348.58

e6/l

0.68

233

Viral haemorrhagic fevers, not elsewhere classified/unspecified

607

1.60

4.55

1.6

1.5

1769.89

1447.20

e6/l

0.12

496

Poisoning by medicine, drug-induced

2.61

4.53

1.3

1.88

127.51

e6/l

1.28

Intestinal malabsorption

350

1.80

4.50

1.4

1.5

1657.58

713.06

e6/l

0.49

279

Exophthalmic conditions

3.02

4.50

1.3

19.86

159.19

e6/l

0.85

Benign neoplasm: Colon

562

4456

1.21

4.50

1.5

1.4

5653.46

1406.60

e6/l

0.57

462

3648

Ulcer of lower limb, not elsewhere classified

141

970

1.46

4.49

1.8

1.4

3352.89

1148.51

e6/l

0.32

111

800

Viral conjunctivitis

163

2.20

4.43

1.4

1.8

164.40

133.27

e6/l

0.09

132

Inflammatory bowel disease

378

3022

1.26

4.42

1.5

666.63

2411.50

e6/l

0.79

306

2459

Chronic periodontitis, including avohilmo

1177

6931

1.14

4.41

1.4

1931.57

2255.90

e6/l

0.15

935

5674

Examination and encounter for administrative purposes

244

1.95

4.41

1.3

1.5

286.74

806.71

e6/l

0.71

190

Vitreous haemorrhage

112

739

1.53

4.40

1.6

1.5

1984.09

957.34

e6/l

0.48

605

Car occupant injured in noncollision transport accident

273

1.90

4.40

1.2

1.5

1683.68

1078.08

e6/l

0.14

225

Nummular dermatitis

581

1.60

4.39

1.8

1.5

88.13

1254.29

e6/l

2.58

475

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

548

1.62

4.39

3.1

2.6

185.15

306.58

e6/l

0.33

430

Periodontitis

1180

6938

1.14

4.38

1.4

1923.46

2255.08

e6/l

0.15

939

5680

Other Crohn's disease

574

1.60

4.37

1.7

1.5

91.24

1451.45

e6/l

1.71

463

Atopic dermatitis

746

5212

1.18

4.36

1.4

1.5

1468.69

2094.18

e6/l

0.23

593

4210

Nail disorders

102

661

1.56

4.36

1.5

1.6

4624.71

1308.89

e6/l

0.38

526

Arthropod-borne viral fevers and viral haemorrhagic fevers

112

741

1.53

4.35

1.6

1.5

1514.96

1324.56

e6/l

0.08

102

607

Diseases of tongue

422

1.70

4.30

1.2

1.4

154.00

8966.75

e6/l

0.53

352

Hepatic failure, not elsewhere classified

261

1.91

4.30

1.4

1.5

544.02

604.90

e6/l

0.04

213

Open wound of lower leg

170

1221

1.40

4.29

1.4

1.6

1021.05

3816.59

e6/l

0.44

142

986

Thyrotoxicosis

276

2132

1.30

4.29

1.6

1.4

1145.39

3044.37

e6/l

0.52

228

1744

Ehlers-Danlos syndrome

2.63

4.28

1.3

1.5

500.94

101.32

e6/l

0.36

Complications following infusion, transfusion and therapeutic injection

102

2.52

4.27

1.4

1.2

755.15

140.68

e6/l

0.57

Residual foreign body in soft tissue

356

1.76

4.26

1.6

1.4

720.71

353.72

e6/l

0.40

289

Toxic effect of ethanol

298

1.84

4.24

1.2

1.8

67757.75

1278.18

e6/l

0.48

238

Other inflammatory liver diseases

493

1.64

4.24

1.3

1.5

359.45

1676.49

e6/l

1.17

407

Dermatophytosis

724

6180

1.17

4.24

1.4

1.5

1445.06

2446.87

e6/l

0.51

565

5064

Syphilis

193

2.06

4.23

1.9

1.3

720.41

1103.59

e6/l

0.20

156

Syphilis

193

2.06

4.23

1.9

1.3

720.41

1103.59

e6/l

0.20

156

Excessive attrition of teeth

695

5921

1.18

4.23

1.3

1.5

2169.63

2459.79

e6/l

0.08

560

4784

Other keratitis

137

950

1.45

4.23

1.6

1.5

661.50

1295.16

e6/l

0.78

106

765

Polymyalgia rheumatica

124

843

1.48

4.22

1.3

1.4

3225.62

1231.61

e6/l

0.43

687

Other epidermal thickening

306

1.82

4.21

1.8

1.7

466.49

1089.96

e6/l

0.50

253

Perineal laceration during delivery

122

1484

0.68

4.21

1.5

1.3

139.58

3500.45

e6/l

0.76

101

1210

Dislocation, sprain and strain of joints and ligaments of knee

754

5956

1.17

4.20

1.3

1.5

1567.06

2470.19

e6/l

0.36

609

4825

Congenital malformations of the circulatory system

186

1321

1.38

4.19

1.8

2.0

343.63

3844.35

e6/l

0.67

145

1054

Cardiac murmurs and other cardiac sounds

117

779

1.50

4.18

1.9

908.94

5956.55

e6/l

0.52

101

606

Hypertrophic scar

411

1.70

4.17

1.4

1.6

19.98

939.67

e6/l

1.85

337

Follicular lymphoma, hilmo

271

1.87

4.17

1.7

1.3

167.44

645.85

e6/l

0.58

221

Other and unspecified injuries of wrist and hand

300

1.83

4.16

1.2

1.9

3094.24

1287.72

e6/l

0.36

242

Other and unspecified vaccines and biological substances

3.22

4.16

1.1

1.2

3.09

29.19

e6/l

1.05

Autoimmune hyperthyroidism

411

1.70

4.16

1.7

1.5

835.74

2112.29

e6/l

0.79

332

Other local infections of skin and subcutaneous tissue

119

806

1.49

4.15

2.7

1.6

3810.32

1172.17

e6/l

0.36

102

659

Crohn disease (strict definition, require KELA)

535

1.61

4.15

1.8

1.6

1352.60

1374.98

e6/l

0.01

430

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

293

1.83

4.14

1.6

1.4

4919.43

335.47

e6/l

0.51

236

Malignant neoplasm of breast, HER-positive

211

2186

0.75

4.13

1.3

1.4

821.47

2378.95

e6/l

1.69

158

1803

Other (not insulin) diabetes medications

1186

6208

1.14

4.13

1.4

944.23

2198.35

e6/l

1.22

970

5045

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

209

2.00

4.11

8.9

1.6

231.90

1346.38

e6/l

0.68

173

Disorders of breast

571

4352

1.20

4.09

1.4

808.37

2461.11

e6/l

1.09

468

3533

Hyperprolactinaemia

266

1.87

4.08

1.2

1.6

1525.53

1254.39

e6/l

0.06

217

Postmenopausal osteoporosis with pathological fracture

376

1.72

4.07

1.4

1.3

252.81

1142.37

e6/l

1.68

310

Hodgkin lymphoma, hilmo

203

2.01

4.06

1.6

1.4

1042.45

694.65

e6/l

0.12

166

Hypertrophic disorders of skin

445

1.66

4.06

1.4

1.6

122.93

879.52

e6/l

1.44

365

Infectious mononucleosis

114

771

1.49

4.02

1.6

1066.46

5672.68

e6/l

0.47

623

Cardiodefibrillation

212

2790

0.75

4.02

1.5

1.4

1413.00

2229.14

e6/l

0.37

170

2286

Rheumatoid arthritis, including avohilmo

402

3273

1.23

4.02

1.3

1.4

2359.11

2516.43

e6/l

0.03

331

2669

Adenomyosis (Endometriosis of uterus)

153

1093

1.41

4.02

1.5

1.4

605.72

1252.57

e6/l

0.83

125

909

Sequelae of inflammatory diseases of the central nervous system

5.18

3.99

3.9

1.1

110.45

123.38

e6/l

0.04

Congenital malformations and deformations of the musculoskeletal system

149

1056

1.41

3.98

1.8

2.1

715.48

4759.11

e6/l

0.59

122

840

Other disorders of kidney and ureter

137

962

1.44

3.97

1.5

4708.33

1207.24

e6/l

0.53

107

780

Pedestrian injured in collision with pedal cycle

219

1.95

3.95

1.2

1.4

474.94

614.68

e6/l

0.10

180

Use of interferon beta-1a

171

2.09

3.95

1.4

1.7

455.46

140.36

e6/l

0.56

141

Excessive earwax

599

4948

1.18

3.95

1.6

1.5

1033.60

2551.69

e6/l

0.97

499

4048

Extracorporeal dialysis

433

1.66

3.95

1.5

470.57

1111.50

e6/l

0.50

344

Sequelae of injuries of upper limb

117

799

1.48

3.94

1.4

1.5

662.24

1131.16

e6/l

0.38

103

652

Crohn's disease of small intestine

566

1.57

3.93

1.9

1.6

1254.72

7795.54

e6/l

0.51

462

Crohn disease (strict definition, all UC cases excluded)

403

1.68

3.93

1.7

1.6

1372.84

1626.48

e6/l

0.09

321

Chronic iridocyclitis

388

1.70

3.93

1.4

1.6

919.23

1310.72

e6/l

0.21

317

Periapical abscess

529

4435

1.20

3.93

1.5

1013.21

2837.91

e6/l

1.07

421

3611

Acute generalized exanthematous pustulosis

328

1.76

3.93

1.8

79.81

1367.32

e6/l

0.90

268

Other and unspecified trigeminal disorders

2.50

3.93

1.3

386.71

116.20

e6/l

0.35

Other and unspecified local infections of skin and subcutaneous tissue

112

759

1.49

3.92

2.8

1.6

4004.86

1176.66

e6/l

0.36

617

Benign neoplasm: Spinal meninges

2.86

3.91

1.9

1.1

1434.18

153.17

e6/l

0.68

Certain zoonotic bacterial diseases

213

1.96

3.91

3.1

1.5

891.38

981.82

e6/l

0.04

170

Crohn disease (strict definition, require KELA, min 2 HDR)

528

1.59

3.90

1.8

1.6

1394.20

1394.42

e6/l

0.00

424

Acute peritonitis

443

1.64

3.87

1.7

1.5

227.34

1437.13

e6/l

1.10

355

Vascular diseases of the intestine

242

1.88

3.85

1.3

7848.13

706.21

e6/l

0.89

201

Anorexia (incl.atypical)

482

1.61

3.85

1.3

1.6

55.39

8471.78

e6/l

0.59

398

Other/unspecified reactive arthropathies

514

1.59

3.85

1.2

1.5

200.01

1278.66

e6/l

1.21

419

Mixed conductive and sensorineural hearing loss

123

853

1.45

3.83

1.4

1.5

318.05

1229.63

e6/l

1.77

107

688

Complications of internal orthopaedic prosthetic devices, implants and grafts

211

1601

1.32

3.79

1.5

1.4

966.20

1102.61

e6/l

0.11

171

1304

Achilles tendinitis

106

716

1.49

3.78

1.2

1.5

1182.38

1149.03

e6/l

0.01

566

Other specified and unspecified strabismus

2.57

3.77

1.9

2.5

9708.64

344.87

e6/l

0.51

Specific developmental disorder of motor function

164

2.09

3.77

2.5

4.9

34.63

541.89

e6/l

1.16

114

Generalized epilepsy, mode (most common among epilepsy diagnosis)

223

1.91

3.76

1.2

1.9

1437.00

1654.70

e6/l

0.05

182

Other disorders starting during childhood or adolescence

520

1.58

3.76

3.3

2.6

193.29

7454.08

e6/l

0.50

409

Type 1 diabetes, wide definition, subgroup 1

252

1960

1.29

3.75

1.5

1.6

2267.58

3214.55

e6/l

0.15

215

1597

Personal history of other diseases and conditions

150

1078

1.40

3.74

1.8

1.6

293.09

4994.89

e6/l

0.76

116

870

Open wound of wrist and hand

532

4381

1.19

3.74

1.3

1.5

741.38

2637.77

e6/l

1.16

420

3560

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1165

6232

1.13

3.73

1.5

1432.95

2208.52

e6/l

0.51

970

5059

Gastroduodenal ulcer

238

1835

1.30

3.72

1.4

1.5

1330.56

1766.12

e6/l

0.25

195

1509

Major coronary heart disease event

980

5197

1.14

3.71

1.4

1.6

2108.37

2099.77

e6/l

0.00

861

4149

Other and unspecified mental retardation

168

2.07

3.70

2.6

4.7

254.67

342.08

e6/l

0.19

123

Other peripheral vertigo

639

1.52

3.69

1.5

1.4

404.48

1355.70

e6/l

1.08

518

Biguanides

1152

6235

1.13

3.69

1.4

915.45

2205.63

e6/l

1.27

937

5067

Melanocytic naevi of upper limb, including shoulder

169

2.05

3.69

2.1

1.7

38.27

779.14

e6/l

0.59

135

Early syphilis

2.54

3.68

2.0

1.5

537.87

221.05

e6/l

0.41

Other/unspecified enthesopathies, not elsewhere classified

559

1.55

3.68

1.3

1.4

774.14

552.84

e6/l

0.28

452

Burn and corrosion of hip and lower limb, except ankle and foot

176

2.03

3.68

2.8

1.5

318.45

1134.21

e6/l

0.54

141

Kidney transplant status

435

1.63

3.65

1.5

1.9

240.87

1053.38

e6/l

0.91

338

Perioral dermatitis

163

2.07

3.64

1.5

209.33

126.66

e6/l

0.24

127

Hyperkalaemia

313

1.74

3.64

1.5

1.4

945.35

951.75

e6/l

0.00

259

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

262

1.82

3.63

1.3

1.5

1658.16

607.70

e6/l

0.29

209

Papulosquamous disorders

428

3548

1.21

3.63

1.3

1.5

824.47

3141.73

e6/l

1.21

342

2896

Diabetic nephropathy, excluding more controls

135

788

1.42

3.63

1.7

1.4

3884.15

966.62

e6/l

0.49

118

640

Other noninflammatory disorders of vulva and perineum

107

731

1.48

3.62

1.6

1.4

426.61

1237.05

e6/l

0.88

601

Artrosis, including avohilmo

1048

5065

1.13

3.62

1.3

1.4

2320.37

2560.69

e6/l

0.07

858

4106

Crushed, pushed or stepped on by crowd or human stampede

642

1.51

3.62

1.3

1.9

840.50

6983.26

e6/l

0.54

512

Later onset COPD

138

1523

0.72

3.62

1.4

2051.47

2713.97

e6/l

0.13

109

1263

Malignant neoplasm of breast, ER-positive, including Hilmo

221

2205

0.77

3.61

1.3

1.4

782.11

2360.62

e6/l

1.79

167

1818

Perforation of tympanic membrane

116

807

1.45

3.59

1.5

760.91

1236.73

e6/l

0.29

662

Other and unspecified iridocyclitis

345

1.70

3.58

1.4

1.6

500.04

1336.93

e6/l

0.68

273

Injuries involving multiple body regions

278

1.79

3.57

1.6

556.93

746.19

e6/l

0.11

226

Unspecified event, undetermined intent

171

2.02

3.57

1.6

1.5

666.04

122.85

e6/l

0.39

140

Ischaemic heart disease, wide definition

861

4660

1.15

3.57

1.3

1.5

1130.42

2207.08

e6/l

1.11

731

3752

Percutaneous Coronary Intervention

913

4910

1.14

3.56

1.4

1.6

2180.28

2135.76

e6/l

0.02

806

3908

Early syphilis

2.38

3.55

1.9

1.4

474.65

929.91

e6/l

0.24

Other diseases of blood and blood-forming organs

501

1.57

3.55

1.5

1.4

708.06

1740.14

e6/l

0.60

403

Dementia due to Parkinson's disease

131

2.17

3.54

1.5

1.3

257.64

1123.59

e6/l

0.52

109

Coeliac disease

144

1044

1.39

3.53

1.5

1.7

673.56

4751.80

e6/l

0.59

123

830

Status post-ami

147

1530

0.73

3.52

1.4

1008.28

2968.49

e6/l

0.68

134

1222

Alcoholic liver disease

107

736

1.47

3.52

1.3

1.4

455.46

1268.79

e6/l

0.94

601

Superficial injuries involving multiple body regions

179

1.99

3.52

1.6

1.3

717.80

1061.81

e6/l

0.14

149

Other and unspecified disorders of vitreous body

428

3510

1.21

3.51

1.4

3208.64

2427.40

e6/l

0.18

348

2849

Infections of genitourinary tract in pregnancy

117

819

1.44

3.51

1.4

1288.61

5980.20

e6/l

0.50

104

646

Endometriosis ASRM stages 1,2

214

1648

1.31

3.50

1.4

555.68

3515.32

e6/l

0.72

171

1334

Coronary revascularization (ANGIO or CABG)

913

4912

1.14

3.49

1.4

1.6

2178.16

2134.67

e6/l

0.02

807

3910

Other and unspecified injuries of lower leg

632

1.50

3.47

1.3

1.6

1703.94

872.53

e6/l

0.22

515

Salpingitis and oophoritis

192

1459

1.32

3.46

1.4

1312.98

1504.71

e6/l

0.09

149

1188

Presence of other functional implants

616

3657

1.17

3.46

1.5

1.4

1107.70

2378.63

e6/l

1.03

525

2969

Congenital malformations and deformations of the musculoskeletal system

122

859

1.43

3.45

1.9

2.3

619.28

5564.68

e6/l

0.59

684

Diseases of arteries, arterioles and capillaries

691

4411

1.16

3.45

1.5

1.4

1864.41

1680.48

e6/l

0.10

568

3610

Preterm labour and delivery

297

2386

1.25

3.44

1.3

1.4

980.06

3481.82

e6/l

0.85

245

1935

Retinal vascular disorders

110

764

1.45

3.43

1.5

1.4

1676.22

837.16

e6/l

0.35

625

Ingrowing nail

411

1.62

3.43

1.6

6481.76

1151.63

e6/l

0.42

334

Exposure to other and unspecified inanimate mechanical forces

634

1.50

3.43

1.4

1.7

126.15

791.17

e6/l

1.29

511

Retinal vascular occlusion

109

756

1.45

3.43

1.5

1.4

1695.36

843.25

e6/l

0.35

617

Injury of nerves at shoulder and upper arm level

2.57

3.43

1.1

1.2

158.71

158.06

e6/l

0.00

Fracture of forearm

629

4959

1.16

3.41

1.4

1.5

1204.42

2311.17

e6/l

0.54

510

4031

Hypertrophy of breast in women and men

225

1751

1.29

3.41

1.6

1.4

958.13

3713.42

e6/l

0.68

188

1408

Dependent personality disorder

147

2.08

3.40

1.2

1.5

19.40

606.22

e6/l

0.61

116

Abnormal results of function studies

676

1.48

3.39

1.3

1.6

146.96

1368.63

e6/l

1.83

554

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

579

1.52

3.39

1.8

1.6

1332.71

7774.03

e6/l

0.50

466

Retinal detachment with retinal break

129

925

1.40

3.39

1.5

1.4

995.11

1072.23

e6/l

0.06

756

Gonococcal infection

261

1.79

3.38

1.7

1.3

2658.60

1979.73

e6/l

0.10

208

Asthma mixed form (mode)

320

1.70

3.38

1.4

1.5

324.71

11618.71

e6/l

0.51

266

Noninflammatory disorders of female genital tract

513

2167

1.19

3.36

1.4

7807.29

1372.17

e6/l

0.43

412

1787

Burns and corrosions of external body surface, specified by site

133

961

1.39

3.35

1.7

1.8

1086.73

4745.32

e6/l

0.45

113

772

Dermatophytosis

137

995

1.39

3.34

1.6

1.5

1196.71

1221.11

e6/l

0.01

117

803

Atopic dermatitis, strict definition with reimbursement

376

2998

1.22

3.34

1.5

1.6

441.75

2081.51

e6/l

0.73

310

2411

Human immunodeficiency virus [HIV] disease

128

2.15

3.33

1.8

1.4

1109.64

2005.32

e6/l

0.23

100

Cerebral atherosclerosis

2.76

3.33

1.4

1.2

4.70

1913.90

e6/l

—

Viral conjunctivitis

292

1.74

3.33

1.4

1.7

202.03

1080.52

e6/l

0.50

236

Thiazolidinediones

112

786

1.44

3.33

1.5

1.4

854.23

1039.51

e6/l

0.16

645

Biomechanical lesions, not elsewhere classified

353

1.66

3.31

1.3

1.5

855.85

936.23

e6/l

0.05

294

Asthma mixed form (mode), excluding more controls

322

1.69

3.31

1.4

1.5

324.71

11602.96

e6/l

0.51

267

L02BG Aromatase inhibitors

192

2487

0.77

3.31

1.3

1.5

478.78

3278.23

e6/l

1.17

147

2028

Pruritus

118

837

1.42

3.31

1.6

1.5

2339.86

5499.93

e6/l

0.29

673

Anogenital herpesviral [herpes simplex] infection

526

1.54

3.31

1.5

1.4

2964.13

8266.05

e6/l

0.31

420

Malignant melanoma, including Hilmo

171

1288

1.34

3.30

1.3

1.4

390.31

1584.33

e6/l

1.78

135

1075

Pregnancy hypertension

496

3765

1.18

3.29

1.3

1.4

2162.54

2446.81

e6/l

0.06

421

3033

Benign neoplasm: Adrenal gland

584

1.50

3.27

1.3

1.5

2853.03

1290.68

e6/l

0.46

473

Open wound of ankle and foot

122

873

1.41

3.26

1.5

1.7

866.89

5285.11

e6/l

0.53

709

Other congenital malformations

159

1187

1.35

3.26

1.6

1.9

1412.99

4118.32

e6/l

0.39

125

953

Benign neoplasm of eye and adnexa

106

740

1.44

3.25

1.5

1.4

238.73

1269.80

e6/l

1.75

596

Recurrent aphthous stomatitis , including avohilmo

161

1206

1.34

3.24

3.3

1.5

1378.93

4252.52

e6/l

0.43

134

966

Anaemia in chronic diseases classified elsewhere

150

2.03

3.23

1.4

1.5

15439.37

869.13

e6/l

0.49

123

Open wound of abdomen, lower back and pelvis

228

1.82

3.23

1.7

1.9

403.93

1586.03

e6/l

0.70

184

Other diseases of lip and oral mucosa

441

3712

1.19

3.22

1.5

976.41

2409.71

e6/l

0.78

334

3039

Disorders of parathyroid gland

189

1431

1.31

3.22

1.4

853.17

1420.08

e6/l

0.57

153

1161

Type 2 diabetes, definitions combined

1144

6015

1.12

3.21

1.5

1.4

909.82

2253.16

e6/l

1.29

926

4885

Ménière disease

660

1.47

3.20

1.3

1.4

1492.55

1433.48

e6/l

0.02

534

Malignant melanoma

141

1038

1.37

3.18

1.3

1.4

378.65

1152.14

e6/l

1.43

113

859

Charcot foot

118

2.16

3.14

1.9

1.3

2021.85

194.08

e6/l

0.72

Iron deficiency

216

1.83

3.13

1.3

2.0

2748.54

176.39

e6/l

0.68

175

Colorectal cancer

124

1659

0.73

3.12

1.4

240.25

1707.66

e6/l

3.60

102

1383

Motor disorders

180

1.93

3.11

2.5

5.0

34.63

310.54

e6/l

1.34

126

Coxarthrosis

521

2933

1.18

3.10

1.4

1.5

2208.75

2618.47

e6/l

0.11

426

2365

Diabetic maculopathy, excluding more controls

116

831

1.41

3.10

1.4

4608.32

945.51

e6/l

0.51

685

Vulvovaginal ulceration/inflammation in other diseases

478

1.54

3.10

1.2

1.5

3227.48

8991.57

e6/l

0.32

389

Injury of unspecified body region

583

1.49

3.09

1.3

1.6

5285.03

1174.03

e6/l

0.38

470

Artificial opening status

407

1.59

3.09

1.8

1.7

1788.33

1043.04

e6/l

0.34

313

Injuries to unspecified part of trunk, limb or body region

112

798

1.41

3.09

1.3

1.6

9599.88

1201.66

e6/l

0.67

648

Other and unspecified epidermal thickening

188

1.89

3.09

1.9

1.8

81.93

698.97

e6/l

0.57

158

Sub-endpoint used in defining T1D endpoints

318

2564

1.22

3.08

1.6

2062.68

2652.83

e6/l

0.12

274

2073

Disorders of multiple cranial nerves

11.49

3.08

1.4

5.40

3.20

e6/l

—

Gonococcal infection

284

1.71

3.08

1.8

1.3

2585.97

1843.37

e6/l

0.11

227

Other and unspecified diseases of blood and blood-forming organs

174

1.93

3.08

1.6

1.3

130.86

742.71

e6/l

0.47

140

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1388

0.70

3.06

1.3

1.4

981.09

1293.26

e6/l

0.23

1156

Psoriatic and enteropathic arthropathies

127

926

1.38

3.06

1.4

1.5

935.59

1358.43

e6/l

0.34

106

750

Benign neoplasm: Skin of lower limb, including hip

189

1.88

3.04

1.1

1.5

302.57

741.63

e6/l

0.32

150

Localized swelling, mass and lump of skin and subcutaneous tissue

326

2684

1.22

3.04

1.8

1.5

861.21

2599.48

e6/l

0.65

262

2184

Additional codes for the location of defect, injury or illness

441

1.56

3.02

1.4

1.6

1100.52

1320.22

e6/l

0.10

359

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

658

1.45

3.02

2.0

2.4

339.20

6570.97

e6/l

0.57

524

Nonalcoholic fatty liver disease

112

802

1.41

3.02

1.6

1.5

4379.67

1354.05

e6/l

0.34

655

Type 1 diabetes, wide definition

256

2055

1.25

3.01

1.5

1.6

2228.32

3113.20

e6/l

0.15

219

1672

Degenerative macular diseases

110

785

1.41

3.01

1.5

1.4

997.37

1143.09

e6/l

0.08

646

Abnormal findings in nipple discharge synovial fluid wound secretions

107

2.20

3.00

1.2

1.3

172.00

142.01

e6/l

0.07

Recurrent dislocation of patella

418

1.57

3.00

1.1

1.4

2501.36

9991.19

e6/l

0.40

339

Disorders of orbit

309

1.67

3.00

1.5

1.6

1257.30

1698.33

e6/l

0.13

250

Malignant melanoma of skin, including Hilmo

141

1049

1.35

2.99

1.3

1.4

449.21

1121.71

e6/l

1.14

109

868

Type 2 diabetes, strict (exclude DM1)

1145

6049

1.11

2.98

1.5

1.4

909.03

2243.41

e6/l

1.29

927

4912

Coronary artery bypass grafting

149

1471

0.75

2.98

1.3

1.4

374.44

2956.02

e6/l

1.02

124

1173

Acute pancreatitis

200

1564

1.28

2.97

2.0

1.4

547.63

1205.35

e6/l

1.36

160

1276

Acute bronchiolitis

507

1.49

2.96

2.4

2.8

133.86

7966.68

e6/l

0.53

396

Hydrocele

106

754

1.41

2.96

1.4

1.6

168.35

3635.51

e6/l

0.66

621

Ovarian dysfunction

664

1.44

2.94

1.2

1.4

220.66

6452.97

e6/l

0.59

539

Other dialysis

228

1.78

2.94

1.7

436.10

967.37

e6/l

0.36

182

Early complications of trauma

319

1.65

2.92

1.5

8917.50

1193.26

e6/l

0.45

260

!Aliquae complicationes praecoces traumatis

319

1.65

2.92

1.5

8917.50

1193.26

e6/l

0.45

260

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

664

0.58

2.91

1.2

1.4

235.67

867.16

e6/l

1.53

550

Gestational [pregnancy-induced] hypertension

304

2494

1.22

2.90

1.3

1.4

2675.73

2456.53

e6/l

0.03

250

2013

Adenocarcinoma and papilloma adenocarcinoma of rectum

638

0.58

2.90

1.1

1.4

247.39

887.25

e6/l

1.45

527

Acne

128

943

1.36

2.89

1.5

1761.18

4745.41

e6/l

0.34

107

761

Other articular cartilage disorders

150

1.96

2.87

1.2

1.3

243.18

668.58

e6/l

0.37

118

Atrial fibrillation and flutter with reimbursement

235

1188

1.26

2.87

1.4

1.3

1364.31

886.27

e6/l

0.42

179

939

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

539

4049

1.16

2.85

1.3

1.4

2006.51

2392.18

e6/l

0.10

457

3257

Atrophic disorders of skin

155

1179

1.32

2.85

1.5

1.4

3877.35

1151.73

e6/l

0.61

121

961

Atopic dermatitis, strict definition

370

3040

1.20

2.85

1.4

1.6

363.06

2450.74

e6/l

1.02

305

2440

Thyrotoxicosis with diffuse goitre

152

1153

1.33

2.85

1.7

1.4

563.91

4397.05

e6/l

0.63

129

925

Haemorrhoids and perianal venous thrombosis

319

2634

1.21

2.85

1.4

753.16

3036.80

e6/l

0.94

267

2162

Colon adenocarcinoma

772

0.62

2.84

1.5

1.4

302.13

1156.80

e6/l

1.75

642

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

146

1102

1.33

2.84

1.4

1.5

716.89

1254.37

e6/l

0.62

117

889

119

871

1.38

2.84

1.1

1.4

501.86

1440.35

e6/l

0.59

720

Sequelae of injuries of lower limb

106

761

1.40

2.84

1.3

1.4

423.22

1220.04

e6/l

0.98

624

Diabetic retinopathy, strict definition

163

1101

1.31

2.83

1.5

1.4

3275.02

2795.64

e6/l

0.06

140

901

Systemic sclerosis (FG)

158

1.93

2.83

1.3

1.7

436.50

730.98

e6/l

0.25

128

Benign neoplasm of other and unspecified sites

231

1.76

2.82

1.3

1253.15

963.88

e6/l

0.13

184

Contact with heat and hot substances

433

1.54

2.81

1.4

1.8

97.58

957.08

e6/l

1.14

343

Other abnormal findings of blood chemistry

346

1.61

2.81

1.6

1.3

243.39

1611.99

e6/l

0.98

283

Postprocedural musculoskeletal disorders, not elsewhere classified

514

1.49

2.80

1.5

1.4

174.72

1032.20

e6/l

1.84

416

Abscess of anal and rectal regions

704

1.42

2.80

1.5

1.6

1940.34

1343.16

e6/l

0.23

571

Vascular disorders of the intestines

425

1.54

2.80

1.3

1.4

5588.31

1076.03

e6/l

0.76

348

Mixed disorders of conduct and emotions

217

1.78

2.79

1.3

2.4

103622.14

135.89

e6/l

0.50

174

Radial styloid tenosynovitis [de Quervain]

378

1.57

2.79

1.6

1.4

732.76

523.78

e6/l

0.22

305

Oligomenorrhoea

285

1.67

2.78

1.9

1.5

221.92

1244.61

e6/l

0.59

234

Diabetes, insulin treatment (Kela reimbursement)

1212

6637

1.10

2.78

1.5

1388.58

2103.06

e6/l

0.49

1008

5367

Allergic urticaria

697

1.42

2.78

2.0

1.8

430.66

6496.55

e6/l

0.59

555

Crohn's disease NAS

532

1.48

2.77

1.6

1.7

1215.50

1299.38

e6/l

0.03

439

Muscle strain

188

1.83

2.76

1.3

1.5

64.71

112.30

e6/l

0.48

152

Other noninflammatory disorders of vagina

598

1.45

2.76

1.7

1.4

2562.30

1166.04

e6/l

0.38

497

Type 2 diabetes, definitions combined, including avohilmo

1146

6035

1.11

2.75

1.5

1.4

843.22

2258.85

e6/l

1.42

921

4916

Other predominantly sexually transmitted diseases, not elsewhere classified

251

2037

1.24

2.75

1.4

2535.20

2843.00

e6/l

0.04

200

1657

Trigger finger

141

1065

1.33

2.74

1.4

1013.49

1112.56

e6/l

0.07

116

870

Other diseases of pericardium

325

1.62

2.74

1.5

1.6

1462.27

695.36

e6/l

0.27

271

Emergency coronary revascularization (for ACS)

961

5238

1.12

2.73

1.4

1.6

2086.67

2092.08

e6/l

0.00

845

4182

Dialysis

310

1.63

2.73

1.5

1.9

308.62

1295.30

e6/l

0.78

248

Malignant melanoma of skin

107

776

1.39

2.71

1.3

1.4

459.95

1325.93

e6/l

1.10

641

Pregnancy with abortive outcome

766

3534

1.13

2.70

1.4

1834.50

2066.62

e6/l

0.06

634

2864

Insulin, fast-acting (human)

159

1224

1.31

2.70

1.6

1.5

3165.39

3946.44

e6/l

0.07

134

1004

Other specified and unspecified retinal disorders

242

1.72

2.69

2.5

1.5

62.51

727.33

e6/l

0.83

196

Mental retardation

356

1.58

2.68

2.3

3.3

398.17

733.17

e6/l

0.36

274

Other follicular disorders

610

1.44

2.68

1.3

1.4

4685.42

7479.71

e6/l

0.15

491

Chronic pancreatitis

125

931

1.35

2.68

1.2

1.5

203.88

1386.72

e6/l

2.56

751

Other contact dermatitis

627

1.43

2.67

1.3

1.5

1157.18

6775.21

e6/l

0.48

517

Impetigo

359

1.58

2.66

3.1

1.9

130.31

1899.70

e6/l

1.28

288

Hordeolum and other deep inflammation of eyelid

447

1.51

2.66

2.3

1.6

354.92

1473.48

e6/l

0.91

363

Unspecified abortion

383

1.56

2.66

1.3

4075.62

1516.54

e6/l

0.28

310

Colonic or urogenital fistula

284

2343

1.22

2.66

1.5

1.4

4874.20

2962.80

e6/l

0.22

226

1897

Acute pancreatitis (for exclusion)

200

1589

1.26

2.65

2.0

1.4

547.62

1310.63

e6/l

1.59

160

1289

Diabetic retinopathy

326

1689

1.21

2.65

1.5

1.4

2009.36

2102.97

e6/l

0.02

270

1390

Hypertrophy of breast

193

1528

1.27

2.64

1.4

808.21

4002.00

e6/l

0.70

160

1226

Complications predominantly related to the puerperium

300

2491

1.21

2.63

1.3

1.4

453.00

2985.10

e6/l

1.03

235

2030

Coxarthrosis [arthrosis of hip](FG)

555

3397

1.15

2.63

1.4

1.5

2082.73

2502.33

e6/l

0.12

457

2760

Disorders of oesophagus in diseases classified elsewhere

134

1.97

2.63

2.0

1.3

520.55

995.93

e6/l

0.21

107

L04AC Interleukin inhibitors

481

1.49

2.63

1.3

1.6

3799.51

1684.01

e6/l

0.26

384

Generalized skin eruption due to drugs and medicaments

290

1.64

2.62

1.7

95.70

1371.45

e6/l

0.76

236

Other and unspecified disorders of white blood cells

290

1.64

2.62

3.7

1.6

311.00

533.84

e6/l

0.23

232

Malignant neoplasm, without specification of site, including Hilmo

274

1.66

2.62

1.5

1.3

347.97

593.78

e6/l

0.24

235

Ehlers-Danlos syndrome

2.36

2.62

1.3

1.6

2.00

121.10

e6/l

0.97

Melanocytic naevi of trunk

131

987

1.34

2.62

1.3

1.4

715.21

1212.89

e6/l

0.33

818

Acute gastritis

522

1.47

2.61

1.6

99.36

1090.68

e6/l

2.60

425

Acute nasopharyngitis (common cold)

131

980

1.34

2.61

1.7

1.5

923.40

4984.71

e6/l

0.55

112

792

Stomatitis and related lesions

220

1771

1.25

2.61

2.9

1.5

1279.04

3190.02

e6/l

0.41

184

1420

COPD (mode)

269

1733

1.22

2.59

1.5

1.4

2224.14

1579.54

e6/l

0.31

214

1421

Other bursopathies

122

911

1.35

2.58

1.3

1.4

1267.12

968.98

e6/l

0.12

738

Allergic rhinitis

380

3192

1.18

2.58

1.3

1.6

567.45

2232.21

e6/l

0.81

313

2579

Caries of enamel

1118

7326

1.10

2.56

1.7

1.5

794.36

2312.10

e6/l

1.72

863

5976

Benign neoplasm: Stomach

683

1.40

2.56

1.4

1933.85

1372.39

e6/l

0.12

550

Injury of muscle and tendon at wrist and hand level

147

1130

1.31

2.55

1.4

1.5

4496.61

1241.26

e6/l

0.35

120

927

Lichen simplex chronicus

231

1.71

2.54

1.5

1.3

7682.75

956.65

e6/l

0.52

189

Other specified/unspecified bacterial intestinal infections

477

1.48

2.52

1.8

1.5

941.18

1480.47

e6/l

0.30

388

Other and unspecified vascular occlusions

584

1.43

2.52

1.5

1.4

763.97

928.09

e6/l

0.11

481

Tuberculosis, wide

428

1.51

2.52

1.5

1.4

84.74

697.98

e6/l

1.32

357

Mental retardation, wide definition

378

1.54

2.52

2.2

3.2

382.04

692.54

e6/l

0.35

291

Systemic sclerosis

165

1.85

2.51

1.3

1.6

436.50

613.91

e6/l

0.14

132

Other diseases of arteries and capillaries

635

1.41

2.51

1.5

2398.88

1282.43

e6/l

0.31

525

Heart failure and coronary heart disease

285

2429

0.83

2.51

1.4

1.5

821.97

2428.88

e6/l

1.00

251

1950

Effects of foreign body entering through natural orifice

273

2259

1.21

2.50

1.6

2795.36

2798.73

e6/l

0.00

225

1819

Erosion of teeth , including avohilmo

291

2423

1.21

2.50

1.6

1.5

1030.73

2636.16

e6/l

0.51

225

1967

Late syphilis

109

2.06

2.49

1.7

1.2

855.50

1087.02

e6/l

0.07

Mantle cell lymphoma, including Hilmo

2.18

2.48

1.2

1.3

176.95

1325.55

e6/l

0.50

Disorders of other and unspecified cranial nerves

3.24

2.47

1.4

1.2

31.40

93.27

e6/l

—

Outcome of delivery

203

1001

1.26

2.47

1.2

1.3

4332.62

5082.22

e6/l

0.05

146

801

Injury of nerves at forearm level

2.28

2.47

1.2

1.3

5.25

1453.88

e6/l

0.55

Seropositive rheumatoid arthritis

242

1974

1.23

2.46

1.3

1.4

1263.22

3246.00

e6/l

0.48

201

1622

Ulcer of oesophagus

455

1.48

2.46

1.4

289.91

945.19

e6/l

1.31

372

Foreign body in alimentary tract

423

1.50

2.46

1.4

1.7

943.92

1011.05

e6/l

0.03

334

Plantar fascial fibromatosis

697

1.39

2.45

1.3

1.4

1486.62

884.83

e6/l

0.22

566

Septal defects

592

1.42

2.45

1.4

2.8

214.65

884.72

e6/l

1.43

468

Tuberculosis, IBD comorbidity

415

1.50

2.44

1.5

1.3

84.74

720.48

e6/l

1.34

347

Female infertility, associated with anovulation

681

1.39

2.44

1.4

216.96

1048.83

e6/l

1.34

568

Exposure to other and unspecified man-made environmental factors

110

2.04

2.43

1.1

1.3

5.53

1114.16

e6/l

0.61

Campylobacter enteritis

189

1.77

2.43

1.3

1.5

13.68

1100.86

e6/l

0.94

153

Other histiocytosis syndromes

6.83

2.43

1.2

1.4

26.20

32.88

e6/l

—

Chronic conjunctivitis

220

1.70

2.40

2.1

1.9

493.20

1009.78

e6/l

0.35

179

Alcohol-induced chronic pancreatitis

483

1.46

2.39

1.2

1.4

98.80

1009.04

e6/l

1.46

389

Systemic sclerosis, icd10

168

1.81

2.39

1.3

436.50

562.54

e6/l

0.10

132

Chronic ulcer of skin, not elsewhere classified

450

1.48

2.39

1.4

1.5

1026.76

979.74

e6/l

0.03

375

Congenital malformations of the respiratory system

161

1.84

2.38

1.7

3.5

1793.96

1872.77

e6/l

0.01

119

Other and unspecified rosacea

685

1.38

2.37

1.4

248.50

1355.74

e6/l

1.75

554

Pneumonia due to Streptococcus pneumoniae

275

1.62

2.36

1.6

1.4

160.79

680.28

e6/l

0.46

227

Other disorders of penis

694

1.38

2.35

1.4

2.0

461.60

886.34

e6/l

0.56

565

Viral warts

238

1958

1.22

2.34

1.4

1.6

999.80

2861.80

e6/l

0.47

202

1587

Pilonidal cyst

101

746

1.36

2.34

1.6

1.5

5124.95

939.29

e6/l

0.49

616

Primary angle-closure glaucoma

268

1.62

2.33

1.5

1.3

198.24

714.56

e6/l

0.62

217

Malignant neoplasm of rectum, including Hilmo

865

0.68

2.33

1.3

1.4

3042.29

1086.40

e6/l

0.32

721

Dislocation, sprain and strain of joint and ligaments of hip

245

1.65

2.33

1.7

1.4

150.82

741.79

e6/l

0.71

200

Arteriovenous malformation of cerebral vessels

2.17

2.32

2.1

1.3

726.58

159.84

e6/l

0.55

Post-traumatic wound infection, not elsewhere classified

192

1.74

2.32

1.3

1.4

14331.58

1030.83

e6/l

0.49

157

Chronic kidney disease

268

2188

1.20

2.32

1.5

2563.74

2318.42

e6/l

0.05

226

1781

DVT of lower extremities

178

1421

1.26

2.32

1.4

2454.56

1227.60

e6/l

0.41

153

1158

Bitten or struck by other mammals

128

981

1.31

2.31

1.2

1.5

274.63

4983.75

e6/l

0.68

105

797

ILD, hospital admission 2, with pulmonary infections

578

1.41

2.30

1.2

1.5

91.16

847.30

e6/l

2.73

484

Other leukaemias of specified cell type

4.12

2.30

8.4

1.2

64.29

374.54

e6/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

663

1.38

2.30

1.3

1.6

85.94

960.94

e6/l

2.03

541

Benign mammary dysplasia

136

1052

1.30

2.29

1.5

1.4

1877.42

1609.50

e6/l

0.08

113

847

Deviated nasal septum

343

2920

1.18

2.29

1.3

1.5

1309.37

2726.06

e6/l

0.51

291

2348

Prepatellar bursitis

301

1.58

2.29

1.3

1.4

223.64

393.02

e6/l

0.42

249

Adalimumab

111

836

1.34

2.27

1.6

6400.24

1342.68

e6/l

0.42

674

Congenital malformations of the respiratory system

171

1.79

2.27

1.7

3.4

1719.21

1747.30

e6/l

0.01

128

Delayed milestone in childhood

201

1.69

2.27

2.7

5.2

228.93

1090.16

e6/l

0.71

141

Angina pectoris

587

3458

1.13

2.24

1.4

1.5

876.96

2040.36

e6/l

0.98

492

2768

Endocrine disorders, other/unspecified

128

1.90

2.23

1.3

10.89

110.00

e6/l

1.28

104

Other diseases of pancreas

600

1.39

2.21

1.3

1.5

161.46

789.26

e6/l

2.19

493

Pyoderma gangrenosum

2.57

2.21

1.1

1.2

24.20

234.36

e6/l

—

Presbycusis

712

1.35

2.20

1.3

1.4

2245.11

1061.22

e6/l

0.33

593

Pneumonia derived septicemia

249

1.62

2.20

1.6

1.9

1614.29

526.50

e6/l

0.45

205

Blepharochalasis

266

2229

1.20

2.18

1.3

1.4

852.31

1249.03

e6/l

0.53

216

1828

ILD, hospital admissions 3, with pneumonia sepsis

509

1.42

2.18

1.3

1.5

99.09

738.89

e6/l

2.23

421

Diseases of external ear

356

3058

1.17

2.17

1.5

1.6

1028.84

2452.37

e6/l

0.57

287

2495

Entropion and trichiasis of eyelid

501

1.43

2.17

1.3

1.4

520.02

633.66

e6/l

0.12

416

Polyarthritis, unspecified

258

1.61

2.16

1.3

1.6

214.17

848.95

e6/l

0.95

214

Volvulus

174

1.74

2.15

1.1

1.4

51.24

859.44

e6/l

0.70

142

Ankylosing spondylitis, ICD10

732

1.35

2.14

1.5

6737.74

1249.64

e6/l

0.44

590

Polycystic ovarian syndrome

478

1.43

2.14

1.1

1.4

162.45

8548.24

e6/l

0.58

396

Other and unspecified follicular disorders

299

1.55

2.12

1.4

8448.10

745.41

e6/l

0.44

247

Thyroiditis

546

1.40

2.12

1.5

1.4

2207.02

1517.12

e6/l

0.13

449

Malignant neoplasm of bronchus and lung

1061

0.75

2.12

1.2

1.4

27446.63

1511.23

e6/l

0.47

882

Tibial collateral bursitis [Pellegrini-Stieda]

2.18

2.11

1.7

1.8

6.00

99.58

e6/l

1.57

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

276

1.58

2.11

1.4

1.9

276.58

793.19

e6/l

0.50

219

Other superficial mycoses

117

900

1.31

2.09

1.3

1.5

232.89

5288.27

e6/l

0.66

727

Chronic hepatitis, not elsewhere classified

237

1.62

2.09

1.6

1.4

12263.93

924.22

e6/l

0.48

195

Other disorders of male genital organs

253

1.60

2.08

1.4

1.5

44.97

1101.32

e6/l

0.94

206

Anxious personality disorder

139

1.82

2.07

1.3

1185.42

629.79

e6/l

0.17

112

Multiple myeloma, including Hilmo

285

1.56

2.07

1.5

1.4

26.68

632.83

e6/l

0.99

240

Female genital prolapse

318

1529

1.18

2.05

1.4

1041.54

1754.86

e6/l

0.45

262

1262

Embolic stroke

238

1.61

2.04

1.8

1.4

2688.81

346.94

e6/l

0.85

196

Otitis externa, unspecified

125

974

1.29

2.04

1.4

1.6

1138.25

4858.40

e6/l

0.48

102

795

Hyperkinetic disorders (excl. ADHD)

183

1.70

2.04

1.4

3.6

21.00

1014.96

e6/l

0.58

141

Bacterial, viral and other infectious agents

103

782

1.33

2.04

1.4

1.6

190.79

5893.07

e6/l

0.65

631

Hernia of abdominal wall

472

4162

1.14

2.02

1.4

5527.77

2266.01

e6/l

0.32

392

3404

Open wound of forearm

100

757

1.33

2.02

1.3

1.6

921.32

5971.56

e6/l

0.53

614

Blood alcohol or alcohol intoxication level

178

1.71

2.00

1.3

1.6

1212.68

2079.27

e6/l

0.26

142

Haemolytic anaemias

264

1.57

1.99

1.4

1.7

835.97

583.07

e6/l

0.15

212

Injury of other and unspecified intrathoracic organs

452

1.43

1.98

1.5

892.53

842.49

e6/l

0.02

376

Vasculitis limited to skin, not elsewhere classified

156

1.75

1.98

1.2

1.7

4.56

843.33

e6/l

0.67

131

Myocardial infarction, strict

351

2887

0.86

1.98

1.3

1.5

492.68

2225.73

e6/l

1.51

298

2324

Benign neoplasm: Other and unspecified parts of mouth

233

1.61

1.97

1.3

1717.84

1039.24

e6/l

0.18

189

Psoriatic arthropathies

102

777

1.32

1.97

1.4

1.5

1111.67

1379.09

e6/l

0.17

621

Hereditary retinal dystrophy

1.97

1.3

1.7

79.36

1241.45

e6/l

0.55

Recurrent dislocation and subluxation of joint

563

1.38

1.96

1.3

1.6

41.27

1067.20

e6/l

2.04

458

Hyperparathyroidism

155

1232

1.25

1.95

1.5

1.4

912.41

1279.66

e6/l

0.28

121

1004

Mixed specific developmental disorders

223

1.60

1.95

1.9

4.2

140.79

370.66

e6/l

0.56

159

Habitual aborter

172

1.71

1.95

1.2

1.5

4.92

1661.63

e6/l

0.63

146

Scoliosis

606

1.36

1.95

1.8

991.94

726.83

e6/l

0.11

493

Otitis externa

237

1990

1.20

1.95

1.4

1.5

1222.90

3145.28

e6/l

0.48

193

1612

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

157

1.74

1.95

1.5

14.60

125.91

e6/l

1.96

134

Other and unspecified vasculitis limited to skin

142

1.78

1.94

1.2

1.7

4.82

916.35

e6/l

0.64

117

Tongue abnormality

446

1.42

1.94

1.2

1.6

96.36

1008.32

e6/l

1.99

366

L02BX Other hormone antagonists and related agents

321

0.53

1.93

1.2

1.4

23.42

1256.89

e6/l

1.83

267

Spontaneous abortion

512

3060

1.13

1.93

1.3

1.4

2096.97

2276.97

e6/l

0.04

415

2470

Other congenital malformations of skin

685

1.34

1.93

1.7

2119.72

6693.61

e6/l

0.38

551

Hydronephrosis

106

815

1.31

1.93

1.3

1.5

221.91

1140.95

e6/l

1.85

673

Biological medication for rheuma

196

1619

1.22

1.93

1.4

1.6

4951.09

3605.92

e6/l

0.13

159

1309

Dysplasia of cervi uteri

272

1669

1.18

1.93

1.2

1.4

14563.32

1576.84

e6/l

0.47

217

1375

Congenital malformations of cardiac septa

622

1.35

1.91

1.4

2.7

209.08

659.39

e6/l

1.14

488

Pneumococcal septicemia

243

1.58

1.91

1.6

1.9

1668.10

620.93

e6/l

0.40

197

Vitamin B12 deficiency anaemia

694

1.33

1.91

1.4

1056.50

1199.06

e6/l

0.08

572

Convalescence

356

1.47

1.91

1.4

5343.88

1646.35

e6/l

0.37

286

Conotruncal defects

141

0.35

1.91

1.0

4.2

405.60

364.58

e6/l

—

106

Injury of nerves at lower leg level

2.20

1.90

1.0

1.2

140.88

190.81

e6/l

—

Seronegative rheumatoid arthritis

109

843

1.30

1.90

1.3

1.4

180.00

1295.50

e6/l

2.52

679

Lichen sclerosus et atrophicus

100

765

1.31

1.89

1.4

5949.42

1233.99

e6/l

0.69

622

Ulcerative colitis

265

2253

1.18

1.89

1.4

1.5

590.75

2960.11

e6/l

0.80

216

1824

IBD patients in KELA-register

258

2189

1.18

1.89

1.6

1.5

902.64

2943.32

e6/l

0.62

210

1774

Diabetic nephropathy

137

1077

1.26

1.89

1.7

1.4

3820.05

2906.09

e6/l

0.10

120

875

Nasal polyp

187

1541

1.22

1.88

1.3

1.4

239.04

3615.91

e6/l

0.81

159

1255

Superficial injury of neck

144

1.76

1.87

1.2

1.6

146.35

835.38

e6/l

0.45

119

Seborrhoeic keratosis

201

1671

1.21

1.86

1.6

1.4

642.57

1330.27

e6/l

1.48

161

1363

Dependence on enabling machines and devices, not elsewhere classified

1.97

1.85

3.9

2.4

1287.18

1503.87

e6/l

0.05

Other and unspecified injuries of ankle and foot

326

1.49

1.85

1.7

1.8

665.83

13296.58

e6/l

0.57

262

Follow-up care involving plastic surgery

250

0.48

1.85

1.5

44.00

2022.29

e6/l

—

196

Diabetic maculopathy

115

847

1.29

1.84

1.5

1.4

4608.32

3423.14

e6/l

0.10

686

Malignant neoplasm of rectum

647

0.68

1.84

1.3

1.4

341.47

777.23

e6/l

0.93

540

Unspecified kidney failure

621

1.34

1.84

1.6

1.4

779.59

845.26

e6/l

0.04

511

Other puerperal infections

717

1.32

1.83

1.3

1.4

45.76

6841.34

e6/l

0.73

585

Gonarthrosis,primary

960

5430

1.09

1.82

1.4

1997.92

1909.80

e6/l

0.04

791

4423

Benign neoplasm: Rectum, anus and anal canal

181

1493

1.22

1.82

1.4

243.46

1381.18

e6/l

4.16

135

1214

Personal history of certain other diseases

153

1.72

1.81

1.6

1.4

34.05

125.68

e6/l

0.94

127

Acne vulgaris

753

1.31

1.81

1.4

1.5

2060.18

5813.74

e6/l

0.34

614

Persons encountering health services in circumstances related to reproduction

704

4297

1.11

1.81

1.6

1384.47

2488.03

e6/l

0.55

565

3432

Congenital malformations of spine and bony thorax

2.41

1.81

1.4

3.6

198.09

362.14

e6/l

0.33

Malignant neoplasm of mesothelium and soft tissue

271

1.53

1.80

1.2

1.3

285.33

640.78

e6/l

0.35

226

Postprocedural disorders of digestive system, not elsewhere classified

239

1.56

1.80

1.5

1.6

8061.63

614.25

e6/l

0.76

194

Other lesions of median nerve

161

1.69

1.79

1.0

1.3

204.74

198.45

e6/l

0.01

130

Achalasia of cardia

109

1.86

1.79

1.2

1.3

137.14

1091.61

e6/l

0.49

Malignant neoplasm of colon

1002

0.75

1.78

1.4

193.54

1286.01

e6/l

2.60

832

Malignant neoplasm of accessory sinuses

3.51

1.78

1.5

1.3

6172.00

385.00

e6/l

—

Malignant neoplasm of endocrine gland

539

1.36

1.78

1.5

1.3

1058.45

1413.99

e6/l

0.18

446

Follicular cysts of skin and subcutaneous tissue

189

1570

1.21

1.78

1.6

1.4

678.13

1164.48

e6/l

0.74

166

1273

Combinations of oral blood glucose lowering drugs

273

2341

1.17

1.78

1.5

1.4

1384.64

1637.27

e6/l

0.19

225

1909

Urethral stricture

337

1.46

1.77

1.2

1.4

2807.51

1462.45

e6/l

0.20

280

Malignant neoplasm of prostate

188

1356

0.83

1.77

1.4

554.43

1563.54

e6/l

1.46

147

1124

Caught, crushed, jammed or pinched in or between objects

404

1.42

1.77

1.2

1.7

3973.06

646.39

e6/l

0.40

322

Nonspecific lymphadenitis

472

1.39

1.76

2.0

1.5

499.35

1103.76

e6/l

0.62

386

Peripheral arterial reconstruction

1057

0.75

1.76

1.4

549.29

924.16

e6/l

0.43

861

Presence of cardiac and vascular implants and grafts

323

2761

0.87

1.76

1.4

887.48

2250.88

e6/l

0.86

276

2252

Non-small cell lung cancer

624

0.68

1.76

1.3

1.4

718.46

858.36

e6/l

0.07

519

Burns and corrosions confined to eye and internal organs

201

1.61

1.76

1.7

1007.40

1294.99

e6/l

0.09

159

Pre-eclampsia or eclampsia

235

1994

1.18

1.75

1.3

1.4

406.61

2900.30

e6/l

0.75

203

1616

Benign lipomatous neoplasm

290

2502

1.16

1.75

1.4

1019.84

2929.16

e6/l

0.67

242

2045

Malignant neoplasm of bronchus and lung, including Hilmo

122

1280

0.80

1.75

1.3

1.4

21043.68

1646.76

e6/l

0.46

1065

Single delivery by forceps and vacuum extractor

127

957

0.80

1.74

1.3

1.4

187.45

5144.95

e6/l

0.67

107

752

Haemangioma, any site

680

1.32

1.73

1.4

1.7

1600.10

1234.93

e6/l

0.11

553

Polypectomy (DHB20)

499

1.37

1.73

1.4

1.5

72.00

1135.60

e6/l

1.88

410

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

323

1.47

1.73

2.6

2.5

593.51

1101.39

e6/l

0.28

260

Other obstructive and reflux uropathy

323

1.47

1.72

1.3

1.7

980.44

487.39

e6/l

0.28

257

Other endocrine disorders

470

1.38

1.72

2.7

2.9

328.63

8735.05

e6/l

0.50

355

Prolonged pregnancy

124

1353

0.80

1.72

1.6

1.3

297.05

3672.93

e6/l

0.67

102

1099

Osteomyelitis

449

1.39

1.71

1.4

679.08

789.27

e6/l

0.08

371

Bronchitis, not specified as acute or chronic

638

1.32

1.70

1.3

1.5

511.75

831.61

e6/l

0.33

522

Other (seronegative) rheumatoid arthritis, wide

176

1460

1.21

1.69

1.3

1.4

236.95

1341.72

e6/l

4.03

139

1198

Other pleural conditions

630

1.32

1.69

1.5

24052.23

707.50

e6/l

0.48

517

Pituitary-dependent Cushing's disease

2.69

1.69

1.3

1.2

89.75

208.21

e6/l

—

Other or ill-defined heart diseases

391

1.42

1.69

2.3

1.5

3207.64

966.98

e6/l

0.71

324

Other acquired deformities of musculoskeletal system and connective tissue

333

1.45

1.69

1.4

1.5

1077.74

880.23

e6/l

0.10

265

Disorders resulting from impaired renal tubular function

268

1.51

1.67

1.5

1.6

12460.00

632.82

e6/l

0.46

212

Other disorders of the genitourinary system

116

922

1.26

1.67

1.5

1.4

324.71

1461.80

e6/l

2.43

751

Hypoplasia of dental enamel, prenatal

2.43

1.67

5.7

4.6

2.83

840.39

e6/l

—

Helminthiases

309

1.47

1.67

1.6

2.1

328.11

12468.07

e6/l

0.51

249

Tumor necrosis factor alpha inhibitors

175

1454

1.21

1.67

1.5

5550.93

3962.25

e6/l

0.14

141

1178

Evidence of alcohol involvement determined by level of intoxication

1.96

1.67

1.4

1.5

2366.73

214.33

e6/l

0.59

Granulomatous disorders of skin and subcutaneous tissue

173

1.64

1.65

1.4

1.3

9242.00

1012.59

e6/l

0.42

141

Female infertility, cervical, vaginal, other or unspecified origin

311

1756

1.15

1.65

1.5

1.4

1149.61

1592.39

e6/l

0.22

241

1441

Other sexually transmitted chlamydial diseases

590

1.33

1.65

1.6

1.5

131.76

7318.23

e6/l

0.61

482

Glomerular disorders in diseases classified elsewhere

111

880

1.27

1.64

1.5

4273.29

1181.07

e6/l

0.38

726

Glucosamine medication

433

3073

1.13

1.64

1.4

1906.35

1884.49

e6/l

0.01

355

2499

Inflammatory bowel disease, strict (require KELA)

258

2220

1.17

1.64

1.6

1.5

902.64

2901.07

e6/l

0.61

210

1799

Chromosomal abnormalities, not elsewhere classified

197

1.59

1.63

1.5

3.7

439.87

325.99

e6/l

0.11

146

Umbilical hernia

275

2379

1.16

1.63

1.5

1.4

8225.41

3234.39

e6/l

0.27

221

1928

Pedestrian injured in collision with car, pick-up truck or van

166

1.64

1.63

1.2

187.24

1145.86

e6/l

0.66

139

Malignant neoplasm of accessory sinuses, including Hilmo

2.57

1.62

1.6

1.3

4649.13

3847.96

e6/l

—

COPD, hospital admissions 1, only main diagnosis

223

2238

0.85

1.62

1.5

1.4

2232.19

2309.50

e6/l

0.02

187

1826

Myocardial infarction, unclassifiable

111

1241

0.80

1.61

1.3

1.4

179.06

1011.65

e6/l

3.99

1023

Pedal cyclist injured in other and unspecified transport accidents

117

936

1.26

1.61

1.5

825.37

4968.92

e6/l

0.53

758

Special screening examination for neoplasms

303

1.46

1.61

1.4

1.5

143.53

894.76

e6/l

1.50

231

Sequelae of infectious and parasitic diseases

532

1.34

1.60

1.7

1.5

574.58

1531.00

e6/l

0.82

435

Suggestive for eosinophilic asthma

698

1.30

1.59

1.3

1.4

307.06

993.75

e6/l

1.24

570

LSIL lesion of the cervix uteri, vagina or vulva

159

1316

1.21

1.59

1.5

1.4

24647.71

1362.82

e6/l

0.49

125

1071

Superficial injury of ankle and foot, unspecified

2.75

1.59

1.0

1.6

1532.43

239.20

e6/l

—

Lichen planus

124

1000

1.25

1.59

1.5

779.41

1226.79

e6/l

0.35

101

803

Superficial injury of ankle and foot

136

1108

1.23

1.59

1.8

1.7

3449.47

4389.45

e6/l

0.08

112

894

AV-block

157

1135

1.22

1.59

1.3

1.6

925.03

2792.52

e6/l

0.47

139

929

Melanoma in situ

296

1.47

1.59

1.1

1.3

15.06

607.86

e6/l

0.98

244

5-aminosalicylic acid

223

1903

1.18

1.58

1.5

1.4

729.02

3188.71

e6/l

0.66

179

1531

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

185

1505

1.20

1.58

1.5

2.0

381.08

3568.31

e6/l

0.70

145

1204

Disorder of external ear, unspecified

231

1.53

1.58

1.3

1.5

98.10

496.29

e6/l

0.66

187

Intestinal adhesions without obstruction

594

1.32

1.58

1.5

456.36

1356.09

e6/l

0.99

487

Burns and corrosions of multiple and unspecified body regions

152

1.66

1.58

3.0

1.4

22.15

1550.89

e6/l

0.78

125

Congenital malformations of spine and bony thorax

2.16

1.57

1.4

3.2

181.83

300.49

e6/l

0.26

Bacterial, viral and other infectious agents

735

1.29

1.57

1.5

1.7

208.62

1265.20

e6/l

1.58

593

Other disorders of breast

131

1065

1.24

1.57

1.4

170.42

5242.57

e6/l

0.81

104

847

Congenital malformations of the musculoskeletal system, not elsewhere classified

145

1.68

1.56

1.3

2.1

483.44

142.39

e6/l

0.32

115

Psoriasis

287

2501

1.15

1.55

1.3

1.4

659.23

2901.13

e6/l

0.86

223

2023

Inflammatory disorders of breast

544

1.33

1.55

1.2

1.4

419.36

7947.58

e6/l

0.57

437

Diabetes mellitus in pregnancy

382

2164

1.13

1.55

1.4

1.3

259.09

3159.46

e6/l

1.02

318

1745

Amiodarone users

681

0.72

1.54

1.4

2119.10

686.02

e6/l

0.53

560

Dissocial personality disorder

100

1.82

1.54

2.9

1.3

3570.83

2362.85

e6/l

0.12

All dysplastic lesions of the vulva

323

1.44

1.54

2.0

1.5

333.23

1463.12

e6/l

0.73

260

Lupus nephritis

2.67

1.53

2.4

2.2

0.57

245.86

e6/l

—

Female infertility

337

1798

1.14

1.52

1.4

1048.86

1604.32

e6/l

0.31

265

1478

Family history of certain disabilities and chronic diseases leading to disablement

400

1.38

1.52

1.4

1.5

209.28

10966.13

e6/l

0.62

326

Other sexually transmitted chlamydial diseases

116

935

1.25

1.51

1.4

1.5

96.49

4673.05

e6/l

0.62

761

Other disorders of conjunctiva

129

1052

1.23

1.51

1.3

1.5

521.88

1192.06

e6/l

0.94

109

863

Separation of retinal layers (serosa)

308

1.44

1.50

1.2

1.3

1544.77

1062.23

e6/l

0.12

243

Endometriosis of rectovaginal septum and vagina

599

1.31

1.50

1.3

1.4

339.07

1384.74

e6/l

1.27

498

Benign neoplasm: Rectum

160

1334

1.20

1.50

1.4

215.49

1338.03

e6/l

3.72

117

1081

Conductive hearing loss, unspecified

643

1.30

1.50

1.9

1.6

207.00

1282.74

e6/l

1.51

518

Premature rupture of membranes

187

1581

0.84

1.50

1.3

1.4

3908.27

3313.82

e6/l

0.06

163

1279

Papillary adenocarcinoma of thyroid gland

384

1.39

1.50

1.4

1330.83

1716.41

e6/l

0.13

316

Maternal care for known or suspected abnormality of pelvic organs

291

1728

1.15

1.49

1.3

1.4

2310.83

3315.33

e6/l

0.13

239

1402

Peritonsillar abscess

227

1952

1.17

1.49

1.4

1.5

1556.25

2875.61

e6/l

0.28

186

1585

Assault by unspecified means

163

1.61

1.48

1.4

1.5

355.90

1721.31

e6/l

0.58

131

Other and unspecified psoriasis

488

1.34

1.47

1.3

1.5

222.54

819.11

e6/l

1.14

392

Sulfonylureas

215

1995

0.86

1.47

1.5

1.4

10952.38

1361.23

e6/l

0.47

174

1635

Congenital deformities of feet

195

1.55

1.47

1.6

1.9

124.64

173.58

e6/l

0.19

149

Benign neoplasm: Liver/bile ducts

187

1.57

1.47

1.4

1.6

589.67

724.44

e6/l

0.06

154

Haemangioma and lymphangioma, any site

734

1.27

1.46

1.4

1.6

1537.29

1383.64

e6/l

0.04

594

Benign neoplasm: Choroid

446

1.35

1.46

1.7

1.5

323.71

963.30

e6/l

0.98

367

Hallux rigidus

123

1003

1.23

1.45

1.3

1.4

828.67

864.48

e6/l

0.03

108

809

Congenital hypothyroidism without goiter

2.37

1.45

1.2

2.2

336.44

362.66

e6/l

—

Molar incisor enamel hypoplasia

348

1.40

1.45

7.1

2.7

469.77

232.85

e6/l

0.36

268

Other predominantly sexually transmitted diseases, not elsewhere classified

194

1653

1.18

1.44

1.5

1.4

3313.52

3470.01

e6/l

0.02

152

1343

Abnormal findings on examination of urine, without diagnosis

311

1.43

1.44

1.7

1.6

55065.48

529.46

e6/l

0.51

251

Retinal breaks without detachment

151

1259

1.20

1.43

1.3

1.4

548.12

1406.92

e6/l

1.57

114

1016

Sequelae of other and unspecified infectious and parasitic diseases

413

1.36

1.43

1.7

1.5

739.98

1726.02

e6/l

0.61

336

Gout, idiopatic and unspecified

209

1793

1.17

1.42

1.4

1016.62

2659.14

e6/l

0.62

172

1474

Multiple myeloma and malignant plasma cell neoplasms

295

1.43

1.42

1.5

1.4

28.31

616.15

e6/l

0.95

241

Personal history of malignant neoplasm

535

1.32

1.42

4.3

1.5

182.59

1443.16

e6/l

1.59

428

Malignant neoplasm of thyroid gland

501

1.33

1.40

1.5

1.4

1147.45

1502.63

e6/l

0.16

414

Pedal cyclist injured in transport accident

235

2039

1.16

1.39

1.4

1.5

535.77

2824.67

e6/l

0.69

188

1653

Endometriosis diagnosis and infertility diagnosis occurring together

118

964

1.23

1.39

1.5

1.3

374.89

5351.54

e6/l

0.72

795

Nontoxic multinodular goitre

173

1465

1.18

1.39

1.3

1.5

792.11

1191.18

e6/l

0.39

141

1190

Primary open-angle glaucoma, strict

210

1802

1.17

1.39

1.6

1.4

1028.36

939.93

e6/l

0.06

180

1479

Carbimazole or st.post thyroidectomy, condition for graves disease

209

1798

1.17

1.39

1.5

1.4

1026.00

3566.84

e6/l

0.65

162

1456

Other misadventures during surgical and medical care

174

1.57

1.38

1.3

1.4

668.82

767.77

e6/l

0.04

135

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.05

1.38

2.0

1.1

5.80

162.08

e6/l

—

Adjustment and management of implanted device

140

1165

1.21

1.37

1.3

1.5

1369.35

2932.05

e6/l

0.36

113

947

Melanocytic naevi, other sites/unspecified

644

1.28

1.36

1.3

1.5

1699.49

1081.18

e6/l

0.15

522

Ventral hernia

220

1903

1.16

1.36

1.5

1.4

1756.67

1413.64

e6/l

0.16

195

1543

Palmar fascial fibromatosis [Dupuytren]

119

975

1.22

1.36

1.5

1.4

1411.26

3230.80

e6/l

0.36

100

804

Melanocytic naevi of lower limb, including hip

349

1.39

1.36

1.4

1.6

206.00

1387.88

e6/l

0.81

282

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

193

1604

1.17

1.35

1.5

1.9

502.14

3300.41

e6/l

0.64

152

1280

Mental and behavioural disorders due to hallucinogens

2.19

1.35

1.2

1.3

328544.33

267.80

e6/l

—

Carcinoma in situ of breast

0.00

1.35

0.0

1.2

—

83.06

—

Complications following myocardial infarction

0.00

1.35

0.0

1.4

—

256.23

—

Carcinoma in situ of breast, intraductal

640

0.73

1.35

1.4

1457.82

1439.72

e6/l

0.01

513

Simple and mucopurulent chronic bronchitis

265

1.44

1.35

1.8

2.0

1274.24

523.85

e6/l

0.35

222

Postpartum haemorrhage due to anatomy

990

0.78

1.34

1.3

1.4

239.41

1508.68

e6/l

1.16

822

Pre-eclampsia

216

1870

1.16

1.33

1.3

1.4

433.78

2857.17

e6/l

0.66

188

1518

Early onset COPD

206

1778

1.16

1.32

1.6

1.4

1615.93

1516.96

e6/l

0.05

168

1436

Toxic liver disease

1.76

1.32

1.8

1.3

218.58

151.10

e6/l

0.12

Malignant neoplasm of thyroid gland, including Hilmo

559

1.29

1.32

1.4

1024.21

1398.59

e6/l

0.20

462

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

660

4812

1.09

1.32

1.4

6521.84

1531.04

e6/l

0.43

528

3918

Macular pucker

128

1062

1.21

1.31

1.4

1510.89

1098.29

e6/l

0.23

860

Other endophthalmitis

2.41

1.31

1.3

1.8

888.25

173.50

e6/l

—

Benign neoplasm: Sigmoid colon

164

1392

1.18

1.30

1.5

1.4

15595.07

1334.91

e6/l

0.53

128

1127

Other abnormal products of conception

362

2142

1.12

1.30

1.2

1.4

3017.80

2739.23

e6/l

0.04

293

1727

2.87

1.30

1.0

1.5

11.20

78.44

e6/l

—

Oesophagitis

369

1.36

1.30

1.4

1.5

170.45

981.37

e6/l

1.24

296

Benign neoplasm: Transverse colon

783

1.24

1.29

1.7

1.4

816.64

916.04

e6/l

0.05

639

Female infertility, tubal origin

378

1.36

1.29

1.3

1.4

94.07

1174.97

e6/l

0.94

312

Other diseases of peritoneum

310

1.40

1.29

1.3

1.5

27.61

1818.50

e6/l

1.32

256

Malignant neoplasm of colon, including Hilmo

108

1314

0.82

1.28

1.4

208.61

1266.11

e6/l

3.23

1100

Other factor of the environment

1.81

1.28

1.7

1.3

643.00

166.40

e6/l

—

Exposure to other specified electric current

186

1.52

1.27

1.3

1.7

109.43

684.76

e6/l

0.48

149

Gluteal tendinitis

252

1.44

1.27

1.5

84.07

554.57

e6/l

0.93

204

Benign neoplasm of ovary

157

1332

1.18

1.26

1.4

581.43

4070.89

e6/l

0.69

123

1085

Endometriosis ASRM stages 3,4

234

2047

1.15

1.26

1.4

1627.06

3023.30

e6/l

0.32

198

1670

Shoulder region

1.76

1.26

1.2

1.6

2436.25

1308.32

e6/l

0.23

Flat foot [pes planus] (acquired)

714

1.25

1.26

1.4

1.5

326.36

1039.76

e6/l

1.57

576

Other diseases of stomach and duodenum

449

1.32

1.26

1.6

1.5

163.83

1699.76

e6/l

1.67

364

Injury of nerves at wrist and hand level

278

1.41

1.25

1.5

1.4

1145.34

1315.43

e6/l

0.07

228

Seborrhoeic dermatitis

706

1.25

1.6

1.5

358.93

1059.40

e6/l

1.37

579

Ulcerative colitis, NAS

144

1215

1.19

1.24

1.4

1.6

726.82

4087.47

e6/l

0.58

119

996

Congenital deformities of feet

304

1.39

1.24

1.5

1.9

128.32

757.73

e6/l

0.79

236

Other and unspecified nail disorders

147

1.58

1.24

1.3

1.4

926.78

966.47

e6/l

0.01

117

Infective dermatitis

106

869

1.22

1.24

1.4

2309.08

1156.28

e6/l

0.37

708

Disorders of continuity of bone

770

1.24

1.23

1.7

1.5

566.31

1388.33

e6/l

0.76

624

Primary open-angle glaucoma

252

2146

1.14

1.22

1.6

1.4

957.56

987.68

e6/l

0.02

216

1766

Tuberculosis of other organs

116

1.65

1.22

1.3

1.4

202.95

187.10

e6/l

0.03

Malignant neoplasm of other connective and soft tissue, including Hilmo

305

1.39

1.22

1.1

1.3

886.79

1035.13

e6/l

0.07

250

Nontoxic goitre/thyroid nodule

271

2401

1.13

1.21

1.4

1010.59

1380.76

e6/l

0.34

220

1956

Other and unspecified abdominal hernia

263

1.42

1.21

1.4

503.63

1050.82

e6/l

0.48

218

Sleepwalking [somnambulism]

2.38

1.20

1.5

2.3

1.83

42.20

e6/l

—

Bicipital tendinitis

323

1.37

1.20

1.5

1.4

884.30

393.09

e6/l

0.33

263

Pre-eclampsia or poor fetal growth

336

3007

1.12

1.20

1.3

1.4

496.23

2562.35

e6/l

0.99

291

2435

Endometriosis of ovary

176

1479

1.16

1.19

1.4

2100.46

1739.89

e6/l

0.10

144

1227

Deep endometriosis

765

1.23

1.19

1.3

1.4

327.98

6573.00

e6/l

0.69

615

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

586

1.27

1.19

1.8

1.4

1149.18

1290.34

e6/l

0.07

481

Hyperaldosteronism

206

1.47

1.18

2.1

1.5

4878.43

176.61

e6/l

0.63

163

Myocardial infarction, with ST-elevation

1138

0.82

1.18

1.3

1.4

936.47

911.65

e6/l

0.02

925

Acquired haemolytic anaemia

157

1.54

1.18

1.4

1.3

1225.59

124.70

e6/l

0.60

134

Bullous disorders

393

1.33

1.18

1.3

1.5

17319.79

839.76

e6/l

0.46

322

Atrioventricular septal defect

0.00

1.17

0.0

4.4

—

557.17

—

Contusion of toe(s) without damage to nail

182

1.50

1.16

2.0

1.6

385.05

781.07

e6/l

0.25

148

Other osteochondropathies

570

1.27

1.16

1.6

1.5

1590.70

1325.26

e6/l

0.10

462

L02BB Anti-androgens

509

0.72

1.16

1.3

1.4

644.89

906.85

e6/l

0.18

424

Alopecia areata

207

1.46

1.16

1.2

1.8

61.17

203.13

e6/l

1.24

159

Laparoscopic right hemicolectomy

380

0.68

1.16

2.2

1.4

77.75

670.24

e6/l

1.29

310

Carcinoma in situ of skin of other and unspecified parts of face

473

1.30

1.16

1.5

1.4

1933.90

837.93

e6/l

0.66

393

Atopic conjunctivitis

360

1.34

1.15

1.9

1.8

1357.33

1410.42

e6/l

0.01

291

Crohn's disease of large intestine

421

1.31

1.15

1.2

1.6

106.63

1781.06

e6/l

1.51

344

Lichen ruber planus, wide definition including periferal and oral lichen planus

205

1792

1.15

1.4

778.67

1323.64

e6/l

0.72

163

1460

Malignant neoplasm of skin

480

3009

1.09

1.14

1.4

5338.34

1652.51

e6/l

0.38

381

2492

Other menopausal disorders

293

1470

1.13

1.14

1.5

1.4

1964.33

1807.86

e6/l

0.05

233

1206

Nontoxic diffuse goitre

208

1.45

1.13

1.6

1.5

253.20

1949.69

e6/l

0.74

168

Other superficial mycoses

151

1.54

1.12

1.2

1.6

176.69

1272.40

e6/l

0.69

124

Other aneurysm

362

1.33

1.12

2.2

1.4

3686.21

820.15

e6/l

0.57

298

Obstructed labour due to maternal pelvic abnormality

144

1229

1.18

1.12

1.3

1.4

5301.36

1847.15

e6/l

0.34

110

994

Congenital deformities of hip

184

1.48

1.12

2.9

2.7

2412.21

278.15

e6/l

0.63

144

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

234

1.42

1.11

1.5

117.22

1549.73

e6/l

0.74

193

Other and unspecified disorders of orbit

2.31

1.11

1.7

1.1

792.57

284.85

e6/l

—

Benign neoplasm of mouth and pharynx

817

1.22

1.11

1.3

1.5

7554.43

1374.45

e6/l

0.47

669

Gout, unspecified

166

1433

1.16

1.11

1.5

1.4

1100.22

2409.89

e6/l

0.36

139

1170

Dislocation, sprain and strain of joints and ligaments of head

328

1.35

1.11

2.0

2.2

257.00

1775.61

e6/l

0.94

264

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

619

1.25

1.11

1.1

1.4

659.16

1588.59

e6/l

0.80

499

Puerperal sepsis

125

1056

1.19

1.10

1.3

1.4

900.13

1392.13

e6/l

0.43

851

Other renal tubulo-interstitial diseases

160

1.51

1.10

1.8

1.6

65.63

167.82

e6/l

0.89

135

Hair colour and hair shaft abnormalities

2.43

1.10

1.6

1.4

18.60

309.20

e6/l

—

Other bullous disorders

193

1.46

1.10

1.4

1.6

33792.86

699.33

e6/l

0.47

154

Seropositive rheumatoid arthritis, wide

241

2137

1.13

1.10

1.3

1.4

1263.22

1229.25

e6/l

0.01

201

1751

malignant neoplasm of male genital organs

207

1438

0.88

1.09

1.4

514.30

1589.87

e6/l

1.71

164

1188

Chalazion

109

910

1.20

1.09

1.3

1.5

1678.73

5191.14

e6/l

0.40

734

Malignant neoplasm of prostate, including Hilmo

208

1409

0.88

1.09

1.4

513.33

1508.23

e6/l

1.52

156

1169

Disorders of purine and pyrimidine metabolism

2.23

1.09

1.0

1.5

249.00

256.63

e6/l

—

Ankylosing spondylitis, strict definition

338

1.34

1.08

1.6

1.5

12946.67

1894.77

e6/l

0.41

274

Postpartum haemorrhage due to retained placenta

1147

0.83

1.08

1.5

1.4

8445.49

1180.93

e6/l

0.57

951

Short stature, not elsewhere classified

234

1.40

1.08

4.1

4.5

635.00

17611.98

e6/l

0.50

175

Contact with sharp glass

304

1.36

1.08

1.7

1.4

259.86

1315.77

e6/l

0.93

247

Hidradenitis suppurativa

287

1.37

1.07

1.3

1.4

430.55

1631.86

e6/l

0.62

231

Abnormal spermatozoa

816

0.79

1.07

1.4

1046.83

981.43

e6/l

0.03

660

Contact with other hot fluids

236

1.41

1.07

1.5

2.0

55.52

920.39

e6/l

0.86

181

Lichen planus, including avohilmo

174

1513

1.15

1.07

1.4

902.40

1338.29

e6/l

0.45

140

1227

Certain conditions originating in the perinatal period

103

760

1.21

1.07

3.0

2.2

248.93

5342.94

e6/l

0.52

597

Atrial septal defect

346

1.33

1.06

1.5

3.1

178.86

536.99

e6/l

0.77

270

Congenital deformities of hip

170

1.49

1.05

3.1

2.8

2530.12

296.23

e6/l

0.58

134

Calculus of lower urinary tract

331

1.34

1.05

1.5

1.4

1129.11

655.81

e6/l

0.23

266

Chronic nephritic syndrome

271

1.37

1.05

1.8

1.5

640.96

829.34

e6/l

0.09

217

Lactose intolerance, other/unspecified

195

1.45

1.05

1.2

1.7

571.48

730.55

e6/l

0.08

157

Unspecified parasitic disease

1.99

1.04

1.6

1.4

164.00

258.20

e6/l

—

Graves disease, strict definition

100

833

1.21

1.04

1.7

1.4

813.05

1402.31

e6/l

0.55

674

Other orthopaedic follow-up care

376

1.31

1.03

1.3

1.5

92.64

2034.65

e6/l

1.59

304

Other benign neoplasms of connective and other soft tissue

761

1.21

1.03

1.5

553.04

1208.63

e6/l

0.71

617

Viral warts

816

1.21

1.03

1.4

1.6

387.74

5587.09

e6/l

0.61

668

Polycystic ovarian syndrome, broad definition

123

1047

1.18

1.01

1.3

223.30

5194.53

e6/l

0.80

103

858

Accidental poisoning by and exposure to alcohol

139

1.53

1.01

1.3

184853.12

1423.33

e6/l

0.47

110

Dislocation, sprain and strain of joints and ligaments of elbow

547

1.25

1.00

1.8

2.0

367.78

8437.79

e6/l

0.61

429

Lichen simplex chronicus and prurigo

440

1.28

1.00

1.6

1.3

5724.70

1003.09

e6/l

0.48

359

Benign neoplasm of major salivary glands

719

1.21

0.99

1.3

1.4

711.28

1283.16

e6/l

0.49

584

Valvular operations

1059

0.83

0.99

1.2

1.7

1368.38

3162.56

e6/l

0.37

845

Iron deficiency anaemia secondary to blood loss (chronic)

135

1160

1.17

0.99

1.5

955.96

1298.67

e6/l

0.16

110

947

LSIL lesion of the cervix uteri

125

1068

1.17

0.99

1.3

32290.88

1536.20

e6/l

0.49

875

Hypertensive heart and/or renal disease

207

1365

1.13

0.99

1.4

728.43

1847.11

e6/l

1.39

188

1111

Other congenital malformations of the digestive system

394

1.29

0.98

2.8

1544.46

725.47

e6/l

0.35

308

Other inflammation of vagina/vulva

292

1.34

0.98

1.2

1.6

45.68

1210.28

e6/l

0.75

243

Neuroendocrine tumor and carcinoma of stomach

0.00

0.98

0.0

1.5

—

92.46

—

Spermatocele

441

1.27

0.98

1.7

1.4

461.96

1041.27

e6/l

0.61

364

Other and unspecified papulosquamous disorders

1.97

0.98

1.6

1.5

60.29

104.13

e6/l

—

Lung transplant status

1.88

0.98

2.1

1095.70

2205.19

e6/l

—

Lung transplantation

1.88

0.98

2.1

1095.70

2205.19

e6/l

—

Benign neoplasm: Ascending colon

115

977

1.18

0.98

1.4

2113.93

891.52

e6/l

0.39

788

Other noninfective disorders of lymphatic vessels and lymph nodes

258

1.37

0.97

1.3

1.6

14069.48

1046.71

e6/l

0.70

210

Spontaneous rupture of synovium and tendon

558

1.24

0.97

1.4

650.90

639.48

e6/l

0.01

450

Exposure to other and unspecified animate mechanical forces

224

1.39

0.97

1.3

1.7

1999.83

628.34

e6/l

0.32

180

Lactose intolerance

224

1.39

0.97

1.4

1.8

959.85

943.54

e6/l

0.01

184

Dilated cardiomyopathy

826

0.81

0.97

1.4

1.5

320.92

904.21

e6/l

1.05

679

Bronchiectasis

523

1.25

0.96

1.4

1.6

1278.25

999.75

e6/l

0.13

437

Burn and corrosion confined to eye and adnexa

174

1.45

0.96

1.2

1.7

1020.45

2071.96

e6/l

0.31

139

Gestational diabetes (for exclusion)

424

2712

1.09

0.95

1.3

258.74

2686.06

e6/l

1.10

348

2201

Carcinoma in situ of skin of scalp and neck

141

1.50

0.95

1.4

1.3

11.00

1234.65

e6/l

0.96

118

Vasomotor rhinitis (mode)

560

1.24

0.95

1.6

1.5

400.03

1528.06

e6/l

1.17

453

Acute epiglottitis

1.63

0.94

1.4

1.3

1195.11

867.56

e6/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

651

1.22

0.94

1.3

1.4

717.25

1366.86

e6/l

0.51

528

Type1 diabetes, definitions combined, early onset

643

0.79

0.94

2.0

2.3

813.47

6165.85

e6/l

0.46

522

Ectropion of eyelid

200

1.41

0.93

1.4

160.95

393.66

e6/l

0.77

166

Burn and corrosion of wrist and hand

286

1.34

0.93

1.4

1.6

3620.65

436.10

e6/l

0.55

229

Other and/or unspecified nontoxic goitre

570

1.23

0.93

1.5

1.4

1522.68

1390.60

e6/l

0.04

454

All dysplastic lesions of the cervix uteri, vagina or vulva

320

2871

1.10

0.93

1.3

12373.38

1393.36

e6/l

0.46

255

2332

Primary hyperparathyroidism

789

1.20

0.93

1.3

1.4

724.85

1294.36

e6/l

0.35

633

Idiopathic urticaria

167

1.45

0.93

1.2

1.8

88.84

157.43

e6/l

0.32

134

Chronic periodontitis, complicated

553

5108

1.07

0.92

1.4

2238.99

2658.39

e6/l

0.16

432

4184

Primary adrenocortical insufficiency

1.69

0.92

1.5

1.3

81.88

130.09

e6/l

—

Viral agents as the cause of diseases classified to other chapters

184

1.42

0.92

1.3

1.7

532.62

771.81

e6/l

0.13

151

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

653

1.21

0.92

1.4

11198.16

6821.42

e6/l

0.18

538

Single delivery by caesarean section

172

1122

0.88

0.91

1.7

1.4

3561.70

4511.72

e6/l

0.07

145

876

Hypertensive Heart Disease

184

1273

1.13

0.91

1.4

924.56

1530.40

e6/l

0.54

165

1032

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

126

1087

1.16

0.90

1.4

1608.94

1268.70

e6/l

0.13

103

883

Subacute thyroiditis

253

1.35

0.90

1.5

4656.55

1508.64

e6/l

0.30

201

Donors of organs and tissues

102

0.49

0.90

2.0

1.3

459.60

1225.54

e6/l

—

Rhinophyma

2.10

0.90

2.2

1.5

1139.33

4284.32

e6/l

—

Hypoplasia of dental enamel , including avohilmo

331

1.30

0.89

7.9

2.6

511.26

227.22

e6/l

0.38

255

Desensitization to allergens

473

0.76

0.89

1.4

1.9

158.65

8792.56

e6/l

0.59

388

Injury of muscle and tendon at lower leg level

140

1219

1.15

0.89

1.3

1.4

933.86

1094.98

e6/l

0.14

109

994

Contusion of ankle

306

1.31

0.89

2.2

1.8

874.97

1506.62

e6/l

0.30

243

Hallux valgus (acquired)

317

2078

1.10

0.89

1.5

1.4

1507.38

3567.76

e6/l

0.54

269

1667

Reiter disease

1.89

0.88

1.1

1.4

633.50

208.94

e6/l

—

Foreign body in respiratory tract

395

1.27

0.88

2.5

1.8

12444.81

948.65

e6/l

0.46

314

Fibrosis of liver

1.89

0.88

2.4

1.6

1964.38

3055.13

e6/l

—

Effects of heat and light

1.89

0.88

1.4

1.2

1336.63

229.39

e6/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.04

0.88

1.5

1.4

1.00

34.77

e6/l

—

Hypoplasia of dental enamel, prenatal , including avohilmo

1.72

0.88

5.3

134.57

536.16

e6/l

—

Follow-up examination after treatment for malignant neoplasms

530

1.23

0.87

1.7

1.4

1555.62

1083.88

e6/l

0.17

423

Postmenopausal bleeding

256

1231

1.11

0.87

1.4

933.79

2087.99

e6/l

0.65

202

1014

Anoxic brain damage

1.73

0.86

1.4

13.45

1801.17

e6/l

0.55

Total colectomy operation

299

1.31

0.86

1.1

1.7

2090.97

739.86

e6/l

0.43

238

Total colectomy

299

1.31

0.86

1.1

1.7

2090.97

739.86

e6/l

0.43

238

Spondylopathies in diseases classified elsewhere

1.69

0.86

1.3

1.4

100.43

71.51

e6/l

—

Lifestyle-related condition

1.64

0.85

1.8

1.3

723.00

145.73

e6/l

—

Other bursitis of hip

112

1.53

0.85

1.3

897.55

287.25

e6/l

0.29

Varicose veins of other sites

496

1.24

0.85

1.3

1.6

1302.41

1124.46

e6/l

0.06

405

Emphysema

469

1.24

0.84

1.7

1.4

4702.51

740.96

e6/l

0.69

387

Benign neoplasm: Parotid gland

578

1.22

0.84

1.3

1.5

353.98

1322.58

e6/l

1.11

469

Gonarthrosis, primary, with knee surgery

469

4011

0.93

0.84

1.4

1298.70

2217.55

e6/l

0.63

376

3279

Postpartum haemorrhage

240

2233

0.90

0.84

1.4

1.3

3478.79

2988.38

e6/l

0.06

198

1810

Contraceptive management

474

3091

1.08

0.84

1.3

1.4

2452.70

2979.45

e6/l

0.11

408

2470

Foreign body entering into or through eye or natural orifice

679

1.20

0.84

1.9

1.8

309.13

773.14

e6/l

0.80

544

Congenital malformations of heart and great arteries

138

1170

1.15

0.83

1.5

2.2

292.35

4186.96

e6/l

0.65

110

932

Congenital nasolacrimal duct obstruction or stenosis

1.77

0.83

3.1

4.3

36.63

50.22

e6/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

1.76

0.83

1.5

1.4

2.63

219.97

e6/l

—

Other congenital malformations of the digestive system

459

1.24

0.82

2.6

2.7

1670.42

662.87

e6/l

0.51

351

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

287

2623

1.10

0.82

1.4

491.58

1786.69

e6/l

2.67

240

2134

Glucagon-like peptide-1 (GLP-1) analogues

287

2623

1.10

0.82

1.4

491.58

1786.69

e6/l

2.67

240

2134

Fall on and from ladder

544

1.22

0.81

1.3

1.4

308.77

782.90

e6/l

0.92

444

Postpartum care and examination

158

882

1.14

0.81

1.3

5617.67

5537.45

e6/l

0.00

138

702

Tuberculosis

355

1.27

0.81

1.6

1.3

23.67

612.20

e6/l

1.25

295

Open wound of shoulder and upper arm

130

1.47

0.81

1.2

1.4

16.57

1249.37

e6/l

0.55

109

Degeneration of macula and posterior pole

402

2963

1.08

0.81

1.4

915.49

2089.95

e6/l

0.86

315

2444

Coxarthrosis, primary, with hip surgery

351

3558

0.92

0.81

1.5

1.4

1263.22

1999.16

e6/l

0.43

287

2908

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.81

0.0

4.5

—

1121.31

—

Abscess of Bartholin gland

224

1.35

0.80

1.1

1.5

350.13

1539.66

e6/l

0.52

183

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

231

2091

1.11

0.80

1.3

1.4

1314.99

1251.99

e6/l

0.02

193

1711

Other blood glucose lowering drugs, excl. Insulins

133

1165

1.14

0.80

1.6

1.4

1483.95

1323.96

e6/l

0.08

107

943

Type 1 diabetes, strict definition, subgroup 2

0.00

0.80

0.0

5.6

—

69.80

—

Maternal care for cervical incompetence

294

1.30

0.80

1.6

1.4

822.44

384.50

e6/l

0.25

236

Other/unspecified seropositive rheumatoid arthritis

234

2120

1.11

0.80

1.3

1.4

1295.25

1237.88

e6/l

0.02

196

1737

Medical treatment for female infertility

191

2115

0.90

0.80

1.4

1099.95

3022.71

e6/l

0.52

152

1737

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.80

0.0

1.4

—

288.22

—

Adrenomedullary hyperfunction

0.00

0.80

0.0

1.3

—

275.44

—

Chondrosarcoma, including Hilmo

1.85

0.80

1.7

1.4

293.17

327.31

e6/l

—

Intentional self-harm by jumping from a high place

1.69

0.79

1.0

1.3

249.88

183.70

e6/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

282

0.71

0.79

1.3

18.20

631.84

e6/l

1.00

240

Malignant neoplasm of vagina, including Hilmo

0.00

0.79

0.0

1.2

—

50.86

—

Respiratory tuberculosis

321

1.28

0.79

1.6

1.4

25.82

642.83

e6/l

1.15

265

Respiratory tuberculosis, confirmed and not-confirmed

321

1.28

0.79

1.6

1.4

25.82

642.83

e6/l

1.15

265

Chronic tubulo-interstitial nephritis

242

1.33

0.79

1.5

1.4

87.30

686.69

e6/l

0.74

201

Myeloproliferative diseases

592

1.20

0.79

1.6

1.4

886.26

1278.73

e6/l

0.19

478

Other disorders of veins

400

3693

1.08

0.78

1.3

1.4

3065.47

2315.05

e6/l

0.15

304

3008

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.78

0.0

4.8

—

274.00

—

Childhood allergy (age < 16)

177

1302

1.12

0.78

1.8

1.9

513.20

3742.01

e6/l

0.58

150

1038

Use of antiglaucoma preparations and miotics

483

1.23

0.78

1.3

1.4

60.07

633.42

e6/l

1.78

398

Interstitial cystitis (chronic), drug-induced

0.00

0.78

0.0

1.2

—

27.82

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

115

1.49

0.77

2.0

1.3

24.80

1170.58

e6/l

—

100

Mumps

174

1.39

0.77

1.3

1.5

883.35

620.47

e6/l

0.11

139

Unspecified contracted kidney

1.79

0.77

1.0

1.5

7.67

277.12

e6/l

—

Paget disease

0.00

0.77

0.0

1.3

—

91.91

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

494

1.22

0.76

1.7

1.4

199.00

854.87

e6/l

1.20

400

Skin changes due to chronic exposure to nonionizing radiation

307

2604

1.09

0.76

1.4

1493.37

2090.94

e6/l

0.25

240

2151

Maternal care related to the fetus and amniotic cavity and possible delivery problems

502

2756

1.07

0.76

1.4

2498.94

2845.56

e6/l

0.07

417

2214

Congenital malformations of the musculoskeletal system, not elsewhere classified

124

1.47

0.76

1.3

2.2

16.15

152.45

e6/l

1.39

Non-small cell lung cancer, including Hilmo

988

0.86

0.75

1.2

1.4

706.48

1533.32

e6/l

0.65

821

Cyst of kidney

504

1.22

0.75

1.4

1.5

2376.39

1056.71

e6/l

0.40

412

Toxic effect of other noxious substances eaten as food

2.12

0.75

1.2

51.60

378.11

e6/l

—

Contact with sharp object, undetermined intent

175

1.38

0.75

1.4

2658.18

1319.69

e6/l

0.31

137

Gout due to impairment of renal function

1.68

0.75

1.3

10.78

2237.98

e6/l

—

Disorders of eyelid in diseases classified elsewhere

227

1.33

0.75

1.5

63.00

520.39

e6/l

0.82

186

ILD, hospital admissions

116

1013

1.15

0.75

1.2

1.4

101.52

971.45

e6/l

4.12

825

Anisometropia and aniseikonia

236

1.32

0.74

1.9

1.8

1552.58

735.77

e6/l

0.32

182

Gout, strict definition

138

1220

1.13

0.74

1.4

1388.37

2525.76

e6/l

0.24

114

1001

Benign neoplasm: Ill-defined sites within the digestive system

1.87

0.74

1.1

1.3

2.43

164.07

e6/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.87

0.74

3.3

2.2

718.29

299.65

e6/l

—

Mantle cell lymphoma

1.65

0.74

1.2

1.5

258.44

238.31

e6/l

—

Idiopathic gout

615

1.19

0.74

1.2

1.4

2611.39

909.30

e6/l

0.42

510

Wet age-related macular degeneration

952

0.85

0.73

1.6

1.4

690.33

1067.29

e6/l

0.47

784

Male infertility

352

1.26

0.73

1.6

5189.47

1007.82

e6/l

0.41

285

Other diseases of gallbladder

281

1.29

0.73

1.5

1.3

154.06

422.06

e6/l

0.73

232

Family history of malignant neoplasm

958

0.85

0.72

1.3

1.4

661.16

5823.23

e6/l

0.73

778

Arthropathic psoriasis

106

923

1.15

0.72

1.4

1.5

1108.27

1298.95

e6/l

0.12

752

Maternal care for known or suspected malpresentation of fetus

168

1357

0.90

0.72

1.3

1.4

2330.65

3687.82

e6/l

0.18

136

1102

Other and unspecified nonscarring hair loss

1.60

0.72

1.2

28.00

80.12

e6/l

—

Impaction of intestines

1.77

0.72

2.9

1.3

486.57

78.56

e6/l

—

Labour and delivery complicated by fetal stress [distress]

240

1721

0.91

0.72

1.2

1.3

121.59

3349.42

e6/l

0.89

201

1405

Acute nephritic syndrome

134

1.43

0.71

1.6

1.4

355.14

1445.53

e6/l

0.57

110

Supervision of high-risk pregnancy

229

1253

1.10

0.71

1.2

1.3

5441.54

4293.37

e6/l

0.10

183

998

Other respiratory diseases principally affecting the interstitium

139

1234

1.13

0.71

1.2

1.4

462.93

946.20

e6/l

0.60

107

1000

Other, unspecified and serous retinal detachments

221

1.32

0.70

1.6

1.4

670.13

978.87

e6/l

0.15

182

conjunctival haemorrhage

546

1.19

0.69

1.2

1.5

240.55

1112.24

e6/l

1.90

446

Sudden idiopathic hearing loss

731

1.17

0.69

1.6

1.4

2965.39

1312.13

e6/l

0.36

596

Injury of blood vessels at abdomen, lower back and pelvis level

1.88

0.69

2.4

1.6

83.20

323.00

e6/l

—

Drowning and submersion while in natural water

1.88

0.69

1.0

1.6

27.40

239.86

e6/l

—

COPD, early/later onset

343

3108

0.93

0.69

1.5

1.4

1793.73

2139.50

e6/l

0.14

276

2557

Congenital malformations of aortic and mitral valves

341

0.76

0.68

1.6

2.2

274.65

1265.96

e6/l

0.94

269

Psoriatic arthropathies, ICD10

100

872

1.15

0.68

1.4

1.5

1134.21

1264.65

e6/l

0.07

706

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

397

0.78

0.68

1.3

19.36

826.86

e6/l

1.62

334

COPD, hospital admissions

340

3089

0.93

0.68

1.5

1.4

1745.45

2147.57

e6/l

0.16

274

2539

Other chronic obstructive pulmonary disease, including avohilmo

429

3779

0.94

0.67

1.5

1.4

1709.42

1938.88

e6/l

0.11

345

3107

Cardiomyopathy (excluding other)

951

0.86

0.67

1.5

1.6

474.79

3074.07

e6/l

0.59

768

Alcohol-induced acute pancreatitis

258

1.29

0.67

1.2

1.4

833.33

1448.72

e6/l

0.23

211

Pneumoconiosis due to asbestos and other mineral fibres

0.54

0.67

1.4

5.80

563.54

e6/l

—

Corns and callosities

475

1.20

0.67

1.9

1.5

380.24

1264.29

e6/l

1.05

390

Abnormal findings in secretions and smears from cervix uteri vagina vulva

546

3896

1.06

0.67

1.4

7606.02

1653.95

e6/l

0.42

434

3174

Abnormalities of forces of labour

907

0.86

0.66

1.2

1.4

555.02

5700.25

e6/l

0.68

731

Other disorders of pigmentation

303

1.26

0.66

1.1

1.4

116.91

1278.61

e6/l

1.61

246

Pollen allergy

215

1940

1.10

0.66

1.3

1.8

429.06

3073.91

e6/l

0.76

174

1561

Major anomalies of jaw size

206

1.32

0.66

1.3

1.9

149.91

1020.76

e6/l

0.76

166

Malignant neoplasm of breast, ER-negative, including Hilmo

157

1660

0.90

0.66

1.5

1.4

712.97

1351.71

e6/l

0.82

117

1375

Superficial frostbite

1.61

0.65

1.4

2.43

193.00

e6/l

—

Impacted teeth

183

1792

0.91

0.65

1.6

1021.58

3042.47

e6/l

0.44

155

1454

Tooth eruption problems

159

1397

1.11

0.65

2.6

1.7

410.81

3525.24

e6/l

0.62

130

1123

Interstitial lung disease

116

1026

1.13

0.65

1.2

1.4

101.52

1029.67

e6/l

4.33

836

Interstitial lung disease endpoints

116

1026

1.13

0.65

1.2

1.4

101.52

1029.67

e6/l

4.33

836

Pneumothorax

486

1.20

0.65

1.5

1.4

2367.34

772.80

e6/l

0.58

402

Disorders of sphingolipid metabolism and other lipid storage disorders

1.75

0.64

1.2

2.20

332.13

e6/l

—

Normotensive glaucoma

560

1.18

0.64

1.5

1.4

912.67

1302.08

e6/l

0.32

458

Other and unspecified diseases of spleen

1.75

0.64

1.2

1.5

2.60

227.42

e6/l

—

Other interstitial pulmonary diseases

116

1027

1.13

0.64

1.2

1.4

101.52

1028.37

e6/l

4.33

837

Hypothermia

112

1.44

0.64

1.2

1.5

2.55

1083.20

e6/l

0.58

Malignant neoplasm of oral cavity, including Hilmo

305

1.25

0.63

1.3

1.4

1308.41

812.14

e6/l

0.18

255

Other specified/unspecified spondylopathies

129

1.40

0.63

1.3

1.4

1530.33

275.14

e6/l

0.37

103

Benign neoplasm: Colon, unspecified

207

1893

1.10

0.63

1.5

1.4

2604.86

1162.73

e6/l

0.33

177

1539

327

2792

1.07

0.63

1.5

1.4

1416.46

2036.06

e6/l

0.28

256

2308

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

155

1.36

0.63

1.1

2.4

410.63

230.63

e6/l

0.26

122

Complications of labour and delivery

694

3672

1.05

0.63

1.4

1791.07

2631.07

e6/l

0.26

554

2974

Other and unspecified glaucoma

442

1.20

0.62

1.6

1.4

1429.59

732.18

e6/l

0.24

365

Use of selegiline

297

1.25

0.62

1.5

1.4

294.13

654.49

e6/l

0.42

240

Myocardial infarction

410

3069

0.94

0.62

1.3

1.5

497.73

2148.32

e6/l

1.53

350

2463

Squamous cell neoplasms and carcinomas of the skin

442

1.20

0.62

1.5

1.4

638.74

1085.34

e6/l

0.41

379

Cysts of oral region, not elsewhere classified

452

1.20

0.62

1.5

1214.30

1607.78

e6/l

0.15

367

Abscess of lung

1.47

0.62

4.2

1.7

2308.78

1249.33

e6/l

—

Pediculosis, acariasis and other infestations

172

1562

1.10

0.62

1.3

1.6

490.54

3284.08

e6/l

0.62

140

1258

Asthma and opportunity respiratory infection

316

1.24

0.61

1.4

1544.00

528.65

e6/l

0.37

266

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

719

1.15

0.61

1.5

1.4

506.96

1062.19

e6/l

0.88

614

Malignant neoplasm of heart, mediastinum and pleura

1.49

0.61

2.2

1.4

30.37

1487.34

e6/l

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.61

0.0

1.4

—

128.27

—

Maternal care for known or suspected fetal abnormality and damage

170

1327

1.10

0.61

1.3

242.38

3719.69

e6/l

0.68

122

1079

Other nonthrombocytopenic purpura

1.58

0.61

1.4

1.8

120.00

204.35

e6/l

—

Carcinoma in situ, bladder

221

0.72

0.60

2.0

1.3

1073.27

841.52

e6/l

0.08

183

Varus deformity, not elsewhere classified

1.51

0.60

1.2

1.5

1474.25

161.61

e6/l

0.50

Thyroid crisis or storm

0.00

0.60

0.0

1.3

—

19.00

—

Mental and behavioural disorders due to tobacco

704

1.15

0.60

1.4

4180.31

1420.38

e6/l

0.53

575

Other protozoal intestinal diseases

148

1.36

0.60

1.2

1.7

114.13

654.38

e6/l

0.57

121

Allergic colitis

245

1.27

0.60

1.8

3.7

39.85

219.41

e6/l

1.26

188

Monoarthritis, not elsewhere classified

308

1.24

0.60

1.2

1.4

254.52

1135.73

e6/l

0.82

257

In situ neoplasms

341

3192

1.07

0.59

1.4

764.47

2958.07

e6/l

0.99

265

2630

Disorders of iron metabolism

1.45

0.59

1.1

1.3

82.63

1254.59

e6/l

—

Smoking dependency

705

1.15

0.59

1.4

4180.31

1427.98

e6/l

0.53

572

Juvenile arthritis (FINNGEN)

399

0.80

0.59

1.5

2.4

1525.41

10143.99

e6/l

0.45

321

Ectopic pregnancy

170

1548

1.10

0.59

1.4

1648.99

3258.19

e6/l

0.28

136

1254

Actinic keratosis

292

2517

1.07

0.59

1.4

1561.14

2041.23

e6/l

0.18

229

2085

Generalized pustular psoriasis

0.00

0.59

0.0

1.7

—

120.59

—

Malignant neoplasm of bladder, including Hilmo

741

0.86

0.58

1.5

1.4

1080.63

688.45

e6/l

0.28

626

Family history of other conditions

115

0.60

0.58

1.1

1.6

2.29

119.16

e6/l

—

Other/unspecified rheumatoid arthritis

876

1.13

0.57

1.3

1.4

434.96

1426.21

e6/l

1.88

714

Left ventricular outflow tract obstruction, narrow definition

419

0.81

0.57

1.6

2.4

215.27

1071.05

e6/l

1.00

324

Haemorrhagic and haematological disorders of fetus and newborn

219

1.28

0.56

5.7

4.4

347.86

936.14

e6/l

0.49

162

Benign neoplasm: Descending colon

503

1.18

0.56

1.3

1.5

350.98

903.15

e6/l

0.91

403

Toxic effect of alcohol

141

1.36

0.56

1.5

1.4

1263.53

1439.50

e6/l

0.04

113

Mandibular hypoplasia

1.47

0.56

1.1

2.2

327.63

177.78

e6/l

—

Vaginal lichen planus

1.64

0.56

1.3

1.1

224.50

88.12

e6/l

—

Frostbite

1.55

0.56

1.3

4.00

145.63

e6/l

—

Type 1 diabetes, strict definition

772

0.86

0.56

1.5

2.0

668.32

5793.20

e6/l

0.56

632

Presence of other devices

194

1776

1.09

0.56

1.6

1.4

2027.78

2304.90

e6/l

0.06

169

1451

Other and unspecified injuries of thorax

107

1.41

0.55

1.1

1.3

7.80

125.54

e6/l

—

Seropositive rheumatoid arthritis, strict definition

132

1192

1.11

0.55

1.3

1.4

2205.12

1258.27

e6/l

0.23

107

961

Other psoriatic arthropathies

851

1.13

0.55

1.4

1.5

1162.90

1265.29

e6/l

0.05

688

Allergic contact dermatitis

128

1154

1.11

0.55

1.3

1.5

893.84

4274.95

e6/l

0.53

111

931

Rheumatic valve diseases

123

0.65

0.55

2.9

1.3

598.75

1098.81

e6/l

—

102

Anomalies of dental arch relationship, including avohilmo

211

1756

1.08

0.54

2.3

1.6

327.66

2979.27

e6/l

0.67

171

1400

Pediculosis, acariasis and other infestations

468

1.18

0.54

1.3

1.6

927.92

931.22

e6/l

0.00

373

Carcinoma in situ of other and unspecified sites

239

0.75

0.54

1.9

1.3

908.46

800.44

e6/l

0.04

195

Mucosal proctocolitis

124

1117

1.11

0.54

1.4

1.5

933.52

4386.52

e6/l

0.53

911

Uterine polyps

772

0.87

0.54

1.3

1.4

5613.43

2451.76

e6/l

0.30

638

Benign neoplasm: Small intestine

285

1.23

0.54

1.7

1.4

2036.20

683.34

e6/l

0.48

231

Mandibular retrognathia

577

0.84

0.54

2.1

1.8

74.12

1179.73

e6/l

1.50

468

Placenta praevia

394

0.81

0.54

1.6

1.4

236.92

10252.55

e6/l

0.55

317

Other diseases of biliary tract

611

0.85

0.54

1.2

1.6

142.49

1025.99

e6/l

2.99

501

Viral agents as the cause of diseases classified to other chapters

160

1.32

0.54

1.3

1.7

693.50

874.65

e6/l

0.07

130

D07AA Corticosteroids, weak (group I)

160

1459

1.10

0.54

1.7

1.9

890.35

3520.22

e6/l

0.52

133

1175

Multiple myeloma

160

1.32

0.54

1.0

1.4

16.06

945.57

e6/l

0.81

136

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

160

1.32

0.54

1.0

1.4

16.06

945.57

e6/l

0.81

136

Malignant neoplasm of breast, HER-negative

137

1481

0.91

0.53

1.5

1.4

823.50

1463.26

e6/l

0.68

101

1232

Sequelae of burns, corrosions and frostbite

1.56

0.53

8.2

1.2

45.33

231.67

e6/l

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.56

0.53

1.8

1.2

86.00

278.48

e6/l

—

Other obstructed labour

631

0.85

0.53

1.3

1.4

3297.42

7033.82

e6/l

0.25

512

Antepartum haemorrhage, not elsewhere classified

769

1.13

0.53

1.2

1.4

4179.22

5409.51

e6/l

0.08

620

Benign neoplasm of bone and articular cartilage

675

1.14

0.53

1.3

1.5

319.01

1293.12

e6/l

1.13

542

Malignant neoplasm of respiratory system and intrathoracic organs

135

1238

0.91

0.52

1.4

19364.68

1501.84

e6/l

0.49

1028

Artificial joint re-operation

470

1.17

0.52

1.3

1.4

2084.04

1045.58

e6/l

0.33

375

Pedal cyclist injured in noncollision transport accidents

111

997

1.12

0.52

1.3

1.7

814.33

4706.34

e6/l

0.53

807

Synovial cyst of popliteal space [Baker]

489

1.17

0.52

1.3

1.4

2422.20

657.72

e6/l

0.39

395

Acne conglobata

1.51

0.52

1.3

2.3

1345.00

157.58

e6/l

—

Bicuspidal aortic valve syndrome

281

0.78

0.51

1.7

323.06

944.57

e6/l

0.64

221

Other nonscarring hair loss

1.48

0.51

1.2

23.09

64.14

e6/l

0.63

Malignant neoplasm of oesophagus, including Hilmo

225

0.75

0.51

1.2

1.4

13.18

1057.44

e6/l

1.17

186

Other complications of labour and delivery, not elsewhere classified

107

1091

0.90

0.50

1.2

1.4

1237.36

4545.43

e6/l

0.46

897

Benign neoplasm: Caecum

744

1.13

0.50

1.4

818.07

1331.08

e6/l

0.35

602

180

1699

0.92

0.50

1.5

1.4

679.16

2214.73

e6/l

0.64

147

1389

Open wound of hip and thigh

243

1.24

0.50

1.4

1.6

637.83

1570.60

e6/l

0.46

196

Other disorders of skin and subcutaneous tissue, not elsewhere classified

119

1078

1.11

0.49

1.3

1.4

704.21

1064.93

e6/l

0.45

884

Disorders of parathyroid gland, other and/or unspecified

1.54

0.48

1.1

1.2

332.86

204.69

e6/l

—

Thyrotoxicosis with toxic multinodular goitre

421

0.83

0.48

1.4

1.5

294.39

1034.69

e6/l

1.17

338

Postpartum hemorraghe, parous women as controls

240

2185

0.93

0.48

1.4

3478.79

964.25

e6/l

0.47

198

1792

Etanercept

522

1.15

0.47

1.2

1.6

3948.92

1599.90

e6/l

0.27

415

Embedded and impacted teeth

269

2364

0.94

0.47

1.6

1.5

723.72

2713.58

e6/l

0.63

227

1912

Polyp of the female genital tract

308

1665

1.06

0.47

1.4

3449.08

1648.51

e6/l

0.36

244

1377

Moderate mental retardation

1.47

0.47

2.4

2.9

455.29

308.82

e6/l

—

Congenital malformations of great arteries

228

0.77

0.47

1.3

4.2

7652.31

980.74

e6/l

0.47

170

Macular cyst

199

0.75

0.47

1.2

1.4

33.78

767.84

e6/l

—

164

Postpartum hemorraghe, all women as controls

240

2522

0.94

0.46

1.4

1.3

3478.79

2538.76

e6/l

0.12

198

2051

Cardiomyopathies, Primary/intrinsic

909

0.89

0.46

1.5

1.6

407.61

3214.77

e6/l

0.62

733

Antenatal screening

220

1325

0.93

0.46

1.4

1.3

1320.50

4091.02

e6/l

0.44

177

1052

Nonischemic cardiomyopathy

696

0.87

0.46

1.5

1.6

146.29

919.71

e6/l

2.03

555

Foreign body on external eye

141

1294

1.09

0.45

1.5

420.03

1098.61

e6/l

1.38

117

1045

Aortic aneurysm

154

1638

0.92

0.45

1.6

1.4

696.35

2772.65

e6/l

0.86

129

1347

Otosclerosis

543

1.14

0.45

1.6

1.4

394.63

950.63

e6/l

0.85

434

Injury of muscle and tendon at hip and thigh level

798

1.12

0.45

1.4

1.5

408.80

1243.90

e6/l

0.99

644

All dysplastic lesions of the cervix uteri

273

2548

1.06

0.45

1.2

1.3

14400.32

1385.05

e6/l

0.47

218

2063

Other congenital malformations of face and neck

219

1.24

0.45

1.2

1.8

228.73

964.48

e6/l

0.62

178

Ulcerative colitis (strict definition, all Crohn cases excluded)

116

1273

0.91

0.45

1.4

1.5

524.59

3962.94

e6/l

0.63

1031

Inguinal hernia

609

3908

1.04

0.45

1.4

1.5

1548.99

2428.42

e6/l

0.37

501

3189

Pregnancy, childbirth and the puerperium

284

1395

1.06

0.44

1.5

1.4

202.36

3827.71

e6/l

0.76

233

1121

Psoriasis vulgaris

173

1604

1.08

0.44

1.3

1.4

443.24

1203.74

e6/l

1.75

133

1301

Unspecified urinary incontinence

629

1.13

0.44

1.6

1.5

3773.80

1207.16

e6/l

0.69

508

Gingival hyperplasia

284

1.20

0.44

2.8

2.2

57.19

592.75

e6/l

0.76

225

Carcinoma in situ of prostate

1.63

0.43

1.0

1.4

2.20

3941.00

e6/l

—

Melanocytic naevi of other and unspecified parts of face

462

1.15

0.42

1.6

1.5

143.67

1521.92

e6/l

1.48

378

Colorectal neuroendocrine tumor and carcinoma

0.63

0.42

1.5

1.3

0.67

1268.25

e6/l

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.42

0.0

1.3

—

466.90

—

Folliculitis decalvans

0.00

0.42

0.0

1.3

—

11.00

—

UC patients in KELA-register (code 208), prior to 1994

323

1.18

0.41

1.3

1.5

91.45

1177.76

e6/l

1.56

258

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

286

1.19

0.41

1.5

19928.21

807.08

e6/l

0.53

229

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.41

0.0

1.1

—

23.45

—

Inhalation and ingestion of food causing obstruction of respiratory tract

1.36

0.41

1.6

2.0

2877.12

162.09

e6/l

—

Rheumatic fever incl heart disease

172

0.75

0.41

2.3

1.3

461.85

801.62

e6/l

0.21

141

Pustular psoriasis

358

0.84

0.40

1.3

1.5

643.00

1537.25

e6/l

0.43

293

Nosocomial condition (hospital)

1.48

0.40

1.4

1.2

411.20

189.23

e6/l

—

Juvenile osteochondrosis

250

1.20

0.40

2.0

1.6

943.40

899.94

e6/l

0.02

199

Other disorders of amniotic fluid and membranes

140

1264

1.08

0.40

1.3

357.12

3873.91

e6/l

0.65

115

1028

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

390

1.16

0.39

1.7

1.3

4155.97

1499.20

e6/l

0.33

321

Precocious puberty

1.44

0.39

1.4

3.3

200.40

222.47

e6/l

—

Changes in corneal membranes

0.00

0.39

0.0

1.2

—

13.43

—

Coxarthrosis, primary

535

4356

1.04

0.39

1.4

2125.18

2196.07

e6/l

0.02

438

3564

Drug-induced gout

0.00

0.39

0.0

1.3

—

15.79

—

Multiple delivery

738

0.89

0.38

1.8

1.4

2185.80

5798.36

e6/l

0.29

573

Inguinal hernia, bilateral

722

1.11

0.38

1.4

1570.86

938.50

e6/l

0.18

588

Abnormality of red blood cells

1.40

0.38

1.2

1.9

119.80

220.10

e6/l

—

Scabies

143

1327

1.08

0.38

1.2

1.6

564.25

3712.48

e6/l

0.58

117

1062

Traction detachment of retina

1.33

0.38

1.8

1.2

46.00

168.93

e6/l

—

Benign neoplasm of breast

957

0.91

0.38

1.4

1933.10

1261.92

e6/l

0.18

776

COPD-related respiratory insufficiency

742

1.11

0.38

1.5

1.4

1050.86

945.13

e6/l

0.05

606

Non-small cell lung cancer, adenocarcinoma, helper endpoint

387

0.85

0.37

1.2

1.3

86.32

598.42

e6/l

1.09

322

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

199

1847

1.07

0.37

1.4

717.50

1714.84

e6/l

1.55

163

1529

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.31

0.37

1.0

1.3

76.78

1688.57

e6/l

—

Abrasion of teeth

302

3172

0.95

0.37

1.3

1.4

2420.50

2648.87

e6/l

0.04

231

2579

Chronic laryngitis and laryngotracheitis

1070

0.91

0.37

1.5

1.4

2824.60

1160.71

e6/l

0.61

864

Pleural plaque with presence of asbestos

407

0.86

0.36

1.2

1.4

366.59

1050.65

e6/l

0.95

339

Whooping cough

1.47

0.36

1.8

1.2

8.67

60.03

e6/l

—

Inguinal or femoral hernia, bilateral

735

1.10

0.36

1.4

1547.42

938.04

e6/l

0.17

599

Respiratory tuberculosis, not confirmed

226

1.20

0.36

1.6

1.3

30.55

755.82

e6/l

0.88

185

Carcinoma in situ of skin of trunk

190

0.79

0.35

1.2

1.3

5.56

957.99

e6/l

—

160

Atherosclerosis, excluding cerebral and coronary sclerosis

296

2460

0.95

0.35

1.4

1611.96

2255.35

e6/l

0.24

249

2022

Gastrointestinal stromal tumor and sarcoma

0.62

0.35

1.2

1.3

11.80

1709.89

e6/l

—

Benign neoplasm: Bronchus and lung

0.62

0.35

1.2

1.3

7.60

1528.26

e6/l

—

Complications of the puerperium, not elsewhere classified

338

1.16

0.35

1.3

1.5

53.93

12183.08

e6/l

0.59

277

Other corneal oedema

1.37

0.34

1.3

1.2

1.00

192.92

e6/l

—

Other congenital malformations of upper alimentary tract

1.34

0.34

4.0

1.3

1.50

218.36

e6/l

—

Peripheral retinal degeneration

228

1.19

0.33

2.5

1.5

1272.80

675.01

e6/l

0.25

189

Conduction disorders

269

2076

1.05

0.33

1.3

1.6

613.11

2290.37

e6/l

0.90

232

1680

Stenosis and insufficiency of lacrimal passages

663

1.10

0.33

1.7

1.5

6928.85

1144.94

e6/l

0.44

536

Inflammation of lacrimal passages (chronic)

0.67

0.33

1.5

1.3

68473.33

215.53

e6/l

—

Malignant neoplasm of small intestine, including Hilmo

210

1.19

0.33

1.7

1.3

54.75

796.11

e6/l

0.87

180

Ankylosing hyperostosis [Forestier]

1.36

0.32

1.1

1.4

130.40

150.92

e6/l

—

Benign leiomyoma with endometriosis

129

1203

1.07

0.32

1.4

1964.67

1189.79

e6/l

0.24

113

978

Non-ischemic cardiomyopathy

259

1985

1.05

0.32

1.6

1.5

477.10

2659.90

e6/l

1.21

229

1581

Toxic effect of contact with venomous animals

313

1.15

0.32

1.3

1.7

716.39

757.76

e6/l

0.02

250

Coronary atherosclerosis

634

3890

1.03

0.31

1.3

1.5

1198.07

1907.83

e6/l

0.55

533

3115

Congenital malformations of genital organs

862

1.09

0.31

1.4

2.0

202.56

5598.53

e6/l

0.67

682

Delayed puberty

1.35

0.31

1.4

2.8

3807.43

99.21

e6/l

—

Colectomy operation

133

1244

1.07

0.31

1.5

738.21

1387.00

e6/l

0.62

107

1011

Contact with other sharp object(s)

570

1.11

0.31

1.2

1.5

278.00

1382.24

e6/l

1.15

459

Benign lipomatous neoplasm of other sites/unspecified

611

0.90

0.31

1.8

1.4

972.14

1177.35

e6/l

0.11

497

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

174

1643

1.06

0.31

1.4

1.5

687.12

3260.90

e6/l

0.60

144

1343

Other assisted single delivery

147

1.23

0.31

1.1

1.4

691.64

134.39

e6/l

0.36

115

Family history of other specific disorders

0.70

0.31

1.0

1.6

92.86

262.86

e6/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

609

1.10

0.31

1.2

1.4

1092.85

7313.91

e6/l

0.51

491

Benign neoplasm: Skin of eyelid, including canthus

109

1172

0.93

0.31

1.3

1.4

1589.29

1211.32

e6/l

0.13

946

Atrial septal defect, secundum type

271

0.84

0.30

2.0

3.0

33.89

256.16

e6/l

1.90

208

Unstable angina pectoris

313

2366

1.04

0.30

1.4

1.5

948.83

2494.43

e6/l

0.88

269

1904

Heart failure,strict

476

3245

1.04

0.30

1.5

684.76

1526.53

e6/l

2.28

418

2634

Congenital malformations of ovaries, fallopian tubes and broad ligaments

476

1.12

0.30

1.3

1.4

35.67

9001.28

e6/l

0.62

389

Preparatory care for dialysis

315

1.15

0.30

1.5

1.6

453.54

817.82

e6/l

0.27

249

Endometriosis of fallopian tube

1.28

0.30

3.0

1.6

479.29

4491.70

e6/l

—

Granuloma annulare

102

1.28

0.30

1.3

1.2

4.50

99.82

e6/l

—

Congenital malformations of the urinary system

486

1.11

0.30

1.3

2.2

811.44

671.18

e6/l

0.08

382

Other obstetric trauma

462

0.89

0.29

1.3

11.47

9246.63

e6/l

0.61

374

Erectile dysfunction

483

0.89

0.29

1.5

646.97

1093.13

e6/l

0.29

393

Secondary malignant neoplasm of respiratory and digestive organs

110

0.72

0.29

1.3

96.00

1324.33

e6/l

—

Other nutritional anaemias

1.23

0.29

3.1

1.4

92.86

203.87

e6/l

—

Amputation

621

1.10

0.29

2.0

1.4

340.04

983.65

e6/l

1.11

514

Retained placenta and membranes, without haemorrhage

1054

0.93

0.28

1.4

550.73

4695.12

e6/l

0.62

851

Type 1 diabetes, strict (exclude DM2)

102

947

1.08

0.28

1.8

1.9

612.36

4784.88

e6/l

0.55

769

Unspecified lump in breast

133

1250

1.07

0.28

1.3

1.4

336.82

4703.31

e6/l

0.84

108

1009

Type 1 diabetes, definitions combined

102

947

1.08

0.28

1.8

2.0

612.36

4779.55

e6/l

0.55

770

Benign neoplasm: Bones of skull and face

1.32

0.28

1.2

106.30

201.48

e6/l

—

Herpesviral keratitis and keratoconjunctivitis

317

1.14

0.28

1.6

1532.28

742.92

e6/l

0.36

256

Obstructed labour due to malposition and malpresentation of fetus

218

2131

0.95

0.28

1.5

1.4

3518.84

3118.33

e6/l

0.04

171

1728

Vitiligo

1.30

0.28

1.4

1.5

330.18

183.18

e6/l

0.26

Type 1 diabetes, strict definition, subgroup 1

730

0.91

0.28

1.5

2.0

668.32

6091.27

e6/l

0.56

601

Other otitis externa (chronic)

498

1.11

0.28

1.4

1.6

2382.43

1124.59

e6/l

0.27

406

Maternal care for other known or suspected fetal problems

259

1569

1.05

0.28

1.3

1.4

366.62

3303.36

e6/l

0.68

217

1272

Serous carcinoma of ovary, including Hilmo

237

0.84

0.28

1.1

1.4

938.47

618.13

e6/l

0.17

196

Other acute skin changes due to ultraviolet radiation

237

0.84

0.28

2.4

1.5

279.47

908.83

e6/l

0.52

194

Barrett oesophagus

346

1.13

0.27

1.2

1.5

226.38

969.51

e6/l

1.08

275

Abdominal aortic aneurysm (AAA)

518

0.90

0.27

1.5

1.4

151.42

990.36

e6/l

1.96

428

Myocardial infarction, without ST-elevation

310

2718

1.04

0.27

1.3

1.4

436.73

2260.94

e6/l

1.54

259

2231

Crossbite

621

1.09

0.27

3.8

2.3

200.73

669.49

e6/l

1.06

486

Peripheral artery operations in Hilmo

778

1.08

0.26

1.9

1.4

605.37

871.29

e6/l

0.27

645

Primary coxarthrosis, bilateral

221

2113

1.05

0.26

1.4

3988.17

2148.12

e6/l

0.26

178

1737

Benign neoplasm: Conjunctiva

234

1.16

0.26

1.1

1.4

129.95

838.45

e6/l

0.78

189

Deep bite that required surgery

1.27

0.26

1.2

1.3

239.92

144.55

e6/l

0.21

Thoracic aortic aneurysm

1059

0.93

0.26

1.6

1.4

999.78

2969.95

e6/l

0.46

870

Myeloproliferative diseases (CML excluded)

539

1.10

0.26

1.4

1063.04

1393.97

e6/l

0.13

435

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

693

1.08

0.26

1.4

1.3

592.56

839.39

e6/l

0.24

578

Olecranon bursitis

386

1.12

0.26

1.3

1.4

178.50

517.75

e6/l

1.20

319

Pulmonary eosinophilia, not elsewhere classified

1.26

0.26

1.0

1.3

4485.67

1542.86

e6/l

—

Malignant neoplasm of kidney, except renal pelvis

578

1.09

0.25

1.4

1.3

664.52

906.96

e6/l

0.20

484

Calcific aortic valvular stenosis

187

1900

0.95

0.25

1.4

1.5

1714.83

2330.78

e6/l

0.18

157

1557

Calcific aortic valvular stenosis, operated

187

1900

0.95

0.25

1.4

1.5

1714.83

2330.78

e6/l

0.18

157

1557

Congenital malformations of the urinary system

512

1.10

0.24

1.3

2.2

858.58

1152.58

e6/l

0.15

404

therapeutic use

217

1.16

0.24

1.4

1.3

37.15

714.59

e6/l

0.77

180

All-cause Heart Failure

481

3492

0.97

0.24

1.5

803.25

2088.79

e6/l

1.22

424

2832

Non-small cell lung cancer, adenocarcinoma

371

0.89

0.24

1.2

1.3

86.32

606.17

e6/l

1.05

311

L01XE Protein kinase inhibitors

388

1.11

0.24

3.7

1.5

119.58

803.43

e6/l

1.28

309

Right hemicolectomy

379

1.11

0.24

1.4

1.3

227.66

892.04

e6/l

1.00

313

Malignant neoplasm of urinary organs

629

1.08

0.23

1.4

1.3

615.27

871.55

e6/l

0.23

528

Other specified disorders of external ear

254

0.86

0.23

1.8

1.4

253.12

496.31

e6/l

0.29

213

Familial hypercholesterolemia, with ischemic heart disease

591

1.08

0.23

1.5

1.4

1717.55

711.96

e6/l

0.27

469

Contact with machinery

878

0.93

0.23

1.3

1.5

96.86

806.18

e6/l

2.39

706

Other infective otitis externa

466

1.10

0.23

1.2

1.5

107.63

1167.27

e6/l

1.14

379

572

1.09

0.23

1.3

1.4

611.20

718.04

e6/l

0.09

469

162

1.18

0.23

1.3

1.8

651.50

144.52

e6/l

0.35

126

Use of entacapone

1.29

0.23

1.8

1.3

24.20

208.88

e6/l

—

Operations 2 for CAVS

187

1893

0.96

0.23

1.4

1714.83

2339.47

e6/l

0.19

157

1551

Calcific aortic valvular stenosis, diagnosis (helper)

187

1893

0.96

0.23

1.4

1714.83

2339.47

e6/l

0.19

157

1551

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

621

1.08

0.22

1.2

1.4

1092.85

2246.84

e6/l

0.36

515

Calcific aortic valvular stenosis, including rheumatic fever

188

1900

0.96

0.22

1.4

1727.27

2331.02

e6/l

0.18

158

1557

132

1178

1.05

0.22

1.5

1.4

745.53

890.73

e6/l

0.18

109

972

Congenital aortic valve stenosis

1.23

0.22

1.0

4.3

126.00

332.71

e6/l

—

Pyogenic granuloma

116

1.21

0.22

1.4

934.07

1068.86

e6/l

0.04

Pemphigus

1.22

0.22

1.6

1.2

160.60

165.87

e6/l

—

Ascorbic acid deficiency

0.00

0.22

0.0

3.0

—

657.00

—

Infections of breast associated with childbirth

305

1.12

0.22

1.2

1.5

229.56

13154.38

e6/l

0.56

250

Transepidermal elimination disorders

0.00

0.21

0.0

1.3

—

185.18

—

Calcium deposit in bursa

0.00

0.21

0.0

2.0

—

257.70

—

Other retinal disorders in diseases classified elsewhere

0.00

0.21

0.0

1.3

—

194.30

—

Open bite

478

1.09

0.21

1.7

2.4

304.69

8672.35

e6/l

0.56

386

Eustachian salpingitis and obstruction

681

1.07

0.21

1.5

292.86

2250.11

e6/l

1.19

557

Hirsprung

0.00

0.21

0.0

4.8

—

543.50

—

Aortic valve malfunction, age under 60 years

792

0.93

0.21

1.7

1.8

3426.95

1316.18

e6/l

0.51

633

Alport

0.00

0.21

0.0

4.4

—

403.17

—

Ulcerative colitis (strict definition, require KELA)

158

1510

1.05

0.21

1.3

1.5

746.14

3380.43

e6/l

0.55

132

1230

Clear cell adenocarcinoma of kidney

315

1.11

0.21

1.5

1.4

883.16

1035.24

e6/l

0.07

267

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.2

—

812.46

—

Distal bite

352

1.10

0.20

3.4

2.8

92.48

149.90

e6/l

0.34

281

Exfoliative dermatitis

1.25

0.20

1.5

1.3

10.00

174.17

e6/l

—

Pleural plaque

573

0.92

0.20

1.3

1.4

255.53

893.76

e6/l

1.42

472

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

403

1.09

0.20

1.4

301.16

913.22

e6/l

0.96

324

Osteitis due to dental implant

1.20

0.20

1.5

1.3

1808.17

173.57

e6/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.20

0.20

1.0

1.2

0.50

255.58

e6/l

—

Pleural effusion

109

1035

1.05

0.19

1.5

1.4

361.92

915.62

e6/l

1.52

846

Dermatitis due to ingested food

350

1.10

0.19

1.8

3.0

281.67

11366.56

e6/l

0.51

271

Other deformity of hallux (acquired)

1.18

0.19

2.0

1.4

63.67

126.71

e6/l

—

Benign neoplasm: Rectosigmoid junction

279

1.11

0.19

1.4

194.84

646.89

e6/l

0.57

226

Other chronic obstructive pulmonary disease

342

2897

0.97

0.19

1.5

1.4

1800.25

2163.20

e6/l

0.14

275

2393

Congenital malformations of eye, ear, face and neck

588

1.07

0.19

1.4

2.3

1162.16

7901.26

e6/l

0.53

466

Duodenal ulcer

676

1.07

0.18

1.2

1.5

813.95

1080.51

e6/l

0.15

557

Basal cell carcinoma

383

2583

1.03

0.18

1.4

6485.98

1495.15

e6/l

0.42

307

2141

Scar conditions and fibrosis of skin

309

1.10

0.18

1.7

1.6

238.54

1091.25

e6/l

0.96

253

Pustulosis palmaris et plantaris

321

0.90

0.18

1.3

1.4

643.00

1731.48

e6/l

0.50

258

Other hammer toe(s) (acquired)

130

1147

1.05

0.18

1.4

1838.16

960.16

e6/l

0.29

103

926

Pyothorax

279

0.89

0.18

1.9

1.4

5738.12

829.66

e6/l

0.99

229

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

672

0.94

0.18

1.4

950.72

1462.81

e6/l

0.29

548

Mandibular retrognathia AND surgery (BSSO)

195

0.87

0.17

1.2

1.6

158.94

1047.39

e6/l

0.73

160

malignant neoplasm of female genital organs

104

1085

0.95

0.17

1.3

1.4

412.07

1507.54

e6/l

2.33

900

Primary gonarthrosis, bilateral

450

3768

1.02

0.17

1.4

829.05

2362.46

e6/l

1.49

370

3081

ILD, hospital admissions 1, main diag only

922

1.05

0.17

1.2

1.4

111.28

994.59

e6/l

3.61

749

Mixed hyperlipidaemia

262

1.11

0.17

1.6

1.4

783.68

900.26

e6/l

0.06

217

Benign neoplasm: Appendix

1.13

0.17

1.7

1.4

294.29

190.74

e6/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

886

0.95

0.17

1.6

1.9

2987.89

1221.38

e6/l

0.49

702

Carcinoma in situ of skin

537

0.93

0.17

1.6

1.4

1717.00

863.28

e6/l

0.39

437

Poor fetal growth

123

1178

1.05

0.17

1.2

1.4

620.18

4383.53

e6/l

0.64

108

967

Pedal cyclist injured in collision with motor vehicle

234

1.11

0.16

1.3

369.41

891.48

e6/l

0.41

187

Nephrotic syndrome

244

1.11

0.16

1.8

2.0

89267.00

621.67

e6/l

0.49

192

Left bundle-branch block

515

0.93

0.16

1.5

227.38

877.62

e6/l

1.44

414

Cystic kidney disease

256

0.90

0.16

1.3

1.8

1778.18

887.44

e6/l

0.25

204

Malignant neoplasm of ovary

339

0.91

0.16

1.1

1.4

661.91

1901.30

e6/l

0.68

281

Heart failure, strict

493

3545

0.98

0.16

1.5

798.00

2103.91

e6/l

1.28

435

2872

Other congenital malformations of female genitalia

1.10

0.16

1.4

1.5

781.50

56.61

e6/l

—

Benign neoplasm: Larynx

203

0.89

0.15

1.7

1.5

2815.00

686.78

e6/l

0.65

167

Acquired absence of organs, not elsewhere classified

1.13

0.15

1.7

1.4

1425.78

166.39

e6/l

—

Inflammatory disease of cervix uteri

449

1.07

0.15

1.3

1.4

903.80

1311.61

e6/l

0.23

363

Glaucoma-related operations

352

1.08

0.14

1.3

60.00

823.32

e6/l

1.39

291

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

733

1.05

0.14

1.2

1.4

992.72

6175.33

e6/l

0.51

588

Other noninflammatory disorders of cervix uteri

347

0.92

0.14

1.1

1.4

2313.30

1991.81

e6/l

0.05

283

Other malignant neoplasms of skin (=non-melanoma skin cancer)

397

2667

1.02

0.14

1.4

6369.75

1471.80

e6/l

0.42

314

2207

Acute appendicitis, with complications

156

1611

0.97

0.14

1.4

265.25

3515.15

e6/l

0.81

122

1302

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

726

0.95

0.14

1.4

135.39

1346.87

e6/l

2.24

581

Cardiomyopathy

144

1392

1.03

0.14

1.5

786.83

2807.02

e6/l

0.65

115

1110

Cardiomyopathy, other and unspecified

587

1.06

0.14

1.4

1.5

1255.22

596.96

e6/l

0.26

481

Malignant cancer of tonsil and base of tongue, including Hilmo

170

1.12

0.13

1.3

131.25

794.35

e6/l

0.52

139

Failed induction of labour

551

0.94

0.13

1.4

1.3

31.41

7684.15

e6/l

0.60

445

Deficiency of other B group vitamins

132

1.14

0.13

1.5

1.6

3830.50

137.35

e6/l

—

110

Polycystic kidney disease

180

1.11

0.13

1.3

1.9

1771.67

718.31

e6/l

0.27

144

Foreign body or object entering through skin

511

1.06

0.12

2.0

1.5

261.21

845.17

e6/l

0.76

409

HSIL lesion of the cervix uteri, vagina or vulva

195

1900

1.03

0.12

1.2

1.4

640.33

3323.90

e6/l

0.76

156

1556

Benign neoplasm: Skin of upper limb, including shoulder

137

0.87

0.12

1.2

1.3

3.86

927.80

e6/l

—

109

Ethmoidectomy

108

1118

0.97

0.12

1.4

1.5

5515.28

4536.81

e6/l

0.06

905

Struck by thrown, projected or falling objec

405

1.06

0.11

1.4

1.6

13.74

1025.02

e6/l

1.35

324

Lesion of plantar nerve

415

1.06

0.11

1.3

1.4

287.65

1608.70

e6/l

1.10

331

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

151

1468

1.03

0.11

1.3

1.5

778.06

3470.23

e6/l

0.54

126

1193

Other secondary gonarthrosis

386

1.06

0.11

1.4

1441.16

695.71

e6/l

0.27

304

Macular hole

377

1.06

0.11

1.5

1.3

854.11

904.20

e6/l

0.02

305

IgA nephropathy (IgA glomerulonephritis)

167

0.90

0.10

1.3

743.56

760.38

e6/l

—

139

Delivery, wide proxy

323

1685

1.02

0.10

1.4

1122.91

3435.66

e6/l

0.49

266

1364

Malignant neoplasm of tongue, including Hilmo

183

1.09

0.10

1.2

1.4

2497.38

764.97

e6/l

0.33

156

Prurigo nodularis

154

1.11

0.10

2.1

1.2

28.25

895.28

e6/l

0.68

128

Malignant neoplasm of tongue

135

1.11

0.09

1.1

1.3

3244.60

960.78

e6/l

—

117

Cardiovascular disorders originating in the perinatal period

1.04

0.09

2.0

6.1

17597.80

924.94

e6/l

—

Major coronary heart disease event excluding revascularizations

565

3720

1.01

0.09

1.3

1.5

656.27

1995.26

e6/l

1.39

482

2974

Motorcycle rider injured in other and unspecified transport accidents

468

1.05

0.09

1.2

1.6

702.20

920.40

e6/l

0.12

362

Glaucoma, exfoliation

614

0.96

0.09

1.5

1.3

686.27

735.71

e6/l

0.05

510

Heart failure and bmi 25plus

261

1732

1.02

0.09

1.4

683.04

2820.12

e6/l

1.01

227

1409

Other specified/unspecified nutritional deficiencies

1.09

0.09

1.2

1.3

22.00

200.67

e6/l

—

Crowding of teeth, including avohilmo

754

1.03

0.08

3.0

2.1

18.03

5562.17

e6/l

0.58

602

Pityriasis rosea

1.05

0.08

1.0

1.5

14.33

269.20

e6/l

—

Trichomoniasis

0.83

0.08

1.2

21977.80

79.14

e6/l

—

Polycythaemia vera

226

0.93

0.08

1.2

1.3

97.36

736.06

e6/l

0.78

194

Contusion of other and unspecified parts of foot

430

1.05

0.08

1.6

1.8

60.03

10229.81

e6/l

0.64

351

Oesophageal varices

287

0.94

0.08

1.3

1.7

49.25

838.19

e6/l

1.06

230

Basal cell carcinoma, including avohilmo

396

2694

1.01

0.08

1.4

6311.46

1462.32

e6/l

0.42

315

2228

Other appendicitis

667

1.04

0.08

1.4

1018.35

1416.36

e6/l

0.26

545

Delivery

399

2079

1.01

0.08

1.4

1476.40

2900.28

e6/l

0.33

325

1661

HSIL lesion of the cervix uteri

174

1773

0.98

0.07

1.2

1.4

689.03

3484.10

e6/l

0.73

141

1460

Benign neoplasm: Short bones of lower limb

0.84

0.07

1.7

1.2

3.00

1641.95

e6/l

—

Congenital ovarian cysts

372

1.05

0.07

1.3

1.4

3.08

1682.96

e6/l

1.48

306

Golimumab

276

0.94

0.07

1.2

1.7

507.61

1365.31

e6/l

0.49

225

Tooth agenesis EXCLUDE clefts and syndromes

323

1.05

0.07

2.7

2.5

684.85

638.35

e6/l

0.03

260

Deep bite

109

933

1.02

0.07

2.5

2.0

513.10

4996.31

e6/l

0.59

751

Benign neoplasm: Skin of lip

0.84

0.07

1.4

1.3

2.00

1546.25

e6/l

—

Leiomyoma of uterus

621

3549

0.99

0.07

1.4

1657.96

2598.35

e6/l

0.36

510

2880

Malignant neoplasm of other and ill-defined sites, including Hilmo

0.89

0.07

4.8

1.3

7.63

261.18

e6/l

—

Other benign neoplasms of skin

315

3187

0.99

0.06

1.3

1.5

1293.64

3010.24

e6/l

0.65

257

2612

Cholangitis (primary sclerosing, PSC), with reimbursement 202

138

1.09

0.06

1.3

2.1

27.50

213.81

e6/l

—

109

Benign neoplasm of thyroid gland

244

0.94

0.06

1.4

1.6

448.43

920.94

e6/l

0.40

198

Ulcerative ileocolitis

305

1.05

0.06

1.1

1.5

49.81

2226.08

e6/l

1.39

247

Nontoxic single thyroid nodule

532

1.03

0.06

1.4

1.5

1016.52

1311.07

e6/l

0.16

420

Graves ophthalmopathy, strict

168

1.07

0.06

1.4

1.5

624.50

167.38

e6/l

0.34

136

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

751

1.03

0.06

1.2

1.4

992.72

1942.19

e6/l

0.35

616

FESS (DNB20)

106

1081

0.98

0.05

1.3

1.5

5633.66

4705.88

e6/l

0.05

871

Embolic stroke with flimmer

139

1.08

0.05

1.4

2180.70

1172.45

e6/l

—

116

Malignant cancer of tonsil and base of tongue

149

1.08

0.05

1.3

151.00

872.45

e6/l

—

124

COPD

364

3002

0.99

0.05

1.5

1.4

2177.73

2111.88

e6/l

0.02

289

2481

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

425

2859

1.01

0.05

1.4

5975.73

1616.30

e6/l

0.40

337

2366

Benign neoplasm: Skin of other and unspecified parts of face

763

1.02

0.05

1.4

819.35

1241.92

e6/l

0.32

619

Cholangitis (primary sclerosing, PSC)

426

1.03

0.05

1.2

1.8

602.50

641.90

e6/l

0.02

350

All dysplastic lesions of the vagina

211

0.95

0.04

1.3

1.5

241.57

378.37

e6/l

0.19

176

Ulcerative rectosigmoiditis

685

1.02

0.04

1.3

1.5

624.39

1278.59

e6/l

0.45

556

Long labour

246

2125

0.99

0.04

1.5

1.3

330.20

3047.54

e6/l

0.92

191

1722

Single spontaneous delivery

389

2075

0.99

0.04

1.3

1.4

1564.01

2907.28

e6/l

0.31

316

1657

Suppurative and necrotic conditions of lower respiratory tract

368

1.03

0.04

2.8

1.5

3767.54

1251.14

e6/l

0.68

302

Benign neoplasm: Tongue

190

0.95

0.04

1.4

1.5

2508.33

768.34

e6/l

0.30

152

Cystic kidney disease

230

0.96

0.03

1.3

1.9

1661.19

966.38

e6/l

0.18

182

Ascites

478

1.03

0.03

1.7

1.5

306.39

1196.00

e6/l

1.39

386

Other disorders of cornea

733

0.98

0.03

1.6

1.5

1314.20

1081.22

e6/l

0.09

587

Pathological resorption of teeth

270

0.96

0.03

1.3

1.6

115.75

809.07

e6/l

0.80

218

Twin gestation

803

0.98

0.03

1.7

1.4

212.66

5270.16

e6/l

0.57

651

COPD, hospital admission 2, with asthma infections

242

2058

1.01

0.03

1.5

1.4

1061.42

2529.13

e6/l

0.70

192

1686

Pacemaker

233

2215

1.01

0.03

1.4

1.5

1418.29

2167.21

e6/l

0.28

205

1816

Supervision of normal pregnancy

227

1286

1.01

0.03

1.5

1.3

134.34

4211.18

e6/l

0.79

174

1021

Ulcerative enterocolitis

221

1.04

0.03

1.0

1.6

69.83

938.31

e6/l

0.87

182

Varicose veins

574

4316

1.00

0.02

1.5

1.4

1945.99

1983.89

e6/l

0.02

487

3521

Rubella [German measles]

251

1.04

0.02

1.8

1.3

1027.17

1469.03

e6/l

0.15

209

Malignant neoplasm of head and neck

540

0.98

0.02

1.4

1120.66

744.58

e6/l

0.20

450

Malignant neoplasm of bladder

369

0.97

0.02

1.4

1299.29

910.69

e6/l

0.16

309

Fibrosis and cirrhosis of liver

540

0.98

0.02

1.6

1.5

631.30

1366.25

e6/l

0.57

441

Benign neoplasm: Long bones of lower limb

238

0.97

0.02

1.5

1.4

858.56

880.43

e6/l

0.01

191

Multiple gestation

830

0.99

0.02

1.8

1.4

203.03

5085.68

e6/l

0.58

675

Cardiac arrest

326

1.02

0.02

1.2

1.4

72.87

1128.84

e6/l

1.55

257

Other abnormal uterine and vaginal bleeding

202

1438

1.01

0.01

1.3

1.4

1353.40

1740.41

e6/l

0.14

159

1189

Cirrhosis of liver, NAS

372

1.02

0.01

1.7

1.4

169.75

810.44

e6/l

1.06

299

COPD, hospital admissions 3, with asthma pneumonia sepsis

193

1639

1.01

0.01

1.6

1.4

696.38

2518.29

e6/l

0.76

153

1343

Malignant neoplasm of ovary, including Hilmo

458

0.98

0.01

1.2

1.4

449.34

1806.99

e6/l

1.21

376

Isolated proteinuria

203

1.04

0.01

1.3

1.5

120492.67

666.66

e6/l

0.50

166

Artificial joint operation, meniscal resection

944

6116

1.00

0.01

1.4

1090.01

2598.54

e6/l

1.27

763

4990

Other other unspecified disorders of the circulatory system

263

1.03

0.01

1.3

1.7

2408.43

897.50

e6/l

0.27

210

Noise effects on inner ear

277

0.97

0.01

1.4

218.00

1468.72

e6/l

1.03

222

Postmenopausal atrophic vaginitis

233

1291

1.00

0.01

1.4

880.56

1992.56

e6/l

0.71

185

1066

Amputation of toe

467

0.98

0.01

2.2

1.4

179.97

821.54

e6/l

1.35

382

Oral lichen planus, including avohilmo , including avohilmo

503

1.01

0.01

1.3

1.4

114.94

1557.75

e6/l

1.73

406

Peripheral artery disease

335

2673

1.00

0.01

1.6

1.4

1489.17

2175.24

e6/l

0.29

281

2195

Carcinoma in situ of skin of lower limb, including hip

124

1.05

0.00

1.2

1.3

28.86

1109.85

e6/l

—

101

COPD related to multimorbidity

304

2560

1.00

0.00

1.5

1.4

2024.53

2384.05

e6/l

0.12

246

2108

Valvular heart disease excluding rheumatic fever

441

3189

1.00

0.00

1.5

1.6

2445.46

3077.33

e6/l

0.14

378

2577

Non-allergic asthma

703

1.01

0.00

1.2

2.1

3063.67

1348.28

e6/l

0.39

577

L01XX Other antineoplastic agents

384

1.02

0.00

1.3

1873.75

742.93

e6/l

0.39

310

Lung cancer and mesothelioma

125

1069

1.00

0.00

1.3

1.4

20560.14

1552.22

e6/l

0.46

883

Carcinoma in situ of cervix uteri

842

1.00

0.00

1.2

1.3

79.61

5303.85

e6/l

0.64

686

Embedded teeth, including avohilmo

872

1.00

0.00

1.8

1.6

78.35

5301.24

e6/l

0.67

711

Chronic suppurative otitis media, including avohilmo

632

1.00

0.00

1.4

2.0

3823.12

787.58

e6/l

0.56

515

Benign neoplasm of middle ear and respiratory system

569

1.00

0.00

1.6

1.5

12930.52

922.20

e6/l

0.55

464

Complications of cardiac and vascular prosthetic devices, implants and grafts

135

1.04

0.00

1.4

1.5

9438.64

1096.34

e6/l

0.40

114

Neonatal jaundice from other and unspecified causes

179

1.03

0.00

6.7

5.0

439.31

958.81

e6/l

0.32

129

Localized scleroderma [morphea]

104

0.96

0.00

1.2

1.3

987.70

177.06

e6/l

—

Impacted cerumen

723

1.00

0.00

1.8

1.7

880.75

702.16

e6/l

0.13

588

Graves ophthalmopathy

184

0.98

0.00

1.4

1.5

624.50

159.64

e6/l

0.34

147

Pericarditis

254

0.98

0.00

1.1

1.7

1318.30

521.05

e6/l

0.39

206

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

281

0.99

0.00

1.0

3.3

123.22

533.14

e6/l

0.77

215

Other noninflammatory disorders of uterus, except cervix

183

1234

1.00

0.00

1.6

1.4

1149.06

1950.95

e6/l

0.42

155

1025

Thyroiditis, unspecified

111

0.99

0.00

1.3

1.9

466.18

290.50

e6/l

0.15

Ulcerative proctitis

518

1.00

0.00

1.2

1.4

348.16

1421.76

e6/l

1.02

425

Maternal care for known or suspected disproportion

352

0.99

0.00

1.5

1.4

17448.17

695.58

e6/l

0.46

286

Non-rheumatic valve diseases

436

3147

1.00

0.00

1.5

1.6

2475.16

3112.00

e6/l

0.14

373

2542

Later onset COPD, excluding more controls

130

1007

1.00

0.00

1.3

1.4

2139.34

1398.04

e6/l

0.19

102

842

Disorders of lacrimal system and orbit in diseases classified elsewhere

181

0.99

0.00

1.4

1.6

624.50

165.03

e6/l

0.34

144

Carcinoma in situ of other and unspecified digestive organs

233

0.99

0.00

1.6

1.3

453.00

782.92

e6/l

0.27

189

Benign neoplasm: Skin of trunk

303

0.99

0.00

1.2

1.5

154.22

787.69

e6/l

0.83

245

Chronic suppurative otitis media

534

0.99

0.00

1.5

1.8

1343.44

915.76

e6/l

0.23

434

Malignant neoplasm of oral cavity

231

1.00

0.00

1.1

1.5

1967.65

988.07

e6/l

0.23

197

Respiratory and cardiovascular disorders specific to the perinatal period

258

1.00

0.00

5.5

4.0

156.71

226.07

e6/l

0.22

190

Other congenital malformations of limb(s)

1.01

0.00

1.5

2.7

67.50

103.83

e6/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

2.7

—

37.14

—

Chondrolysis

0.00

-0.00

0.0

1.0

—

793.67

—

Deficiency of other/unspecified nutrient elements

0.00

-0.00

0.0

1.2

—

6.60

—

Choroidal degeneration

0.00

-0.00

0.0

1.2

—

309.17

—

Actinic reticuloid

0.00

-0.00

0.0

1.3

—

11.83

—

Lipid storage disorder, other/unspecified

0.00

-0.00

0.0

1.6

—

10.00

—

Myxoedema coma

0.00

-0.00

0.0

1.2

—

776.00

—

Other and unspecified disorders of pigmentation

0.94

-0.00

1.4

1.1

100.00

187.39

e6/l

—

Myelofibrosis

0.00

-0.00

0.0

1.4

—

14.00

—

Acquired keratosis follicularis

0.00

-0.00

0.0

1.1

—

11.29

—

Other benign neoplasm of uterus: Cervix uteri

1.00

-0.00

1.2

33.60

87.67

e6/l

—

Placental disorders

0.96

-0.00

1.1

1.5

20.43

27.46

e6/l

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.2

—

127.80

—

Traumatic amputation of forearm

0.00

-0.00

0.0

1.4

—

13.57

—

Other birth injuries

0.00

-0.00

0.0

1.2

—

983.50

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.2

—

374.60

—

Benign neoplasm: Oesophagus

0.94

-0.00

1.1

1.5

8.00

1427.04

e6/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.2

—

9.00

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

-0.00

0.0

1.1

—

273.14

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythrocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS